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Characterisation of HP1γ in mammalian cells 
Meike Wiese 
The degree of chromatin compaction plays a fundamental role in controlling the accessibility 
of DNA to the transcription machinery as well as other DNA-dependent biological pathways. 
The mammalian HP1 (Heterochromatin protein 1) protein family consists of three members: 
HP1α, β and γ. Each paralogue regulates formation and maintenance of heterochromatin by 
binding to the repressive chromatin marks H3K9me2/3 with their chromodomains (CDs). 
Despite high sequence conservation, each HP1 paralogue possess specific functions, which 
are likely to be cell type specific. The aim of my thesis was to find novel functions for HP1γ 
in mouse embryonic stem cells (mESCs) and breast cancer cells. 
Mass spectrometry analysis identified citrullination of residues R38 and R39 within the CD of 
HP1γ. I show that these residues are citrullinated by peptidyl arginine deiminase 4 (PADI4) in 
vitro and in vivo. Mutations in HP1γ (R38/9A), designed to mimic the loss of charge 
accompanied with citrullination, affect HP1γ’s binding to H3K9me3 peptides and reduce its 
residence time on chromatin in differentiated mESCs, indicating a role for citrullination in 
regulating HP1γ binding to chromatin during differentiation.  
Furthermore, I studied the phenotype of HP1γ depletion in two human breast cancer models 
and found that HP1γ is essential for cell proliferation and viability of cancer, but not of 
normal epithelial cells. I performed whole transcriptome analysis in breast cancer cells 
depleted of HP1γ and cross-referenced it with its genomic localisation, which identified 
increased expression of interferon/antiviral defense genes and activation of pro-apoptotic 
pathways. Whilst genes involved in these pathways were not directly bound by HP1γ, this 
analysis also identified HP1γ as a novel regulator of zinc finger (ZNF) genes. 
In summary, I identified novel post-translational modifications in HP1γ and characterised 
them in mESCs. I further demonstrated a role for HP1γ regulating breast cancer cell viability 
and identified HP1γ as a novel regulator of ZNF genes. My findings highlight HP1γ as a 
potential target for breast cancer therapy. 
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  Chapter 1
Introduction 
 
1.1. Chromatin 
1.1.1. A brief history of chromatin 
Circa 1840, nuclear components of eukaryotic cells were visualised for the first time using 
basophilic aniline dyes. Decades later, Walther Flemming named this stainable material 
within eukaryotic nuclei ‘chromatin’1. We now know that chromatin is a macromolecular 
complex of DNA and histone proteins, which provides the packaging scaffold for the entire 
genome of eukaryotic cells. Given the limited technology of the late 19th century, Flemming 
and others made incredible observations simply through staining biological material studied 
by light microscopy. In the early 20th century, Theodor Boveri noted that chromatin condenses 
into chromosomes during mitosis and decondenses into less defined structures after cell 
division2. About 20 years later, Emil Heitz named these differentially stained regions 
corresponding to condensed and decondensed chromatin in plant cell nuclei ‘heterochromatin’ 
and ‘euchromatin’ and proposed the revolutionary idea that euchromatin exclusively contains 
active and heterochromatin repressed genes3. Although this model is not entirely accurate 
anymore, these scientific contributions lined the path for major discoveries in chromatin 
biology.  
First indications for the repressive properties of heterochromatin originated from work by 
Hermann Mueller in 1930, who observed that X-ray-irradiated Drosophila mutants showed 
variegated (mosaic) expression of the white gene in the eyes, evidenced by changes in eye 
color in a subset of cells. This effect was later directly related to the translocation of the white 
gene from its normal euchromatic location into the vicinity of pericentric heterochromatin and 
was termed position effect variegation (PEV). PEV represented the first link between 
chromatin state and expression of a gene. 
 2 
The following decades were largely devoted to identifying nuclear components encoding the 
genetic information. Research was greatly determined by the realisation of DNA as the 
genetic material by Avery, MacLeod and MacCarty4, the decoding of the molecular structure 
of DNA by Watson and Crick5, and the discovery of mRNA and the principle of transcription 
by Jacob and Monod6.  
With the discovery of the nucleosome - the basic building block of chromatin - in the 1970s, a 
new era in the field of transcription arose7-10. It became increasingly evident that gene 
expression is strongly impacted by the chromatin structure. 
1.1.2. A definition of epigenetics 
The term ‘epigenetics’ was originally proposed by Conrad Waddington in the 1950s to 
describe heritable changes in a cellular phenotype that were independent of alterations in the 
DNA sequence11. However, despite decades of research, a consensus definition of epigenetics 
remains controversial. Most commonly, epigenetics is used to describe chromatin-based 
events that regulate DNA-templated processes. An epigenetic phenotype is most likely 
triggered by a change in the environment of a cell. Environmental cues can then initiate 
signaling cascades that lead to the activation of factors that are capable of determining the 
precise chromatin location and/or DNA location such as DNA-binding proteins, noncoding 
RNAs or other factors, which then establish an epigenetic pathway12. To maintain an 
epigenetic state over succeeding generations these pathways involve the recruitment of 
chromatin modifying enzymes or histone variants, resulting in nucleosome repositioning, 
gene expression changes or changes in higher order chromatin structure. 
1.1.3. The nucleosome 
The basic functional unit of chromatin is the nucleosome, which consists of 147 bp of DNA 
wrapped around a histone octamer containing two copies of histones H2A, H2B, H3 and H413-
16. Nucleosome units are further compacted into larger 30nm chromatin fiber, at least in vitro, 
by incorporating the linker histone H1 and other architectural chromatin proteins. The exact 
mechanisms of chromatin architecture beyond the 30nm fiber are less well known. However, 
it is clear that condensation and decondensation of higher order chromatin structures is a 
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highly regulated process that controls key DNA based processes including transcription, DNA 
repair and replication16.  
The first X-ray crystal structure of the nucleosome confirmed that the interaction of DNA 
with histones occurs primarily with the phosphodiester backbone on the inner surface of the 
DNA superhelix. The interaction is multifaceted and consists of electrostatic and hydrogen 
bonds with the DNA phosphates and non-polar interactions with the deoxyribose groups13. 
Contact between DNA and histone proteins is made every 10 base pairs where the minor 
groove faces inwards13. As DNA bases are not in direct contact with histones, DNA 
packaging by histones is not directly dependent upon the DNA sequence, although it can 
affect where nucleosomes are positioned (see below). The histone octamer structure contains 
a highly structured globular domain, an unstructured flexible amino-terminal and carboxy-
terminal tail for each of the core histones. Histones tails extend from the nucleosome and can 
contact DNA and histones of adjacent nucleosomes. All components of the nucleosome are 
subject to a plethora of covalent modifications, which profoundly impact the organisation and 
function of these basic modules of chromatin17.   
1.1.4. Nucleosome positioning and remodeling 
Nucleosomes need to retain a certain degree of flexibility to allow DNA based processes to 
occur. Homeostatic histone concentrations ensure that only ~75-90% of the DNA is wrapped 
in nucleosomes with consecutive nucleosomes classically separated by ~20-50 bp of 
unwrapped ‘linker’ DNA. This limiting number of nucleosomes creates competition among 
different regions of the genomic DNA18. Nucleosomal DNA is much less accessible to 
proteins than linker DNA, hence nucleosome positioning strongly influences the ability of 
proteins to bind target sequences within DNA. Several different factors can influence 
nucleosome positioning in vivo such as the DNA sequence preference of nucleosomes 
themselves, DNA methylation, histone variants and covalent modifications of either DNA or 
histones18.  
DNA sequence preference is not mediated through direct interaction between DNA base pairs 
and the histones, but rather results from sequence-dependent mechanics of the wrapped DNA. 
The almost circular wrapping of nucleosomal DNA requires a sharp bending every 10bp and 
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specific dinucleotide or longer DNA motifs facilitate this conformation19. Also modifications 
on DNA such as cytosine methylation can influence nucleosome positioning by decreasing 
DNA flexibility20. Genomic regions that are critical for transcriptional regulation including 
promoters and transcription factor (TF) binding sites are usually nucleosome free.  
Nucleosome dynamics can be significantly influenced by chromatin remodeling complexes, 
histone chaperones and post-translational modifications of histones. Histone chaperones were 
initially characterised as passive mediators that import newly synthesised histones to be 
incorporated into newly replicated DNA during S phase of the cell cycle21. It is now clear that 
these factors are not passive chaperones, but rather play an active role in the assembly and 
disassembly of nucleosomes during transcription21.  
Chromatin remodelers play an essential role in DNA based processes. The majority of them 
catalyse the sliding of nucleosomes along DNA in an ATP dependent manner resulting in 
nucleosome repositioning, sliding, ejection or editing22. Chromatin remodelers and indeed 
many of the proteins that function on the chromatin interface are recruited, at least in part, by 
specific interactions with covalent modifications on nucleosomes.  
1.1.5. Covalent modifications of the nucleosome 
1.1.5.1. DNA methylation 
The most abundant and one of the best-characterised epigenetic marks is DNA methylation of 
carbon 5 of cytosine (5mC), which occurs almost exclusively in CpG dinucleotides. DNA 
methylation is a key regulator of embryonic development and genomic imprinting, genome 
stability and chromatin structure in mammals. 5mC is primarily detected within centromeres, 
pericentromeres, telomeres, the inactive X chromosome and repetitive genomic regions and 
plays a crucial role in heterochromatin formation and transcriptional repression at these 
genomic loci23-25. Areas of high CpG density are called CpG islands, which colocalise with 
approximately 60-70% of all promoters annotated in the human genome. Methylation of CpG 
islands plays a fundamental role in transcriptional regulation. CpG islands at most active 
genes in normal cells tend not to be methylated and this process is commonly deregulated 
during malignant transformation26. Furthermore, loss of normal imprinting due to aberrant 
DNA methylation contributes to several inherited diseases in humans25.  
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In higher eukaryotes three DNA methyltransferases (DNMT) have been identified27. DNMT1 
is a maintenance methyltransferase that mainly functions after DNA replication to copy the 
methylation pattern of the parental strand28. Conversely, DNMT3a and DNMT3b, function 
predominantly as de novo methyltransferases to establish DNA methylation during 
embryogenesis29.  
DNA methylation was generally considered to be a relatively stable chromatin modification. 
Conversely, studies assessing the global distribution of this modification during 
embryogenesis had identified a global loss of DNA methylation in the male pronucleus of the 
early zygote, suggesting the existence of an enzymatic activity within mammalian cells that 
either removes or alters methylated DNA30. The identification of 5-hydroxymethylcytosine 
(5hmC) presented first insights into the metabolism of 5mC31. It is well established now that 
the TET 1–3 (ten-eleven translocation 1-3) family of proteins are mammalian DNA 
hydroxylases responsible for converting 5mC to 5hmC32. 5hmC plays an important role in 
transcriptional regulation and TET proteins are crucial for diverse biological processes, 
including zygotic epigenetic reprogramming, pluripotent stem cell differentiation and 
hematopoiesis32. Iterative oxidation of 5hmC mediated by TET proteins can result in further 
oxidation derivatives, including 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), which 
can be followed by replication-dependent dilution or thymine DNA glycosylase (TDG)-
dependent base excision repair to integrate an unmodified cytosine.  
DNA methylation provides a platform for several methyl-binding proteins, which function to 
recruit other chromatin modifying enzymes regulating changes in chromatin structure, 
including histone deacetylation, methylation, and local chromatin compaction23,33,34. Most of 
these effects are mediated by one of two families of methylated CpG DNA binding proteins, 
containing the MBD family (MeCP2 and MBD1–4) and the BTB/POZ family (Kaiso and 
ZBTB4/38). For example, MeCP2 interacts with histone methyltransferases SUV39H1/2, 
which methylate histone H3K935. Like DNA methylation, trimethylation of H3K9 
(H3K9me3) is generally associated with transcriptionally repressed gene regulatory elements 
and heterochromatic regions (see Section 1.1.8.5). Indeed, MeCP2 and H3K9me3 appear 
concentrated at pericentromeric regions of heterochromatin in immunofluorescence studies of 
mammalian nuclei34. Conversely, H3K9 methylation can also promote DNA methylation at 
pericentric heterochromatic regions. In these regions DNMT3a/b can be recruited by the 
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H3K9me3 binding protein HP1 (heterochromatin protein 1) resulting in increased DNA 
methylation within heterochromatic regions36,37. The interplay of H3K9 methylation and 
DNA methylation provides one of the best examples for cross-talk between histone and DNA 
modifications. 
1.1.5.2. Histone modifications 
In 1964, Vincent Allfrey was the first to hypothesise that histone modifications might have a 
functional influence on transcription38. Ever since, numerous post-translational modifications 
of histones have been identified and it has been the focus of intense study over the past two 
decades to unravel their roles, not only in transcription, but in all DNA based processes39. 
Generally histone modifications serve two main functions: they alter chromatin structure by 
enhancing or weakening the non-covalent histone-histone or DNA-histone interactions and/or 
provide docking sites for chromatin readers that specifically recognise these modifications 
and in turn recruit other chromatin modifiers and remodeling enzymes. Besides modifications 
of amino-terminal tails, a plethora of modifications of the histone core have been identified, 
which more directly alter protein-DNA interactions and lead to altered chromatin architecture 
and stability40.  
To date there are at least 8 different classes of modifications and over 60 distinct 
modifications described in the major core histones39. These modifications include lysine 
acetylation41, lysine, arginine and glutamine methylation42,43, serine, threonine and tyrosine 
phosphorylation44, lysine ubiquitylation45, glutamate poly-ADP ribosylation46, lysine 
sumoylation47, arginine deimination (citrullination)48,49 and proline isomerization50. An 
overview of modifications on all 4 core histones is illustrated in Figure 1-1 and major cellular 
processes associated to each of these modifications are summarised Table 1-1. Histone 
methylation and deimination will be discussed in more detail in Section 1.1.8 and 1.19.  
Chromatin mediated gene regulation of eukaryotic cells is highly complex and is controlled 
by extensive cross-talks between histone modifications. Cross-talk can either occur between 
residues on the same histone, between histones within the same nucleosome or across 
nucleosomes. An increasing number of histone modifying complexes are found to contain 
more than one enzymatic activity, which coordinate multiple histone modifications to 
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establish a specific chromatin environment. Histone modifications can act combinatorially in 
a context-dependent manner to facilitate or repress chromatin-mediated transcription. Here, 
the modification of one residue can act as binding site for enzymes mediating the 
modification of a second residue. A well-characterised example is the requirement of histone 
H2B mono-ubiquitination for proper H3K4 methylation by the H3K4 methylase complex 
COMPASS, which is an important mechanism mediating transcription elongation45. 
Conversely, modifications of neighboring residues can also prevent the recognition of another 
histone residue by an enzyme. For example, methylation of histone H3 arginine 2 (H3R2) 
interferes with H3K4 methylation by COMPASS-like complexes, thereby impeding 
transcriptional activation of target genes51.  
Many histones are modified by different classes of enzymes at the same residue, which can 
influence chromatin function in sometimes opposing ways. For instance, H3K9 can be both 
methylated, a modification associated with transcriptional silencing, as well as acetylated, 
which occurs predominantly at actively transcribed genes. De novo heterochromatin 
formation strongly depends on a precise cross-talk between these two modifications. SIRT1 
(NAD-Dependent Protein Deacetylase Sirtuin-1) specifically deacetylates H3K9ac (and 
H4K16ac) at promoters. Chromatin compaction is subsequently achieved by further reduction 
of active marks and an increase of repressive histone marks such as H3K9me3 and 
H4K20me3 mediated by methyltransferases such as SUV39H1 (suppressor of variegation 3-9 
homolog 1)52. 
1.1.5.3. Histone variants 
Canonical histones can be replaced by variant histones to carry out distinct functions in 
transcription, replication or heterochromatin formation, all of which are mediated by histone 
chaperones, chromatin remodeling and histone-modifying enzymes53. Whilst canonical 
histones are expressed from non-intronic genes, variant histone genes contain introns and are 
therefore subject to alternative splicing54. Structural differences introduced by a core histone 
variant influence the interactions between histone proteins within a nucleosome, which can 
affect nucleosome stability as well as chromatin conformation. Histone variants H2A.Z and 
H3.3 for instance are predominantly linked to a more open chromatin conformation and found 
at promoters of active genes, whilst incorporation of macroH2A stabilizes the nucleosome 
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and is often associated with repressive chromatin54. Interestingly, although H3.3 differs from 
the canonical H3.1 by only 5 amino acids, it is recognised by different histone chaperones. 
Whilst H3.1 is incorporated during replication by CAF1 (chromatin assembly factor 1), H3.3 
can be deposited replication-independently by chaperones such as HIRA or DAXX (death 
domain-associated protein)55,56. Whereas HIRA deposits H3.3 at the promoter region of active 
genes, DAXX was shown to incorporate H3.3 at telomeric and pericentric heterochromatin55.  
Besides structural differences, variant histones can be subject to specific post-translational 
modifications reflecting an additional layer of complexity in the modulation of chromatin. 
The best-characterised modification is the phosphorylation at Ser139 of histone variant 
H2A.X, which occurs specifically at sites of DNA double strand breaks (DSB) and is required 
for efficient DSB repair57. 
1.1.6. Histone modifying enzymes  
Histones are modified by a large number of enzymes. As many of them have also non-histone 
targets, it has been challenging to deconvolute the cellular consequences of individual histone 
modifications from other targets of many of these enzymes14. Histone modifications are not 
static entities but a dynamically changing and complex landscape that evolves in a cell-
context dependent fashion. For example, acetylation, phosphorylation or methylation of 
histones can appear and disappear within minutes in response to particular cell signals.  
Table 1-1 Chromatin modifications14. me1 (monomethylation); me2 (dimethylation); me3 
(trimethylation); me2s (symmetric dimethylation); me2a (asymmetrical dimethylation). 
Modification Nomenclature Function 
acetylation K-ac transcription, repair, replication 
and condensation 
methylation (lysine) K-me1, K-me2, K-me3 transcription and repair 
methylation (arginine) R-me1, R-me2s, R-me2a transcription 
phosphorylation S-ph, T-ph, Y-ph transcription,repair and 
condensation 
ubiquitylation K-ub transcription and repair, 
sumoylation K-su transcription 
ADP ribosylation E-ar transcription 
deimination (citrullination) R to cit transcription 
proline isomerisation P-cis to P-trans transcription 	
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Very crudely, histone-modifying enzymes can therefore be classified into modification 
writers and erasers. Figure 1-1 summarises the main histone modifying enzymes, which are 
currently known in higher eukaryotes. In addition to their catalytic function many enzymes 
also possess very specialised reader domains allowing them to bind specific regions in the 
genome and respond to information conveyed through upstream signaling cascades.  
1.1.7. Binders of histone modifications 
Histone modifications provide a dynamic binding platform for various factors. Proteins that 
bind histone modifications contain specialised structured domains that recognise distinct 
covalent modifications of the nucleosome and other nucleosomal features simultaneously. 
This combination allows proteins with very similar binding domains to dock at different 
modified residues or at the same amino acid displaying a different modification state. Figure 
1-2 illustrates the main types of domains that bind modified histones with examples of 
proteins that harbor these specialised binding modules. Domain types recognising lysine 
methylation show the highest degree of diversity, implying the relative importance of lysine 
methylation. These domains include PHD fingers and the Tudor ‘royal’ family of domains, 
containing chromodomains, Tudor, PWWP and MBT domains39. Several domains can 
recognise the same modified histone lysine. For example, H3K4me3 is bound by the tandem 
chromodomains within the ATP-dependent chromatin remodeler CHD158 and by the double 
Tudor domains within the histone demethylase JMJD2A (jumonji C domain-containing 2A)59.  
In the early 2000s, the ‘histone code’ hypothesis was proposed, which defined the 
combinatorial pattern of histone modifications and the ability of various chromatin interacting 
proteins to recognise the presence and absence of modifications to translate the code into 
biological functions60. The term ‘code’ has been controversial, as it implies that it is as 
predictable as the genetic code, which is not strictly the case for histone modifications. 
However, ignoring semantics, there are endless examples of how physiological events are not 
regulated by a single histone modification, but by a combination of several. Many binders 
and/or protein complexes contain more than one binding module recognising different 
modifications or different states of modifications at the same time. The transcriptional 
repressor L3MBTL1 (lethal 3 malignant brain tumor-like 1) is a good example for a 
multifaceted chromatin binding protein. 
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Figure 1-1 Post-translational modifications of histones.  
The 4 core histones are schematically illustrated with currently known histone modifications 
annotated. Listed above each modification are the enzymes known to deposit or erase the 
modification. (Image was adapted with permission from Dr. Andrew Bannister.) 
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It contains three MBT domains recognising H4K20me, as well as H1.4K26me/me2 either on 
the same nucleosome, on adjacent or on nucleosomes of different chromosomes61. In addition, 
L3MBTL1 interacts with the H3K9me3 interacting protein HP1, thereby linking three 
repressive chromatin modifications to increase chromatin compaction and transcriptional 
silencing61.  
1.1.8. Histone methylation  
In contrast to phosphorylation and acetylation, methylation does not alter the overall charge of 
the histone protein. Histones can be methylated to different degrees: lysines may be mono, di 
	
Figure 1-2 Specialised domains of binders of histone modifications.  
Most common domains of binders of histone modifications are indicated.  Listed below each 
domain are examples of proteins harbouring that particular domain together with their target 
histone modifications (Image was adapted with permission from Dr. Andrew Bannister). 
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or trimethylated, whilst arginines may be mono, symmetrically or asymmetrically 
dimethylated39,62. The best-characterised sites of histone methylation are lysines. Various 
histones are methylated on lysine residues either in the histone core or the N-terminal tails. 
The best-studied lysine methylations are those of the histone tails such as H3K4, H3K9, 
H3K27, H3K36 and H4K20. Some of these (H3K4, H3K36) are often associated with active 
genes in euchromatin, whereas others (H3K9, H3K27 and H4K20) are associated with 
heterochromatic regions of the genome63. However, different methylation states on the same 
residue can be found in different locations in the genome. For example, trimethylation of 
H3K9 is associated with repressed genes, whilst monomethylation of H3K9 can be detected at 
active genes63.  
1.1.8.1. Histone lysine methyltransferases (HKMTs) 
Many HKMTs have been identified with the vast majority methylating histone tails. All of 
them contain a SET domain, which possess the methyltransferase enzymatic activity. The 
only exception to this is hDOT1L, the enzyme that methylates H3K79 in the histone globular 
core. All HKMTs catalyse the transfer of a methyl group from S-adenosylmethionine (SAM) 
a lysine’s ε-amino group. HKMTs tend to be highly specific enzymes that specifically target 
certain lysine residues39.  
1.1.8.2. Histone demethylases  
The initial hypothesis, that histone methylation is a static modification, has been disproved by 
the identification of two classes of lysine demethylases. The first class of enzymes 
demethylate lysines via an amine oxidation reaction with flavin adenine dinucleotide (FAD) 
as a cofactor. The most prominent example for this group of enzymes, and the first lysine 
demethylase to be identified is LSD1, which catalyses the removal of H3K4me1/264. 
However, due to this reaction requiring a protonated nitrogen, amine oxidases only 
demethylate mono and dimethylated lysine. The second and more expansive class of lysine 
demethylases is referred to as the Jumonji demethylases. They have a conserved JmjC 
domain, which functions via an oxidative mechanism and radical attack (involving Fe(II) and 
α-ketoglutarate). This reaction allows demethylation of trimethylated lysines. The first 
enzyme identified as a trimethyl lysine demethylase was JMJD2 that demethylates H3K9me3 
and H3K36me365.  
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1.1.8.3. H3K36 methylation 
In yeast, H3K36 methylation is catalysed by scSet2 (SET domain-containing 2), which 
performs mono-, di- and trimethylation. The mammalian paralogue of scSet2 is SETD2, 
however at least eight distinct mammalian enzymes have been described to methylate H3K36, 
which have varying preferences for H3K36 residues in different methylation states66 
(compare Figure 1-1). H3K36me3 is found in euchromatin. It accumulates at the 3′ end of 
active genes and is associated with the serine 2 phosphorylated elongating form of RNA pol 
II. At least in S. cerevisiae, it serves as a mark for histone deacetylases (HDACs) to bind and 
remove any acetylation that was placed in the gene body during the process of transcription. 
In this way, initiation of inappropriate transcription from cryptic promoters within the gene 
body is suppressed67,68. Evidence suggests this may also be true in humans. However, in 
humans methylation of H3K9 is used in conjunction with H3K36 to repress aberrant 
transcription. 
1.1.8.4. H3K4 methylation 
High levels of H3K4me3 are associated with the 5′ regions of virtually all active genes. 
Furthermore, there is a strong positive correlation between this modification, transcription 
rates, active RNA polymerase II occupancy, and histone acetylation69. H3K4me1 is a 
modification associated with enhancers70. The first H3K4 methyltransferase to be identified 
was S. cerevisiae Set1, the sole enzyme responsible for H3K4 methylation in yeast. In 
mammals, the complexity of methyl writers is greater. At least ten known or predicted H3K4 
methyltransferases exist (compare Figure 1-1). H3K4me3 is a bona fide mark of active genes 
and often coincides with H3K9ac and H3K14ac at TSSs69. The most notable exception of this 
paradigm is the existence of ‘bivalent domains’ where H3K4me3 occupies the same promoter 
as repressive marks, such as H3K27me3. These bivalent domains often mark important 
developmental genes in stem cells71. They are believed to have a role in keeping promoters of 
developmental genes inactive, yet ‘poised’ ready to be transcribed72. 
1.1.8.5. H3K9 methylation 
While H3K9me1/2 localise specifically to silent domains within euchromatin, H3K9me3 is 
implicated in the formation of heterochromatin together with HP1. Conversely, H3K9me3 
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was also described in the gene body of actively transcribed genes, where it is associated with 
HP1γ73, indicating that H3K9me3 deposition is not strictly restricted to repressive chromatin 
and is most probably locus dependent.  
Different methylated states of H3K9 are directed by specific histone methyltransferases to 
mark distinct domains of silent chromatin. The first H3K9 methyltransferase, and the very 
first HKMT to be identified was SUV39H135. An important paralogue of this enzyme is 
SUV39H2. Both enzymes catalyse mono-, di-, and trimethylation of H3K9 with a strong 
preference for H3K9me3. They are crucial for H3K9me3 deposition on pericentromeric 
heterochromatin74.  
Another important HKMT depositing H3K9me3 is SETDB1 (SET domain bifurcated 1), also 
called ESET (ERG-associated protein with SET domain)75,76. SETDB1 is involved in 
transcriptional silencing within euchromatin and its specificity is dependent on various 
interaction partners. It has been shown to bind various proteins, including KAP1 (Kruppel-
associated box domain (KRAB)-associated protein), DNMT3A and transcription factors such 
as OCT4 and SP377. SETDB1’s interaction with KAP1 is well characterised. Both proteins 
form a repressor complexes with components of the NuRD (nucleosome remodeling and 
histone deacetylation) complex and HP1 to silence coding and non-coding genes in 
euchromatic regions.  
Major depositors of H3K9me1 and H3K9me2 in euchromatin are the HKMTs G9A and GLP, 
also called EHMT2 and EHMT1 (euchromatic histone-lysine N-methyltransferase 2/1)78. 
Besides H3K9, both enzymes also methylate a number of non-histone substrates, for instance 
the tumour suppressor protein p5379. 
	
1.1.9. Histone deimination 
1.1.9.1. Peptidylarginine deiminases (PADIs) 
Deimination (or citrullination) describes the process of converting peptidyl-arginine to the 
non-coding amino acid peptidyl-citrulline. This modification results in loss of a positive 
charge that can change the overall charge of the protein and affect the ability of hydrogen 
bonding with neighbouring proteins or nucleic acids80 (Figure 1-3A). The reaction essentially 
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replaces an imine group with a ketone group and is therefore referred to as a deimination 
reaction. It is mediated by calcium dependent enzymes called peptidylarginine deiminases 
(PADIs). In vertebrates, the PADI family consists of 5 tissue-specific isozymes: PADIs 1 - 4 
and 6. PADIs 1-4 are enzymatically active, whereas PADI6 appears to be a pseudoenzyme. 
The enzymatic activity is highly dependent upon the calcium concentration. PADIs 1, 3 and 4 
bind five Ca2+ ions in their catalytic pocket, whilst PADI2 binds six81. X-ray crystal structures 
of PADI2 and PADI4 enzymes revealed that allosteric binding of Ca2+ outside of their 
catalytic pocket triggers severe structural rearrangements within the pocket82,83. In PADI2 this 
so called ‘calcium switch’ results in the movement of the ‘gate keeper’ residue R347 away 
from the catalytic pocket, thereby facilitating movement of the catalytically important 
cysteine residue C647 (C645 in PADI4) into the catalytic pocket83. Figure 1-3B illustrates 
conversion from the apo PADI2 to the holo PADI2, which is controlled by 3 Ca2+ ions.  A 
very similar mechanism was described for PADI483. 
All PADI isozymes are associated with the development of different pathological states such 
as autoimmunity, cancer and neurodegenerative disorders84. The enzymatically active 
members PADIs 1-4 are widely expressed in mammalian tissues. PADI1 is predominantly 
expressed in the epidermis and the uterus, PADI3 in hair follicles, whilst PADI4 is expressed 
mainly in neutrophils and eosinophils. PADI2 is the ubiquitous member of the family, 
expressed for example in skeletal muscles, spleen, brain, secretory glands and other tissues81. 
1.1.9.2. Functions of histone deimination 
So far only PADI1 1, 2 and 4 have been reported to localise to the nucleus and regulate gene 
expression by directly citrullinating histones48,85,86. PADI4 citrullinates histone H3 at R2, 8, 
17 and 26, as well as histones H2A and H4, both at R348,49,87.  
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Citrullination of histones can result in both gene activation and gene repression. For instance, 
citrullination of H3R17 suppresses estrogen-dependent expression of the pS2 gene in estrogen 
receptor α (ERα)-positive MCF7 breast cancer cells, thereby antagonising transcriptional 
activation mediated via H3R17 methylation by CARM148. In contrast, estrogen-mediated 
stimulation of PADI4 in the same system was shown to induce citrullination of H3R8 at 
	
Figure 1-3 Peptidyldeimination is catalysed by PADI enzymes.  
A Deimination describes the conversion of peptidylarginine to peptidylcitrulline. 
Deimination reaction is illustrated. 
B Illustration of the X-ray crystal structure of apo and holo form of PADI2. Conversion is 
triggered by binding of 3 Ca2+ ions at the calcium switch, which promotes the relief of ‘gate 
keeper’ R374 and proper positioning of the catalytic C647 and subsequent docking of the 
substrate’s arginine. Figure adapted from reference 64. 
 17 
promoters of cytokine genes and several human endogenous retroviruses (HERVs). 
Citrullination of H3R8 at these genomic loci promotes transcription by interfering with 
H3K9me3 directed binding of HP1α88. Also, PADI2 resides within nuclei, where it mediates 
citrullination of H3 at R2, 8, 17 and 2686,89,90. Work from Coonrod's laboratory suggests that 
PADI2, and not PADI4, exclusively citrullinates H3R26 at ERα target genes in MCF7 cells in 
response to estrogen stimulation86. The authors further propose that H3R26 citrullination 
leads to local chromatin decondensation, which increases transcriptional activation by 
enhancing accessibility of ERα to its target genes90. In conclusion, these studies show that 
gene regulation mediated by citrullination of histones is diverse. PADI mediated citrullination 
interferes with other histone modifying enzymes, binding of chromatin readers or locally 
affects chromatin structure.  
Recently, a role was suggested for nuclear PADI1 in early mouse development85. PADI1 
expression is induced at the 2-cell stage of mouse pre-implantation development. Knockdown 
of PADI1 in embryos resulted in loss of citrullination at H4R3 and H3R2, 8 and 17, 
accompanied by decreased transcriptional activity, and finally complete developmental 
arrest85. It is the first study to demonstrate an enzymatic activity of PADI1 on histones. 
Besides epigenetic regulation of gene expression by histone citrullination, PADI4-mediated 
hypercitrullination of histones is an essential mechanism for the innate immune response91. 
Histone hypercitrullination is critical for neutrophil extracellular trap (NET) formation, a 
specialised defense mechanism that neutrophils exert against bacterial92 and fungal 
pathogens93. Rapid chromatin decondensation promotes chromatin extrusion from cells to 
form web-like structures that capture pathogens. Hypercitrullinated H3 is an important 
molecular marker for this form of cell death94. 
1.1.10. Constitutive vs. facultative heterochromatin 
In contrast to euchromatin that contains active genes, predominantly marked by H3K4me3 
and H3K36me3, heterochromatin is generally repressive and contains silenced genes. But not 
all heterochromatin is the same. In multicellular organisms, two distinct types of 
heterochromatic regions have been classified: (I.) constitutive heterochromatin and (II.) 
facultative heterochromatin (Figure 1-4).  
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(I.) Constitutive heterochromatin predominantly forms at pericentromeric regions and 
telomeres. Constitutive heterochromatin is characterised by high levels of H3K9me3, HP1α/β 
and SUV39 enzymes39. Telomeres and pericenters are gene-deprived regions and usually 
made of tandem repeats, called satellites, which vary in size from 5bp up to a few hundreds 
bp. Pericentromeric repeats in particular show weak sequence conservation across species and 
do not contain significant functional genic features such as promoter elements. A conserved 
characteristic is the tandem iteration of DNA motifs, however the mechanisms into how 
repetitive elements contribute to heterochromatin formation at pericenters repeats remain 
largely unknown. Interestingly, major satellite repeats are transcribed in sense as well as 
antisense direction and transcripts were shown to remain chromatin associated and form 
DNA:RNA hybrids. For both HP1 and Suv39h KMTs interaction with those transcripts is 
important for their recruitment and retention to pericentric chromatin, suggesting repeat 
transcription plays an important role in establishing constitutive heterochromatin at these 
loci95,96. 
(II.) Facultative heterochromatin is more dynamic and can be defined as condensed, 
transcriptionally silent chromatin, which decondenses and allows transcription in response to 
developmental cues and/or during cell differentiation97. Factors involved in the establishment 
and/or maintenance of facultative heterochromatin are less well understood. However, it is 
broadly accepted that combinations of several processes are involved. They include (i.) the 
incorporation of alternative chromatin components, such as different variants of histone H1, 
(ii.) interplay of different chromatin modulating factors such as HDACs, HKMTs, DNMTs, 
chromatin remodelers and/or non-coding RNAs and (iii.) activities of various trans-activating 
factors such as HP1γ, polycomb group (PcG) proteins or methyl-CpG-binding domain (MBD) 
containing proteins97. A classic example of this type of heterochromatin is the mono-allelic 
inactivation of the X chromosome in female mammalian organisms in early stages of 
development. Before gastrulation, the long ncRNA Xist coats the inactive X chromosome 
(Xi), which is followed by hypo acetylation of the entire Xi chromosome and the appearance 
of repressive chromatin marks H4K20me1 and H3K27me3 mediated by PR (polycomb 
repressive) complex I and II97. This state is then maintained throughout the whole lifetime of 
the organism.  
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1.2. Heterochromatin protein 1 (HP1) 
A major breakthrough in our understanding of heterochromatin-mediated gene silencing was 
achieved in the 1980s, when extensive mutagenesis analyses of modifiers of PEV in 
Drosophila were performed. This resulted in identification of more than 100 genes that either 
enhanced or suppressed PEV when mutated. Amongst those genes, Heterochromatin protein 1 
(HP1), which had previously been described as a non-histone protein that predominantly 
localises to pericentromeric heterochromatin98,99, was identified as a dominant suppressor of 
PEV100-102.  
 
	
Figure 1-4 Constitutive vs. facultative heterochromatin.  
There are two distinct types of heterochromatin: constitutive heterochromatin (CH) and 
facultative heterochromatin (FH). CH is highly condensed and predominantly contains 
HP1α/β and SUV39H1/2 enzymes. Condensation of CH is in part mediated by dimerisation of 
HP1 (hetero- or homo-dimerisation) proteins binding to adjacent histones or interaction with 
non-HP1 proteins. FH formation is regulated by chromatin modulators (chromatin modifying 
enzymes) and transacting factors such as HP1γ. FH structure is less condensed. Histone H1 
variants are structural proteins that play a role in both CH and FH formation and maintenance. 
Image adapted from reference 77. 
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1.2.1. Structure and function of HP1  
HP1 is widely conserved throughout the eukaryotic animal kingdom ranging from fission 
yeast to humans. While fission yeast have only one HP1 paralogue, Drosophila (HP1a, HP1b 
and HP1c) and mammals (HP1α, HP1β and HP1γ) have 3 paralogues. In mammals HP1α 
(22kDa), HP1β (25kDa) and HP1γ (21kDa) are expressed from the genes CBX5, CBX1, and 
CBX3, respectively. Members of the HP1 family are characterised by 2 evolutionary 
conserved domains: an N-terminal chromodomain (CD) and a C-terminal chromo-shadow 
domain (CSD), which are separated by a variable linker, the hinge region (Figure 1-5A). 3D 
structures of CD and CSD have been resolved by nuclear magnetic resonance (NMR) 
spectroscopy103,104 and X-ray crystallography105. Both CD and CSD are globular domains 
consisting of an anti-parallel, three-stranded β-sheet, against which one (CD) or two α-helices 
(CSD) are packed. Despite their structural similarity, CD and CSD have distinctive functions. 
Functions of HP1’s CD, hinge and CSD are summarised in Figure 1-6. 
In general, HP1s are multifunctional proteins and their association with chromatin is directly 
or indirectly involved in a myriad of physiological processes such as regulation of gene 
expression, replication, DNA damage repair, telomere maintenance, cell differentiation and 
cell cycle progression. 
1.2.1.1. The chromodomain (CD) of HP1 
CD is known to be the chromatin-binding domain as it specifically interacts with N-terminal 
tails of H3 that are di- and trimethylated at K937,106-108. Lack of, or mutations in the CD 
abolish localisation of HP1 at centromeric heterochromatin37,109. Figure 1-5C depicts the X-
ray crystal structure of msHP1γ CD in complex with a H3K9me3 peptide. In 3-dimensional 
space, three key amino acids (in msHP1γ: F30, W51 and F53; highlighted in light blue Figure 
1-5C) form a ‘hydrophobic cage’ that specifically recognises di- and trimethylation of H3K9. 
Other specific sites in the CD interact with the neighboring H3 amino acid residues to 
stabilize the flexible N-terminal histone tail106. Residues forming the ‘hydrophobic cage’ are 
highly conserved across HP1 homologues (compare Figure 1-5B). Furthermore, HP1’s CD 
directly interacts with the globular domain of H3.  
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Figure 1-5 Functional domains of HP1. 
(Figure legend is located on the next page.) 
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1.2.1.2. The chromo-shadow domain (CSD) of HP1 
The CSD is the dimerization domain of HP1104. HP1 molecules can interact with each other to 
form homo – or heterodimers between different homologues. Furthermore, HP1 interacts with 
several other proteins via its CSD104,105. The CSD contains a consensus sequence, the PxVxL 
motif (where P = proline, V = valine, L = leucine and x is any amino acid). Figure 1-5C 
depicts the X-ray crystal structure of the CDS dimer of mouse HP1γ, with PxVxL residues 
highlighted in yellow. HP1 interacts with a myriad of different chromatin associated proteins, 
many of which contain this consensus motif. This ever-growing list of HP1 interactors 
includes a number of chromatin components, chromatin remodelers, chromatin modifiers, 
transcriptional regulators, replication-, cell cycle- and DNA repair-implicated factors, and 
nuclear structure proteins110. A list of examples of HP1 interacting proteins are depicted in 
Table 1-2. 
SUV39 homologues, as important interactors of HP1 also contain a PxVxL motif. In 
particular at pericentric heterochromatin, their interaction reinforces heterochromatin 
formation and spreading110. Furthermore, HP1 is part of KAP1 co-repressor complexes, where 
it interacts with KAP1 via its PxVxL motif 111. Its interaction with HP1 anchors these 
complexes on chromatin via H3K9me3. When associated with KRAB zinc finger 
transcription factors, KAP1 co-repressor complexes are the main repressors of transposable 
elements in eukaryotic cells112.  
Figure 1-5 Functional domains of HP1. 
A Cartoon of domain structure of mouse HP1 paralogues. Chromodomains (CD) are 
highlighted in blue, hinge regions in orange, chromo-shadow (CDS) domains in green and 
NTE (N-terminal extension) and CTE (C-terminal extension) in grey. 
B Multiple sequence alignment of mouse HP1 paralogue protein sequences. Multiple 
sequence alignment was performed using Clustal Omega. CD, hinge region and CSD are 
colour-coded as indicated in A. Beta sheets and alpha helix of CD are indicated. Residues 
forming the hydrophobic pocket are highlighted in light blue and those of the PxVxL motif 
in yellow. Citrullinated residues are highlighted in pink. C X-ray crystal structure of 
msHP1γ CD (blue, turquoise, grey) in complex with H3K9me3 peptide (yellow). PDB file 
‘5t1i’ was adapted using the PyMOLE software. Beta sheets and alpha helix of CD are 
colour-coded as indicated in B. Residues F30, W51 and F53 forming the hydrophobic cage 
are highlighted in light blue. 
D X-ray crystal structure of msHP1γ CSD dimer. PDB PDB file ‘3kup’ was adapted using 
the PyMOLE software. Residues of PxVxL motif are highlighted in yellow. 
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            Table 1-2 Examples of HP1 interacting proteins. (Adapted from reference 113). 
Protein Function Domain 
H3 chromatin structure CD 
H1 chromatin structure CD, hinge 
H3K9m2/3 chromatin structure CD 
SUV39H1/2 chromatin modification CSD 
DNMT3a/b transcription CSD 
KAP1/TIF1β transcription CSD 
TIF1α transcription CSD 
TAFII130 transcription CSD 
E2F6 transcription ? 
RB transcription ? 
SNF2β/BRG1 transcription CSD 
p150CAF-1  replication CSD 
KU70 DNA repair CSD 
INCENP centromere structure hinge 
Lamin B receptor chromatin structure CSD 
Lamin B chromatin structure CD 
RNA 
FACT 
transcription/chromatin structure 
transcription 
Hinge 
CSD 
 
 
1.2.1.3. The hinge region of HP1 
CDs and CSDs are connected via a less conserved and less structured hinge region. For 
example, the CD and CSD of all three mammalian paralogues share approximately 70% 
sequence identity, while hinge regions show less than 30% identity. The length of the hinge 
region varies substantially between paralogues. It contains HP1’s nuclear localisation 
sequence and is the site of several post-translational modifications including phosphorylation 
and SUMOylation114. The hinge region is implicated in HP1’s interaction with RNA and 
DNA115,116. Because of its weak sequence conservation, the hinge region represents an 
important source of functional differences between HP1 paralogues. HP1 proteins have 
different affinities for RNAs in vitro116. For example, in vivo interaction with RNA transcripts 
originating from pericentric repetitive elements is essential for the initial targeting of HP1α 
(not HP1β or γ) to pericentric domains and subsequent spreading of heterochromatin96,116. 
However, the molecular basis of this difference is not entirely understood, as the critical 
charged residues responsible for nucleic acid binding (KRK and KKK) are conserved between 
all paralogues. Structural differences between the hinge regions of HP1 paralogues are yet to 
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be identified. Due to its flexible nature, crystallisation of the hinge region is technically 
extremely challenging.  
1.2.2. HP1 and chromatin compaction 
The general binding affinity of HP1 to H3K9me3, although it differs between paralogues, is 
relatively weak and may not solely account for HP1’s tight association with 
heterochromatin110. It is therefore likely that all three domains contribute to HP1’s association 
with chromatin and all downstream effects that may result from it. The modular nature in 
which individual HP1 domains bind a nucleosome raises the possibility that different types of 
HP1-nucleosome complexes are formed depending upon which HP1 domains are engaged 
with the nucleosome and which HP1 domains are engaged with other proteins. In condensed 
chromatin, H3K9me3 within adjacent nucleosomes and therefore HP1 molecules are closer 
together; increasing the probability of HP1 proteins associated with adjacent histones to 
interact (Figure 1-4).  
 
For example, in vitro, human HP1α’s specific recognition of H3K9me3 in tetra nucleosomes 
depends on both the hinge and the chromo-shadow domain117. Furthermore, whilst HP1α 
	
Figure 1-6 Schematic diagram of HP1. 
All HP1 paralogues have a conserved N-terminal chromodomain (CD) and a C-terminal 
chromo-shadow domain (CSD), which are connected via a flexible hinge region. The main 
functions of each domain and examples of interaction partners are indicated.  
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predominantly associates with H3K9me3 on decondensed nucleosomes in vitro, HP1γ’s 
binding affinity is specifically enhanced upon addition of histone H1 and Mg2+ ions, 
components that are known to induce compaction of nucleosomes118. HP1γ’s increased 
binding affinity to condensed nucleosomes may, therefore, be due to HP1γ’s direct interaction 
with H1. HP1γ is regarded as a trans-acting factor for facultative heterochromatin formation 
(Figure 1-4). 
Condensation of chromatin could also be supported by HP1’s interaction with different 
histone modifications. For example, besides H3K9me3, HP1 also binds methylated 
H1.4K26119. Since linker histone H1.4 is involved in heterochromatin structure, an interesting 
hypothesis could be that HP1 dimers bind to both modifications simultaneously to reinforce 
chromatin compaction.   
The multipartite organization of HP1 proteins allows several proteins to bind simultaneously 
and has led to the idea that HP1 can function as a structural adaptor that may be vital for the 
assembly of macromolecular complexes on chromatin. A good example for this is HP1’s role 
in sequence-specific heterochromatin formation mediated by small RNA pathways. H3K9me3 
bound HP1 anchors RNA-induced silencing complexes composed of Argonoute proteins and 
small guide RNAs to chromatin120. These complexes further recruit chromatin modiying 
enzymes resulting in the spreading of silenced heterochromatin. This mechanism seems to be 
conserved from yeast to man120. 
1.2.3. Roles for HP1 in DNA damage repair 
High compaction of chromatin in heterochromatin is hypothesized to constitute a barrier for 
DNA repair. DNA double strand breaks (DSBs) that are formed in heterochromatin are 
processed slower than in euchromatin121. Conversely, all HP1 paralogues are recruited to 
DNA lesions, indicating HP1 proteins play an active role in the DNA damage response121. In 
fact, HP1 depleted cells showed persistent γH2AX foci at late time points after irradiation, 
which indicates persistent and unrepaired DNA lesions. HP1’s recruitment to DSBs is 
independent of H3K9me3, but depends on interaction with the largest subunit of the histone 
chaperone chromatin assembly factor 1, CAF1p150 and KAP1121. Loss of HP1 paralogues 
has no effect on non-homologous end joining (NHEJ), however, it affects homologous 
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recombination (HR). Interestingly, studies using a reporter construct to measure HR 
efficiency showed that loss of HP1α and β decreases the efficiency of HR, whereas HP1γ 
depletion results in increased HR efficiency122,123. These studies suggest different roles for 
HP1 paralogues in DNA repair. However, to date it remains unclear how these functional 
differences are mediated.  
1.2.4. Roles for HP1 during cell cycle progression 
Localisation of HP1 paralogues during the cell cycle is highly dynamic and paralogue specific 
functions are still being investigated. What is known is that HP1α predominantly associates 
with centromeres of metaphase chromosomes, whereas HP1β associates with interphase 
centromeres but is replaced at the centromere by HP1α as the cell enters metaphase. HP1γ 
seems to preferentially associate with distinct sites along the chromosomal arms in 
metaphase110. What exactly causes the redistribution of HP1 during cell cycle remains poorly 
understood. One possible mechanism is post-translational modification of HP1. Indeed, HP1α 
and γ, but not HP1β were reported to be differentially phosphorylated during the cell cycle. 
Different kinases such as PIM1 (proviral intergration site 1) and Aurora kinase B 
phosphorylate HP1 in specific phases of the cell cycle101. The latter also phosphorylates 
H3S10, which leads to eviction of all HP1 paralogues from chromatin during mitosis124. 
Furthermore, it has been proposed that the CD is required for HP1 localisation to chromatin in 
interphase nuclei, whereas during metaphase the CSD and hinge region that are needed for 
correct HP1 localisation, indicating that in mitosis HP1’s association with chromatin is 
dependent on other proteins. Indeed, HP1α interacts with centromeric protein INCENP via the 
hinge region and HP1γ was reported to interact with cohesin during cell division125.  
HP1s are known to associate with proteins involved in chromatin assembly during DNA 
replication.  In late S phase, HP1 interacts with CAF1p150, which transports a tetramer of 
histone (H3/H4) to the replication fork via interaction with proliferating cell nuclear antigen 
(PCNA). Recruitment of HP1 to the replication fork maybe important to maintain both 
heterochromatin integrity (especially at centromeres and telomeres) and possibly the 
epigenetic status of silenced genes. It suggests that CAF1 somehow promotes incorporation of 
HP1 into heterochromatin during its replication in late S phase110. 
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Distinct localisations of HP1 paralogues during cell cycle progression indicate that they 
acquire specific functions. These differences seem to be, at least in part, regulated through 
post-translational modifications and/or interactions with different proteins. Further 
mechanistic insights are necessary to fully understand the function of each HP1 paralogue in 
cell cycle progression. Specifics for HP1γ will be discussed in Section 1.2.8.2.  
1.2.5. Knockout of CBX1, CBX5 and CBX3 in mice 
All three HP1 paralogues are ubiquitously expressed and due to high sequence conservation, 
they display functional redundancy. Nevertheless, it has become evident that each paralogue 
harbours specific functions with respect to chromatin formation and transcriptional regulation 
and we are only now starting to understand these functional differences. Knockout mice of 
HP1 paralogues show distinct phenotypes126-128 (Table 1-3). Whilst CBX1 (HP1β) knockout is 
perinatally lethal, CBX5 (HP1α)-null mice develop normally. CBX3 (HP1γ) knockout mice 
are sterile due to severe defects in spermatogenesis. These knockout phenotypes indicate that 
HP1 paralogues are not fully redundant. 
                                      Table 1-3 Phenotypes of HP1 knockout mice 
Gene Knockout phenotype 
CBX5 no phenotype;  
mice develop normally 
CBX1 perinatal lethal due to genomic instability; 
defects in neuronal development  
CBX3 severe defects in spermatogenesis;  
C57BL/6 knock-out mice exhibit neonatal lethality 
 
HP1 research of the past 2 decades concentrated mainly on HP1α and HP1β. The next 
sections summarise the main functional and structural differences between HP1 paralogues in 
mammalian cells with the main focus on HP1γ.  
1.2.6. HP1α 
HP1α is predominantly found in constitutive heterochromatin, especially in pericentric 
heterochromatin110. In general, binding affinity of HP1α to H3K9me3 is significantly lower 
than that of HP1β and γ. However, phosphorylation of mouse HP1α at serine residues in the 
N-terminal extension (NTE) significantly increases its affinity for H3K9me3 peptides and 
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H3K9me3 within nucleosomes114,129. Intriguingly, these NTE serine residues are only present 
in HP1α, indicating that NTE phosphorylation is a unique way of regulating HP1α’s binding 
to chromatin. As constitutive heterochromatic regions must undergo coordinated assembly 
and disassembly during developmental transitions and cell cycle, HP1α’s binding to 
chromatin, probably more than any other paralogue, has to be coordinately regulated over 
large stretches of the genome. Dynamic phosphorylation and dephosphorylation may be a 
way of regulating HP1α during processes requiring global nuclear rearrangement.  
Two very recent studies reported an exclusive role for phosphorylated HP1α in initiating 
phase separation of heterochromatin in vitro130,131. These two papers very elegantly 
demonstrate that intracellular membrane-less compartments can contain heterochromatin, 
which suggests that heterochromatin-mediated gene silencing occurs in part through spatial 
organisation of compacted chromatin in phase-separated HP1α droplets. Droplet formation 
was significantly enhanced by phosphorylation of HP1α at the NTE and the hinge region131. 
HP1α seems to be the only paralogue that is regulated by SUMOylation. Lysine 84 in the 
hinge region of mouse HP1α is SUMOylated, which promotes its association with noncoding 
transcripts originating at major satellite repeats. Interaction with these RNAs is essential for 
HP1α’s recruitment to pericentromeric regions and the silencing of repetitive elements located 
in these genomic loci96.  
Chromodomains of all human HP1s bind to a specific peptide sequence (PGTVAL) within the 
globular domain of histone H3132. HP1α additionally recognises H3Y41, which is located two 
residues upstream from the PGTVAL motif in H3. Phosphorylation of Y41 by nuclear JAK2 
(Janus kinase 2) inhibits this interaction and HP1α’s eviction from chromatin correlates with 
increased transcription of specific genes133. In contrast, neither HP1γ nor HP1β seem to 
require Y41 for binding the PGTVAL region and might therefore be insensitive to Y41 
phosphorylation. The molecular nature of this specificity remains unclear.  
Other interactors of HP1α include Brm (Protein Brahma Homolog) and Brg1 (BRM/SWI2-
related gene 1), the two mutually exclusive catalytic subunits of the human SWI/SNF 
(hSWI/SNF) chromatin-remodeling complex. This interaction mediates repression of a 
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reporter construct by a transfected Gal4-HP1α fusion protein, indicating a co-repressive 
function of HP1α and the SWI/SNF complex106.  
In summary, HP1α is predominantly localised to constitutive heterochromatin. HP1α’s 
recruitment to, and retention on chromatin are regulated through different post-translational 
modifications, such as phosphorylation and SUMOylation and by specific interaction 
partners.  
1.2.7. HP1β 
Similarly to HP1α, HP1β is mainly found in constitutive heterochromatin, but also plays a 
role in selectively silencing genes in hetero- and euchromatic regions. Very early on, mouse 
HP1β was reported to cause dose-dependent silencing of transgenes in centromeric regions, 
but not other genomic regions, indicating a chromosomal context dependent role for HP1β 
gene silencing101. Additionally, HP1β tethering experiments in mammalian cells showed that 
HP1β localisation leads to transcriptional repression of reporter genes located in repetitive 
regions of the genome, which is induced by chromatin condensation. Such chromosomal 
condensation was accompanied by recruitment of SETDB1 and subsequent spreading of 
H3K9me3ref.113. Hence, HP1β can play an active role in promoting local heterochromatin 
formation.  
HP1β is excluded from active promoters, but it is found at promoters of inactive genes located 
in euchromatic regions. For example, HP1β is present at the repressed cyclin E promoter in a 
complex with the Rb (retinoblastoma) protein and SUV39H1, which is released upon Rb 
phosphorylation134. Furthermore, HP1β was shown to be involved in transient repression of 
an inducible viral promoter. In absence of stimulation, HP1β is bound to the promoter via 
H3K9me3, functioning as a negative regulator of transcription. Upon activation, HP1β is 
rapidly released, accompanied by removal of H3K9me3, subsequent H3S10 phosphorylation 
and recruitment of HP1γ135. This study nicely demonstrates that HP1 paralogues can acquire 
different, in this case even antagonistic functions.  
CBX1-null mice die before or shortly after birth, while knockouts of other HP1 paralogues are 
viable. The CBX1-null phenotype is caused by genomic instability characterised by severe 
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chromosomal abnormalities that are indicative of pericentric heterochromatin 
dysfunction126. One hypothesis is that the essential interaction of HP1β with chromatin is 
not mediated by H3K9me3, but rather by its interaction with the globular domain of H3, 
which could be directly required for HP1β incorporation into heterochromatic regions136. 
However, binding affinities of all HP1 paralogues to the globular domain of H3 have not been 
compared yet. 
To summarise, HP1β is predominantly found in constitutive heterochromatin, but it is also 
involved in transcriptional silencing of genes within euchromatin. The dramatic phenotype of 
CBX1 knockout mice suggests a general role for HP1β in establishing higher order chromatin 
structures during development.    
1.2.8. HP1γ 
In contrast to HP1α and HP1β, HP1γ is less enriched in constitutive heterochromatin and 
predominantly found in euchromatic regions. The first study to identify mammalian HP1γ 
occupancy in the gene body of active genes, was published by the group of Gerd Blobel in 
200573. They showed for the first time that the repressive H3K9me3 mark can be deposited in 
the gene body of active genes, which is then bound by HP1γ. Ever since, many groups have 
attempted to decipher HP1γ’s function in actively transcribed genes.  
1.2.8.1. Regulation of gene expression 
Depending on where HP1γ is located within a gene (promoter, gene body or 3’UTR), it can 
acquire distinct functions. Figure 1-7 summarises the roles of HP1γ in regulating gene 
expression that have been proposed within the last decade.  
1.2.8.1.1. Promoter bound HP1γ 
HP1γ at promoters functions either as a transcriptional repressor or activator. HP1γ mediated 
silencing of genes within euchromatin has been demonstrated using inducible viral 
transgenes. For example, HP1γ is part of a co-repressor complex, which is recruited to silence 
an actively transcribed hormone-regulated viral transgene137. This transgene contains a 
hormone-regulated KRAB repression domain. Upon hormone treatment, KAP1 co-repressor 
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is recruited to the promoter together with HP1γ and the histone methyltransferase SETDB1 
leading to local H3K9me3 deposition and rapid gene silencing137. A similar mechanism was 
demonstrated for endogenous genes. In quiescent cells, together with histone 
methyltransferases, HP1γ is targeted to E2F response genes mediated by the transcription 
factor E2F-6, resulting in gene repression138. Both of these mechanisms involve local 
heterochromatin formation at the promoter of HP1γ target genes.  
HP1γ can also be displaced from repressed gene promoters upon gene activation. In a breast 
cancer cell line carrying an integrated single copy of a transgene containing a hormone 
inducible MMTV-LTR promoter, HP1γ participates in the repression of the viral promoter139. 
Upon treatment, a hormone receptor complex triggers phosphorylation of H3S10, which 
results in rapid displacement of HP1γ from the promoter. Similarly, HP1γ was found to be 
part of a repressor complex together with the unliganded progesterone receptor (PR), ncRNA 
SRA (steroid receptor RNA activator) and several histone modifying enzymes140. This 
complex is rapidly displaced from promoters upon hormone stimulation, which is mediated 
though the H3K9me3 - H3S10ph switch (compare 1.1.5.3)140. 
In contrast to HP1γ’s gene silencing function, it is also recruited to many promoters upon 
activation. Several different stimuli have been reported to trigger HP1γ’s recruitment to 
chromatin, such as cytokine treatment, heat shock or treatment with drugs such as phorbol 
ester PMA132,135,141-144. 
In the human colorectal cancer cell line HCT116, upon treatment with DNA damaging agents 
HP1γ is recruited to the promoter of the BIRC5 gene, which coincides with HP1β’s 
displacement142. The antagonistic relationship between silencing HP1β and activating HP1γ 
seems to be a common mechanism to regulate inducible genes. However, it remains an open 
question how HP1γ is binding these active promoters.  
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One possibility is that HP1γ directly interacts with the core of H3. HP1γ was shown to be 
recruited to the promoter of interferon inducible genes upon interferon alpha (IFNα) treatment 
and its recruitment is essential for gene activation132. Interestingly, this recruitment depends 
on the chromatin remodeling complex SWI/SNF. As the core of H3 is not directly accessible 
for the CSD of HP1, the action of SWI/SNF may open up the chromatin enabling HP1γ to 
bind H3132. 
Another option is that HP1γ specifically interacts with certain histone variants. Evidence 
supporting this idea comes from the human HSP70 (heat shock 70kDa protein 2) genes. HP1γ 
is recruited to the HSP70 promoters upon heatshock induced gene activation, which is 
accompanied by increased incorporation of histone variant H3-3144. Both HP1γ and H3.3 
physically interact and loss of either protein results in repression of HSP70, indicating HP1γ 
and H3.3 cooperate in activating HSP70 upon heatshock144.  
In summary, HP1γ bound at promoters can either function as a transcriptional repressor or 
activator. In both settings it is likely to be part of larger protein complexes.  
	
Figure 1-7 Functions of HP1γ in euchromatin. 
Schematic illustration of a gene with transcriptional start site (TSS) and termination site 
(TES), HP1γ binding at TSS, gene body and TES is indicated together with associated 
functions of the protein. 
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1.2.8.1.2. HP1γ bound in gene bodies 
HP1γ is the only HP1 paralogue that is found within gene bodies of actively transcribed 
genes. Several functions for HP1γ within active genes and distinct mechanisms of recruitment 
have been proposed. As mentioned beforehand, HP1γ binding within active gene bodies can 
coincide with H3K9me3 deposition73,145. But not every HP1γ target gene is marked by 
H3K9me3143. What about other genes? 
HP1γ directly interacts with RNA Pol II, more precisely with the elongating form of RNA Pol 
II as determined by immunoprecipitation using antibodies against the carboxy-terminal 
domain of RNA Pol II phosphorylated at serine 5ref.73,141,143. This interaction can result in 
different transcriptional outputs. HP1γ was proposed to function globally as a transcriptional 
activator143. In HCT116 cells, genes bound by HP1γ within the gene body were found to be 
predominantly down-regulated upon HP1γ depletion, indicating a positive influence of HP1γ 
on elongation143. Work in drosophila showed that HP1c interacts with the histone chaperone 
complex FACT and recruits it to active genes, which links FACT to the active form of RNA 
Pol II146. Loss of HP1c impairs recruitment of FACT to heat-shock loci and causes a defect in 
heat-shock gene expression.  
Conversely, HP1γ was also reported to limit RNA Pol II’s elongation rate141,145,147. For 
example, HP1γ can function as a transcriptional modulator to ‘fine tune’ gene expression of 
immune response genes in mouse embryonic fibroblasts (MEFs)141. In unstimulated cells 
immune response genes are repressed by HP1γ binding to H3K9me3 at their promoters. Upon 
infection with bacteria, H3K9me3 is removed and H3S10 is phosphorylated by the map 
kinase MSK1. The same kinase phosphorylates HP1γ at serine 83 (S83) in the hinge region, 
which they show is a prerequisite for the protein to bind RNA Pol IIref.141. Its interaction with 
elongating polymerase results in moderate transcription. Only upon complete loss of HP1γ do 
these immune genes become hyper activated in response to stimuli, resulting in a full-blown 
immune response. The authors propose a model in which phosphorylated HP1γ acts as a 
transcriptional modulator to fine-tune the expression of immune response genes141.  
Other studies suggest a role for HP1γ in attenuating RNA Pol II elongation rate145,147, which 
can result in different effects on gene expression. For example, HP1γ regulates inclusion of 
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alternate exons within the CD44 gene via a mechanism involving decreased RNA polymerase 
II elongation rate. CD44 is comprised of constant and variant exons. The latter are subject to 
enhanced alternative splicing. Together with H3K9me3, HP1γ is specifically enriched at 
variant exons of the gene145. Furthermore, it directly binds the nascent pre-mRNA, thereby 
stabilising the RNA on chromatin. It is therefore regarded as a bridging factor connecting 
chromatin and pre-mRNA to create structures that slow elongating RNAP II, which in turn 
facilitates recruitment of the spliceosome. Besides CD44, loss of HP1γ results in decreased 
inclusion of alternate exons of several other genes, indicating HP1γ plays a more general role 
in alternative splicing145. Smallwood et al. addressed HP1γ’s role in alternative splicing 
genome wide143. In contrast to the previous study, they reported that loss of HP1γ results in a 
general increase in intron inclusion and loss of splicing and therefore in accumulation of 
unspliced RNAs, predominantly those originating from genes bound by HP1γ143. The same 
study also showed direct interaction of HP1γ with components of the spliceosome, 
demonstrating a direct link between the splicing machinery and HP1γ on chromatin. In 
conclusion, HP1γ favours alternate exon usage by slowing down elongating RNA Pol II and 
loss of HP1γ either results in reduced usage of alternate exons145 or a general reduction of 
splicing143. Both studies propose a role for HP1γ in alternative splicing. However, it must be 
noted that the effects on splicing displayed in both studies are fairly mild and gene specific, 
which suggests that HP1γ should be regarded as a modulator rather than a main regulator of 
alternative splicing.  
1.2.8.1.3. HP1γ bound to transcriptional termination sites 
In the previous section, a functional association between repressive histone marks, HP1γ, Pol 
II pausing and pre-mRNA processing was discussed145. A similar mechanism of RNA Pol II 
pausing is involved in transcriptional termination. At termination sites G-rich sequences 
promote R-loop formation, which in turn leads to the synthesis of local dsRNA147. As a result 
dsRNAs recruit the RNAi machinery leading to local heterochromatin formation by 
deposition of H3K9me2 and recruitment of HP1γ. This local heterochromatin promotes RNA 
Pol II pausing, a requirement for efficient termination of transcription147. HP1γ’s recruitment 
to chromatin within active genes is therefore involved in two very different processes that 
both require attenuation of RNA Pol II’s elongation rate. 
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To conclude, in contrast to HP1α and β, HP1γ is predominantly found at active and silenced 
genes within euchromatin, where it is directly associated with gene regulation. Depending on 
where it is bound within a gene it can acquire distinct functions. At promoters, HP1γ can act 
as a bivalent regulator of gene expression, as it regulates gene silencing as well as activation. 
HP1γ occupancy within gene bodies is linked to its interaction with the elongating RNA Pol 
II. This interaction can either enhance the rate of transcription by of RNA Pol II or attenuate 
it. HP1γ mediated attenuation of RNA Pol II is associated with alternate splicing, 
transcriptional termination or ‘fine tuning’ of transcription of inducible genes.  
How HP1γ mediates RNA pol II’s elongation rate and whether this interaction is the only 
mechanism of recruiting HP1γ to gene bodies of active genes remains unknown. Due to the 
multipartite nature of HP1γ, it is likely that additional, yet unknown interactors are involved 
in HP1γ mediated gene regulation. 
1.2.8.2. Structural features of HP1γ 
In contrast to HP1α and β, HP1γ contains 10 extra amino acids at its NTE (Figure 1-5B). 
Surprisingly little is known about this N-terminal extension. Although the peptide sequence 
(msHP1γ 1-10: HP1MASNKTTLQK) is not modified in untreated mammalian cells148, it may 
influence HP1γ’s interaction with histone or non-histone proteins. Furthermore, HP1γ 
possesses fewer acidic residues in its NTE compared to HP1α and HP1β. Molecular dynamics 
studies suggest that these differences make the HP1γ CD-H3K9me3 complex more flexible 
than the HP1β CD-H3K9me3 complex, indicating structural differences between HP1β and 
HP1γ heterochromatin149. Since active transcription requires a flexible chromatin 
conformation, structural differences between HP1β and HP1γ may be one of the reasons why 
predominantly HP1γ is recruited to H3K9me3 within active genes. 
The hinge regions of HP1 paralogues show weak sequence conservation. HP1γ’s hinge region 
shows lower binding affinity to RNA in vitro than that of HP1α116. In vivo, binding of HP1γ 
to RNA may be dependent on the correct display of the target within a chromatin structure. 
Alternatively, HP1γ RNA binding may be more sequence-specific than that of HP1α. In 
support of this notion is HP1γ’s role in modulating splicing of specific transcripts. HP1γ’s 
interaction with nascent pre-mRNAs seems to be gene specific, as not all HP1γ bound genes 
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show an effect on splicing upon depletion of the protein143. Serine residue 83 within the hinge 
region of HP1γ is differentially phosphorylated150, whilst the same residue in HP1α is subject 
to SUMOylation96. HP1γ’s recruitment to active genes and its interaction with RNA Pol II 
depends, at least in part on phosphorylation of S83150,151. Kinases known to mediate S83 
phosphorylation of HP1γ are IKKα (inhibitor of nuclear factor κ-B kinase α)151, MSK1141, 
PKA (protein kinase A)150, PIM1152, HIPK2 (homeodomain interacting protein kinase 2)153 
and Aurora kinase B154. The latter phosphorylates HP1γS83 specifically during G2/M phase of 
the cell cycle. HP1γS83ph then localises to the spindle pole, which is necessary for proper 
cell division in HeLa cells154. Loss of HP1γ or rescue with a S83A mutant in the same cell 
line results in severe mitotic aberrations. Besides the interaction with RNA Pol II, 
phosphorylation of HP1γ promotes its interaction with other proteins such as the NHEJ repair 
protein KU70150. 
Taken together, HP1γ’s exclusive functions in euchromatin may partially be explained by 
structural differences of the protein compared to other HP1 paralogues. Furthermore, HP1γ is 
regulated by post-translational modifications, which promote interactions with other proteins 
and affect subnuclear localisation.  
1.2.8.3. HP1γ in cancer 
HP1 proteins are involved in many different physiological processes such as cell cycle 
progression, DNA repair, gene regulation or telomere and centromere stabilisation, all of 
which are directly linked to tumourigenesis. It is therefore not surprising that HP1 paralogues 
are involved in cancer progression. To date no human diseases have been associated with 
mutations in the HP1 genes CBX1, CBX5 and CBX3. However, changes in the levels of 
expression have been detected in different cancers.  
High protein levels of HP1γ were linked to enhanced cell proliferation and oncogenesis in 
different cancers such as colorectal 155,156, non-small cell lung 157, prostate 158, cervical and 
breast159,160. Mechanistic insights into how HP1γ may be involved in tumourigenesis, 
however, remain poorly investigated. Given HP1γ’s versatile role in regulating gene 
expression, overexpression of HP1γ in cancer cells is likely to be linked to aberrant gene 
regulation. First insights into how HP1γ may be involved in deregulating genes linked to 
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malignant growth were provided in colorectal cancer155,156. In human colorectal cancer 
HCT116 cells, elevated levels of HP1γ repress gene expression of the cell cycle regulator 
p21(Waf1/Cip1) resulting in uncontrolled cell proliferation155. Consequently, knockout of 
HP1γ in HCT116 cells leads to cell cycle arrest and impaired proliferation in vitro and in vivo. 
Survival of mouse with xenografts of HP1γ depleted HCT116 is significantly increased when 
compared to control mice. The same study identified a tumour-suppressive microRNA (miR-
30a) that is commonly down-regulated in colorectal cancer to target HP1γ155.   
Another recent study demonstrated a role for HP1γ mediated gene regulation in controlling 
the tumour immune environment161. In CD8 positive T cells HP1γ suppresses the expression 
of effector T cell factors such as perforin, granzyme B and the inflammatory cytokine 
interferon γ161. These factors are all necessary for CD8 positive effector T cells to kill target 
cells. HP1γ deficient CD8 positive T cells express high levels of these factors and therefore 
harbour increased tumour-killing capacity. In fact, the tumour burden of mice treated with 
HP1γ deficient CD8 positive T cells is reduced, indicating that targeting HP1γ in CD8 
positive T cells may be a novel therapeutic approach to control growth of solid tumours161. 
HP1γ mediated gene regulation and their association to cancer progression may therefore be 
highly cell type specific.  
Given the number of putative HP1 interactors it is likely that HP1γ participates with, or acts 
downstream of other oncogenic transcriptional regulators. For example, HP1γ is part of 
repressive steroid hormone receptor complexes (compare Section 1.2.8.1.1), which are 
deregulated in different solid and blood cancers162. Furthermore, several H3K9 
methyltransferases are known to be deregulated in cancer163. Thus, HP1γ (and other HP1s) 
could act downstream of these enzymes to reinforce their malignant behaviour. 
Besides regulating gene expression, HP1γ may contribute to tumourigenesis by directly 
regulating physiological processes. Loss of HP1γ causes chromosome segregation defects, 
while over-expression of the protein enhances cell proliferation154. HP1γ interacts with 
cohesin at the spindle poles and is thought to be physically involved in chromosome 
segregation. Furthermore, HP1γ interacts with the shelterin complex at human telomeres and 
is therefore involved in sister telomere cohesion and maintaining telomere lengths by 
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mediating telomerase activity164. Telomerase and telomere length are often deregulated in 
human cancers165.  
HP1γ plays a role in DNA damage repair. It seems to be the only paralogue that suppresses 
homologous recombination (see Section 1.2.3), suggesting that enhanced levels of HP1γ 
could severely affect genomic instability - a key feature of cancer progression165. 
Additionally, HP1γ interacts with different proteins directly involved in the repair of 
DSBs150,153,166,167. 
In summary, elevated levels of HP1γ protein are associated with enhanced cell proliferation 
and tumourigenesis. HP1γ is a versatile transcriptional regulator and its over-expression 
results in aberrant gene regulation linked to malignant cell growth. Given its function in cell 
cycle regulation, DNA repair and telomere regulation, HP1γ is a protein with high oncogenic 
potential. However, to date, only a few studies report mechanistic insights into how HP1γ 
may be involved in cancer progression. 
1.2.8.4. HP1γ in stem cell differentiation 
Mouse embryonic stem cells (mESCs) are derived from the inner cell mass of the blastocyst 
approximately 4 days after fertilisation. They are pluripotent stem cells with the unique ability 
to differentiate into every cell type of the body and to self-renew. These characteristics 
correlate with a distinct nuclear architecture, epigenetic signatures enriched for active 
chromatin marks and hyperdynamic binding of structural chromatin proteins. The process of 
differentiation is accompanied by major chromatin remodeling, which predominantly requires 
formation of facultative heterochromatin to establish cell type specific gene expression 
patterns. HP1 and other structural chromatin factors such as histone H1 play important roles 
in this process97,168. It is therefore not surprising that the subnuclear localisation of HP1 
changes dramatically during differentiation. For all three paralogues, increased 
heterochromatic foci formation was observed upon differentiation of mESCs by 
immunofluorescence staining169,   
Overexpression (OE) of HP1γ in P19 embryonal carcinoma (EC) cells, which are pluripotent 
cells that share many features of mESCs, affects spontaneous cell differentiation170. 
Undifferentiated HP1γ OE cells exhibit no phenotypic differences to P19 parental cells and 
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continue to express pluripotency markers. Interestingly, after embryoid body formation, HP1γ 
OE cells spontaneously differentiate equally into cells of all three germ layers (meso, endo 
and ectoderm), indicating that HP1γ may play a role in the decision of cell fate170. In 
agreement with these results is the recent observation that HP1γ regulates neuronal 
differentiation171. Loss of HP1γ significantly impairs differentiation of mESCs to neural 
progenitor cells (NPCs), while up-regulating genes involved in mesodermal lineage decisions. 
In mESCs, HP1γ binds to promoters of differentiation-related genes, suggesting it directly 
regulates neural and mesodermal gene expression programs during cell fate decision171. In 
addition, loss of HP1γ enhances reprogramming by de-repressing expression of the 
pluripotency gene Nanog172. Importantly, the same study identified a switch in the location of 
HP1γ between pluripotent and non-pluripotent cells, confirming its dynamic role in gene 
regulation during stem cell differentiation. In summary, these studies highlight an important 
function for HP1γ in maintaining the integrity of pluripotent stem cells and regulating the 
establishment of cell type specific gene expression during differentiation. 
1.2.9. Dynamics of HP1 molecules  
The maintenance of stable heterochromatin domains in living cells involves the transient 
binding and dynamic exchange of HP1 from chromatin. Fluorescence after photo-bleaching 
(FRAP) experiments using living cells with GFP-tagged HP1 variants showed relatively rapid 
exchange of HP1 molecules in both heterochromatin and euchromatin. This implies that 
heterochromatin is not a static entity and not completely inaccessible to other 
molecules109,173,174. Although HP1 molecules are highly dynamic, the mobility of all three 
HP1 paralogues is significantly lower in heterochromatin when compared to euchromatin. For 
example, for euchromatic HP1 full recovery after photo-bleaching is reached after 5s, whilst it 
takes 60s to recover when HP1 is associated with heterochromatin109. This difference in 
mobility or the amount of the ‘immobile’ fraction in these two regions may be due to 
differences in the density of HP1 binding sites in euchromatin versus heterochromatin.  
With fluorescence correlation spectroscopy (FCS), a technique to determine the diffusion 
coefficient by monitoring the Brownian movement of individual proteins, different 
populations of molecules within euchromatin and heterochromatin with distinct diffusion 
modes were discovered174,175. This analysis revealed at least two differently mobile HP1 
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populations in euchromatin and three in heterochromatin of mammalian cells, the latter 
including a fraction of very slow molecules in constitutive heterochromatin. There is a highly 
mobile population (fast) of all HP1 isoforms with diffusion coefficients (DC) ranging 
between 0.6 and 0.7±0.03µm2s-1 and a second (slow), much less mobile population with 
diffusion coefficients ranging from 0.07 to 0.04±0.02µm2s-1ref.174,175. In heterochromatin, an 
additional population (DC<<0.04µm2s-1) of immobile molecules was identified. In 
euchromatin, about 70% of molecules show fast and 30% slow diffusion, while in 
heterochromatin the opposite is the case with 30% of molecules showing fast and 60% slow 
diffusion, while the immobile population contains about 10% of all molecules174,175. Taken 
together, these analyses indicate three distinct binding modes of HP1 molecules on chromatin. 
In heterochromatin the majority of molecules move relatively slowly, whilst in euchromatin 
the majority of molecules diffuse relatively fast. These studies did not detect any significant 
differences between HP1 paralogues. 
Studying the plasticity of HP1 molecules during stem cell differentiation can provide valuable 
insights into how HP1 paralogues orchestrate local and global chromatin condensation. 
mESCs show highly diffused staining of HP1, while differentiation to NPCs is accompanied 
by the appearance of defined heterochromatic foci176. FRAP experiments revealed that a 
global reduction of dynamic binding of HP1 precedes formation of distinct heterochromatin 
foci, suggesting that immobilisation of HP1 is an early step in differentiation-dependent 
chromatin remodeling and silencing process176. To date, no differences in subnuclear 
dynamics of HP1 paralogues during differentiation have been identified.  
In summary, the maintenance and de novo formation of heterochromatin during physiological 
processes such as cell differentiation involves the transient binding and dynamic exchange of 
HP1 molecules on chromatin. In general, within mammalian nuclei the fraction of HP1 
molecules with fast diffusion is higher in euchromatic regions than in heterochromatic 
regions. 
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1.3. Aims of PhD thesis 
The overall purpose of this PhD thesis is to discover novel functions of HP1γ in different 
mammalian cell systems. This work has the following aims: 
I. Determine the role of residues R38 and R39 located within the CD in HP1γ’s association 
with chromatin and characterise a novel post-translational modification of HP1γ at these very 
residues in vitro and in vivo using mouse embryonic stem cells (mESCs).  
II. Understand whether HP1γ regulates growth of breast cancer cells by characterising the 
phenotype of HP1γ depletion in different human breast cancer cell models. Furthermore, I 
asked the question whether HP1γ is a transcriptional regulator in breast cancer cells using 
whole transcriptome analysis in cells depleted of HP1γ, cross-referenced the with genomic 
localisation of HP1γ.  
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  Chapter 2
Materials and methods 
 
2.1. General materials 
2.1.1. Standard solutions 
The composition of bacterial media and stock solutions used in this thesis are shown in Table 2-1. 
All modifying and restriction enzymes were purchased from Roche or New England Biolabs.  
Table 2-1 Standard solutions. 
Name Composition per litre 
LB 5g NaCl, 5g yeast extract, 10g bacto-tryptone 
SOB 20g bacto-tryptone, 5g bacto-yeast, 0.58g NaCl, 0.19g KCl,10mM MgCl2, 
10mM MgSO4 and 0.4% glucose 
SOC 
 
20g bacto-tryptone, 5g bacto-yeast, 0.58g NaCl, 0.19g KCl, 10mM MgCl2 and 
10mM MgSO4  
TE 10mM Tris, 1mM EDTA, pH 8.0 
TBE 90mM Tris-borate, 2mM EDTA, pH 6.5 
TBS 150mM NaCl, 20mM Tris-HCl pH 7.6 
PBS 150mM NaCl, 2.5mM KCl, 10mM Na2HPO4, 2mM K2HPO4 
IPH 150mM NaCl, 50mM Tris-HCl pH 8.0, 5mM EDTA, 0.5% NP-40 
RIPA  10mM Tris (pH 8.0), 1mM EDTA, 1% Triton X-100, 0.1% sodium 
deoxycholate, 0.1% SDS, 140mM NaCl 
 
2.1.2. Vectors 
The plasmids used for the various applications detailed below are summarised in Table 2-2. The 
cDNA for human PADI4 was a kind gift from Maria Christophorou (MRC Human Genetics Unit, 
University of Edinburgh). The vector pSB7 was a kind gift from Srinjan Basu (Department of 
Biochemistry, University of Cambridge). It was generated from the pEF/myc/ER backbone 
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(Invitrogen), where the myc/ER regulatory elements were replaced with the sequence encoding 
mEeos3.2-HaloTag. The remaining plasmids were present as stocks in the Kouzarides laboratory 
(Gurdon Institute). 
Table 2-2 Vectors. 
Vector Insert Application 
pcDNA3.1 Human HA-PADI4 Transfection into mammalian cells 
pcDNA3.1 Mouse HA-HP1γ Transfection into mammalian cells 
pSB7 Mouse HA-HP1β/γ WT and 
mutants 
Transfection into mammalian cells 
pCMV6-SPORT Human PADI2 Transfection into mammalian cells 
pLKO.1 shHP1γ_1, shHP1γ_2, shCtrl 
(Sigma) 
Lentiviral infection of mammalian cells 
lentiCRISPR v2 sgRNAs against human CBX3 Lentiviral infection of mammalian cells 
PGEX-2T Mouse HP1β/γ WT and 
mutants 
Recombinant protein expression from 
E. coli 
PGEX-6P Human PADI4 Recombinant protein expression from 
E. coli 
	
 
2.2. Bacterial strains and transformation 
2.2.1. E.coli strains 
XL10-Gold: TetrD(mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte [F ́ proAB lacIqZDM15 Tn10 (Tetr) Amy Camr] 
BL21(DE3): F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 
nin5]) 
DH5a:  F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 
Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
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2.2.2. Growth of bacterial cultures 
Plated cultures were grown at 37°C overnight on LB plates (LB with 20g bacto-agar per litre). 
Bacterial suspension cultures were grown in LB at 37°C overnight. To allow the selection of 
bacteria transformed with plasmid DNA expressing the gene of interest, ampicillin (100µg/ml) or 
kanamycin (100µg/ml) were included in the media. 
2.2.3. Transformation of E. Coli by heat shock 
For the transformation of E. Coli, 0.1µg plasmid DNA was added to 100µl of competent bacteria 
and incubated on ice for 30 min. Samples were heat shocked for 45 seconds at 42°C, returned to 
ice for 3 min following which 1ml of SOC was added. This was incubated at 37°C for 1 hour. 
Bacteria were plated immediately. 
2.3. Preparation of DNA 
2.3.1. Large scale (maxi prep) plasmid DNA preparation from E. coli 
The Qiagen Maxiprep kit was used according to the manufacturer’s instructions. 300ml LB and 
antibiotic was inoculated with a single colony of the appropriate transformant and grown 
overnight at 37°C. Bacteria were harvested by centrifugation at 3500rpm for 10 minutes. The 
bacterial pellet was resuspended in 10ml P1 solution (50mM Tris-HCL pH 8.0, 10mM EDTA, 
100ug RNase A) and then lysed by the addition of 10ml P2 solution (200mM NaOH, 1%SDS). 
Following 5min incubation at room temperature, 10ml ice-cold P3 solution (3.0M potassium 
acetate pH 5.5) was added, the lysate was gently mixed by inversion and incubated on ice for 20 
minutes. The lysate was cleared by centrifugation for 30 minutes at 4000rpm, 4°C. The cleared 
lysate was applied through muslin to a Qiagen 500 (anion-exchange) column, previously 
equilibrated with 10ml QBT buffer (750nM NaCl, 50mM MOPS pH 7.0, 15% isopropanol, 
0.15% Triton-X100). The column was washed two times with 30ml QC buffer (1.0M NaCl, 
50mM MOPS pH 7.0, 15% isopropanol). Plasmid DNA was eluted with 15ml buffer QF (1.25M 
NaCl, 50mM Tris pH 8.5, 15% isopropanol) and precipitated by the addition of 10.5ml 
isopropanol. The DNA precipitate was centrifuged for 30 minutes at 4000rpm, 4°C. The DNA 
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pellet was washed with 70% ethanol and dried prior to being dissolved in TE or nuclease-free 
H2O. DNA concentration was determined by measuring the absorbance at 260nm using a 
NanoDrop® spectrophotometer. 
2.3.2. Small scale (mini prep) plasmid DNA preparation from E. Coli  
The QIAprep Miniprep kit (Qiagen) was used according to the manufacturer’s instructions. 3ml 
LB and antibiotic was inoculated with a single bacterial colony and grown at 37°C overnight. 
Bacteria were pelleted by centrifugation at 3500rpm for 5 minutes. The bacterial pellet was 
resuspended in 250µl P1 buffer (50mM Tris-HCl pH 8.0, 10mM EDTA, 100µg/ml RNase A) and 
lysed by the addition of 250µl of P2 buffer (200mM NaOH, 1% SDS). Following incubation at 
room temperature for 5 minutes, 350µl ice cold N3 buffer was added, the solution mixed by 
inversion and incubated on ice for 5 minutes. The debris was pelleted by centrifugation and the 
supernatant transferred to a Qiagen plasmid spin column and centrifuged again for 1 minute. The 
column was sequentially washed in 500µl PB buffer, 750µl PE buffer and centrifuged for 1 
minute. After the final wash, the column was spun a second time to remove any residual buffer 
and then the DNA eluted in 50µl EB buffer (10mM Tris-HCl, pH8.5) by micro-centrifugation for 
1 minute. 
2.4. DNA cloning 
Several precautions were taken to maximise the generation of recombinant plasmids. (i) Both 
vector and insert fragments were gel-purified to exclude the presence of undigested plasmids in 
the ligation reaction. (ii) Recircularisation of vector fragments was minimised in two ways: (a) 
Where possible DNA fragments were inserted into vectors cut with two enzymes generating 
incompatible ends. (b) If compatible ends were generated, the 5’ terminal phosphate was 
removed from vector DNA with alkaline phosphatase. Ligation by T4 DNA ligase requires the 
presence of 5’ phosphate groups on only one of the two DNA fragments.  
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2.4.1.  DNA restriction digests and dephosphorylation 
0.5-1µg DNA was digested with 5-10 units of restriction endonuclease for 1 hour at 37°C. The 
enzyme buffer and incubation temperature were followed according to the manufacturer’s 
instructions (NEB). 10 units of calf intestinal alkaline phosphatase (Roche) was added directly to 
the completed restriction digest of the vector DNA, and incubated for a further 15 minutes at 
37°C. 6x agarose gel loading buffer (0.25% bromophenol blue, 30% glycerol in H2O) was added 
to the digestions before gel electrophoresis. 
2.4.2. Agarose gel electrophoresis 
DNA fragments were resolved using horizontal agarose gels. 0.8-2.0% agarose gels were made 
by dissolving agarose in 150ml TBE and adding ethidiumbromide to a final concentration of 
0.5µg/ml. The gel was poured into a tray and allowed to set. Once solid, the gel was mounted in 
an electrophoresis tank and covered with TBE. DNA samples were loaded onto the gel in 1x 
agarose gel loading buffer, and electrophoresed at 140V. 1kb ladder (Invitrogen) was run 
alongside the samples as a marker. 
2.4.3. Purification of DNA from agarose gels 
DNA that was stained with ethidiumbromide was visualised in an agarose gel by low wavelength 
UV light. The relevant fragments were cut from the gel with a scalpel. DNA was extracted from 
the agarose using the QIAquick Gel Extraction kit (Qiagen), according to the manufacturer’s 
instructions. Three volumes of QG buffer were added to the agarose slice and the mixture 
incubated at 50°C for 10 minutes with shaking. 1 gel volume of isopropanol was added to the 
dissolved agarose, the mix was then applied it to the Qiagen spin-column and micro-
centrifugation. The DNA was retained in the column. The column was then washed with 750µl of 
PE buffer and micro centrifuged for 1 minute. Any residual buffer was removed by a second spin. 
DNA was eluted in 30µl of EB buffer. 
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2.4.4. DNA ligations  
Purified, linearized vector and insert DNA were ligated with T4 DNA ligase, using the Rapid 
DNA ligation Kit (NEB) according to the manufacturer’s instructions. A molar ratio of 1:5 or 1:7 
(vector : insert) DNA and 5 units of T4 DNA ligase were used as appropriate. The ligation 
reaction was carried out for 5 minutes at room temperature before transformation into competent 
E. coli. 
2.4.5. Polymerase chain reaction (PCR) 
PCRs were carried out in PCR Eppendorf Mastercycler Nexus Gradient Thermal Cycler. PFU 
(Stratagene) was used according to manufacturer's instructions. See Table 2-3 for reaction 
mixtures and protocol. After the PCR, 5µl of the PCR product was analysed by agarose gel 
electrophoresis. Table 2-4 summarises primers used to amplify cDNA constructs for restriction 
cloning. 
Table 2-3 PCR protocols. 
 Standard PCR Mutagenesis PCR 
Mix: 
Made up to 50µl in 
ddH2O 
 
5 µl each primer (10uM) 
4µl of 2.5mM dNTP mix 
5µl of 10x reaction buffer 3ul of MgCl2 
100ng template DNA 
 
125ng each primer 
1µl 10uM dNTP mix  
5µl 10x reaction buffer 
(including 20mM MgSO4) 
2.5µl DMSO 
50ng DNA template 
Enzyme:  
0.25ul Amplitaq Gold 
 
Pfu (2 units) 
Protocol  
95oC, 5 minutes 
95oC, 1 minute 
58oC, 1 minute 
72oC, 2 minutes per kb 
Back to 2 (35 cycles) 
72oC for 10 minutes  
 
 
95oC, 1minute 30 seconds 
95oC, 50 seconds 
60oC, 50 seconds 
68oC, 2 minutes per kb 
Back to 2 (18 cycles) 
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2.4.6. PCR product purification 
PCR products were purified using the QIAquick PCR purification kit (Qiagen), according to the 
manufacturer's instructions. Five volumes of PB buffer were added to the PCR sample. The 
sample was applied to the QIAquick spin-column and micro-centrifuged (13,000rpm, 1min). The 
DNA was retained in the column. The column was then washed with 750µl of PE buffer and 
micro-centrifuged. Any residual buffer was removed by a second spin. DNA was eluted in 30µl 
of EB buffer by micro-centrifugation.  
Table 2-4 Cloning primers. Construct	 PCR	primer	pcDNA3.1	HA-/	pGEX-2TK	-HP1γ	 F_EcoR1:GGAGAATTCATGGGAAAGAAACAAAATGGAAA R_BamH1:GGAGGATCCTTATTGTGCTTCATCTTCAGGAC pGEX-2TK	-HP1β	 F_EcoR1:GGAGAATTCATGGGGAAAAAGCAAAACAAGAAG 
R_BamH1: GGAGGATCCCTAATTCTTGTCGTCTTTTTTGTC pSB7-Halo-mEos3.2-HP1β	 F_Xho1: GGACTCGAGATGGGGAAAAAGCAAAACAAGAAG R_Xba1:	GGATCTAGACTAATTCTTGTCGTCTTTTTTGTC		pEF-Halo-mEos3.2-	HP1γ	 F_Xho1: GGACTCGAGATGGGAAAGAAACAAAATGGAAA R_Xba1:	GGATCTAGATTATTGTGCTTCATCTTCAGGAC	
 
2.4.7. Site-directed mutagenesis 
Mutagenesis was carried out using the Quickchange Site-directed Mutagenesis kit (Stratagene) 
according to the manufacturers instructions. The parental vector was PCR extended with two 
complementary mutagenic primers using PFU DNA polymerase.  See Table 2-3 for reaction mix 
and protocol and Table 2-5 for mutagenesis primers used in this thesis.  The PCR product was 
then treated with 10 units of the restriction endonuclease DpnI (specific for methylated and hemi-
methylated DNA) and incubated for 3 hour at 37ºC.  This digests the parental vector strand (dam 
methylated from E. coli) and selects for mutated synthesised DNA. 5µl of the DpnI digested PCR 
product was transformed into DH5α E. coli.  After plating, single colonies were grown overnight 
at 37ºC. The mini prep kit (see Section 2.3.2) used to isolate DNA and subsequently sequenced. 
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      Table 2-5 Mutagenesis PCR primers. 
Construct generated Primer sequence 
msHP1γ R38/9A Fwd: AAAGTACTGGACGCGGCGGTAGTGAATGGGAAG 
Rev: CTTCCCATTCACTACCGCCGCGTCCAGTACTTT 
msHP1γ R38/9K Fwd: AAAGTACTGGACAAGAAGGTAGTGAATGGGAAG 
 Rev: CTTCCCATTCACTACCTTCTTGTCCAGTACTTT 
msHP1γ R39A Fwd: AAAGTACTGGACCGTGCTGTAGTGAATGGGAAG 
 Rev:  CTTCCCATTCACTACAGCACGGTCCAGTACTTT 
msHP1γ R38A Fwd: AAAGTACTGGACGCTCGTGTAGTGAATGGGAAG 
 Rev: CTTCCCATTCACTACACGAGCGTCCAGTACTTT 
msHP1γ V32M Fwd: CCTGAAGAATTTGTGATGGAAAAAGTACTG 
 Rev: CAGTACTTTTTCCATCACAAATTCTTCAGG 
msHP1γ I165K Fwd: TGTCCTCAGATTGTCAAGGCCTTCTACGAGGAG 
 Rev: CTCCTCGTAGAAGGCCTTGACAATCTGAGGACA 
msHP1β I161M Fwd: TGCCCACAGGTTGTCATGCCCTTCTATGAGGAA 
Rev: TTCCTCATAGAAGGGCATGACAACCTGTGGGCA 
 
2.4.8. Oligonucleotides and DNA sequencing 
All oligonucleotides were synthesised by Sigma Genosys and IDT.  The automated DNA 
sequencing service at the Department of Biochemsitry performed all sequencing.  
2.5. RNA purification and mRNA quantification 
2.5.1. RNA purification 
RNA isolation was performed using the RNeasy Plus RNA isolation kit (Qiagen) according to 
manufacturer’s instructions. With this method all RNA molecules longer than 200bp are purified, 
therefore RNA is enriched for mRNA molecules. Up to 106 cells were pelleted and lysed in 350µl 
RLT Plus lysis buffer supplemented with β-mercaptoethanol at 0.143M concentration. To remove 
genomic DNA, the homogenised lysate was transferred to a gDNA eliminator spin column and 
centrifuged for 30 s at 10000rpm. One volume of 70% ethanol was added to the flow-through and 
mixed by pipetting. The mix was then transferred to a RNeasy spin column to bind total RNA 
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and centrifuged for 15 s at 10000rpm. Flow-through was discarded, column was washed with 
700µl of RW1 wash buffer and centrifuged for 15s at 10000rpm. Column was washed another 2 
times with 500µl RPE wash buffer and centrifuged for 15s and 2min respectively. Column was 
then placed in a fresh Eppendorf tube and RNA was eluted in 50µl nuclease-free H2O. RNA 
concentration was measured using a Nanodrop spectrophotometer at 260nm. 
2.5.2. First strand cDNA synthesis 
The Superscript III Reverse Transcriptase kit (Invitrogen) was used according to manufacturers 
instructions to synthesise first strand cDNA. RNA purified as described (Section 2.5.1) was 
mixed with 1µl of DNase I for 30 minutes at room temperature. The enzyme was inactivated by 
heating for 10 minutes at 37°C. 500ng of RNA was mixed with 1µl hexanucleotide primers 
(100ng/µl), 1µl of oligo (dT) primers (50µM), 1µl dNTP (10mM) and 12µl H2O. Samples were 
heated for 5 minutes at 65°C then mixed with 4µl 5xfirst strand buffer, 1µl 0.1M DTT, 1µl of 
RNAse out (a recombinant ribonuclease inhibitor at 40U/µl) and 1µl Superscript III RT for 5 
minutes at 25°C. cDNA was synthesised by incubating samples at 50°C for 30-60 minutes. 
Reactions were inactivated for 15 minutes at 70°C. RNA complimentary to cDNA was removed 
by the addition of 1µl RNase H for 15 minutes at 37°C.  
2.5.3. Quantitative real-time RT-PCR 
cDNA purified as described (Section 2.5.2) was used to quantify mRNA levels. Alternatively 
genomic DNA isolated from cell lines, primary human samples or chromatin 
immunoprecipitation analysis was used to quantify DNA. Quantitative real-time PCR was 
performed with the ABI Prism 7300 apparatus (Applied Biosystems) sequence detection system 
using SYBRGreen as the detector. A 10µl reaction was used on 96 well plates (SYBRGreen 
master-mix 5µl, forward primer (200 µM) 0.05µl, reverse primer (200 µM) 0.05 µl, cDNA 1 µl, 
RNase-free water 3.9 µl.) A standard curve was included for each gene. PCR amplification was 
performed with an initial step of 10 minutes at 95°C, followed by 40 cycles of 15 seconds at 
95°C and 1 minute at 55-60°C. Primes are summarised in Table 2-6.       
Table 2-6 RT-PCR primers. (next page) 
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Gene Primer sequence 
hsHP1γ exon 3-4 Fwd:TTCCTGAAGTGGAAGGGATTT 
Rev: TTTTCTTTGCCAGCTTTCTGA 
hsHP1γ exon 4-5 Fwd: GCTGGCAAAGAAAAAGATGG 
Rev: TCTGGCAAATCCTCTTGGTT 
hsB2M Fwd: GAGTATGCCTGCCGTGTG 
Rev: AATCCAAATGCGGCATCT 
hsTUBB exon                                      Fwd:GTCCTGGATGTGGTACGGAA 
                                    Rev: GCTGATAAGGAGAGTGCCCA 
hsTUBB exon                                     Fwd: GGTGGCAAATATGTTCCTCGT  
                                    Rev:CCAAAAGGACCTGAGCGAAC 
hsZHX1 
 
Fwd: TGTTGGTACTGCACAGCCTA 
Rev: CTGAAGGACACGAAGCTGC 
hsZNF229 Fwd: GCCTCAGCCATTTCCCAAG 
Rev: GCTCCTCCTCAGTGAAGACC 
hsZNFX1 Fwd:CTGGCTATTATTCAAGGACCT 
Rev: GGGGAACTTCTGGAGGCTAA 
hsZNF778                                     Fwd: CCAGCACTTCGGCAGGATA  
                                    Rev: GAAAGCTTCTCCACACTGCG 
hsZBTB43 Fwd: TCCCAAAGCCCAAGAACTGA 
Rev: TCATGCTCTGTGGACGAGTT 
hsZMAT1 Fwd: GCCAGAGGACTAGAGCCAA 
Rev:TCTGGAAAGTCTCACATGGGA 
hsZNF124 Fwd: GGAATGCGGAAAGAAGCCAT 
Rev: ACTGTGTCTCTGTGAACCCT 
hsPIM1 Fwd: CGCGACATCAAGGACGAAAA 
Rev: GAGGGCTATACACTCGGGTC 
hsIFIT3 Fwd: CAAACAGATGTCCTCCGCAG 
Rev: CCTTGTAGCAGCACCCAATC 
hsIFNL2/3 Fwd: CTGGGACCTGAGGCAGCT 
Rev: TATGGTGCAGGGTGTGAAGG 
hsIFNB1 Fwd: TGCTCTCCTGTTGTGCTTCT 
Rev: AAGCCTCCCATTCAATTGCC 
hsSTAT1 Fwd: TGCCACCATCCGTTTTCATG 
Rev: GACATCTGGATTGGGTCTTCC 
hsCXCL8                                     Fwd: CAGTTTTGCCAAGGAGTGCT 
                                    Rev: TGGTCCACTCTCAATCACTCT 
hsXAF1 Fwd: CTGCCAACTTCACCCTCCAT 
Rev: ACACATCGTACACCCAACCT 
hsBIK Fwd: GAGATGGACGTGAGCCTCAG 
Rev: TGATGTCCTCAGTCTGGTCG 
hsBID Fwd: CGCTTGGGAAGAATAGAGGC 
Rev: GGAGGGATGCTACGGTCC 
hsTNF Fwd: GTCAACCTCCTCTCTGCCAT 
Rev: CTGAGTCGGTCACCCTTCTC 
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2.6. Protein purification, detection and analysis 
2.6.1. SDS polyacrylamide gel electrophoresis (PAGE) 
Proteins were separated in 10-20% acrylamide gels according to size, by the standard Laemmli 
procedure of one-dimensional gel electrophoresis under denaturing conditions. The mini-protean 
II gel apparatus (BioRad) was assembled according to the manufacturers instructions with 
0.75mm spacers and combs. To prepare a 10% separating gel, 2.5ml 30% acrylamide (37.5:1 
acrylamide:bisacrylamide), 2.8ml 1M Tris pH8.8, 37.5ml 20% SDS and 2.18ml ddH2O were 
mixed. For preparation of gels with lower or higher acrylamide concentration the volumes of 
acrylamide and ddH2O used were adjusted accordingly. 20µl 20% APS and 10µl TEMED were 
added to initiate polymerisation of the acrylamide.  The gel solution was applied to the 
sandwiched glass until the height of the solution was 2cm from the top of the small plate. ddH2O-
saturated butanol was then overlaid and the gel left to polymerise. After polymerisation, the 
overlaid butanol was removed. The stacking gel was prepared by mixing 0.85ml 30% acrylamide 
(37.5:1 acrylamide:bisacrylamide), 0.625ml 1M Tris pH6.8, 25ml 20% SDS, 3.5ml ddH2O, 20µl 
20% APS and 5µl TEMED. The solution was applied into the glass sandwich, a comb inserted 
into the stacking solution and the gel was left to polymerise. Protein samples were denatured by 
boiling in 1xSDS loading buffer (200mM Tris-HCl pH6.8, 20% (v/v) β-mercaptoethanol, 2% 
(v/v) SDS, 0.1% (w/v) bromophenol blue, 40% (v/v) glycerol) for 5 minutes, and then loaded 
onto the gel. The gel was electrophoresed in Tris-glycine running buffer (25mM Tris-HCl, 
250mM glycine, 0.1% (v/v) SDS) at 150-200V. Pre-stained high molecular weight protein 
markers were run alongside the samples (Bio-Rad).  
2.6.2. Coomassie-blue staining of protein gels 
Following electrophoresis, proteins were visualised by staining the gel with a staining solution 
(0.5% (w/v) Coomassie Brilliant Blue 40%, (v/v) methanol, 10% (v/v) acetic acid). Gels were 
incubated at room temperature for 60 minutes with gentle agitation. The staining solution was 
hsDDX58 Fwd:CGTCAGTGATAGCAACAGAA 
Rev: TCTCTGTGTCCCTCATCAGC 
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then replaced with de-stain solution (20% (v/v) methanol, 10% (v/v) acetic acid) and shaken 
gently until blue bands containing protein were visible against a clear background within the gel.   
2.6.3. Preparation of mammalian cell samples for Western blotting 
Approximately 1x106 cells washed twice in 1xPBS buffer to remove residual culture medium 
components and pelleted. Pellets were lysed by the addition of 500µl 1x SDS loading buffer. The 
lysed cells were transferred to an Eppendorf tube and sonicated at the high setting (Utrasound 
waterbath) for 5 minutes with 30 seconds off and 30 seconds on. The samples were then boiled 
for 5 minutes. 10-30µl of the whole cell extracts (lysate from ~ 20000-60000 cells) were analysed 
by SDS-PAGE and immunoblotting.  
2.6.4. Western blotting 
Proteins were transferred from polyacrylamide gels to nitrocellulose membranes using the mini-
trans blot cell (BioRad). Following electrophoresis, gels were transferred into transfer buffer. 
Tris-glycine transfer buffer (192mM glycine, 25mM Tris-HCl) was used for proteins > 50kDa 
and for proteins <50 kDa phosphate transfer buffer (50x: 500mL of 1M Na2HPO4, 425ml 1M 
NaH2PO4) was used. The gel was sandwiched next to nitrocellulose (Amersham Protram), 
between 2 pieces of Whatman 3MM paper and between 2 sponge pads. The sandwich was 
inserted into the transfer chamber filled with 1x phosphate transfer buffer such that the 
nitrocellulose was facing the positive anode. Proteins were transferred to the nitrocellulose by 
applying a constant current (0.4A) for 1.5h, using an ice-block to keep the buffer cool. After the 
transfer, the nitrocellulose membrane was stained with ponceau S to ensure equal transfer and 
then placed either in milk blocking buffer (TBS with 0.5% (v/v) Tween-20, 5% (w/v) non-fat 
milk powder) or BSA blocking buffer (TBS with 0.5% (v/v) Tween-20, 5% BSA), for a 
minimum of 1 hour at room temperature. The filter was then sealed in a bag containing primary 
antibody diluted in blocking buffer, and incubated at room temperature on a rocking table for 2 
hours or overnight at 4°C. The filter was washed three times for 5min in TBS with 0.1% (v/v) 
Tween-20 and gentle agitation. The filter was then incubated with secondary antibody 
(conjugated to horse-radish peroxidase) diluted in blocking buffer. This was incubated at room 
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temperature for 1 hour and the filter washed twice for 20 minutes in TBS with 0.1% (v/v) Tween-
20. Detection of protein bands was carried out using the ECL system (Promega) according to the 
manufacturers instructions. ECL reagents were mixed 1:1 and incubated with nitrocellulose for 
required time. After incubation, excess fluid was drained off and the filter was exposed to X-ray 
film (Fuji) or analysed using a Chemidoc™ imaging system (BioRad).  
2.6.5. Dot blot assays 
Dot blot assays were performed by spotting synthetic peptide onto pre-wet PVDF membranes. 
Membranes were blocked in BSA blocking buffer for 1 h at RT. Blocked membranes were then 
probed with primary antibodies at 4°C o/n. Membranes were washed 3 times for 30s in TBS with 
0.1% (v/v) Tween-20 followed by another 10m wash in the same buffer to remove residual 
antibodies. Membranes were then incubated in appropriate secondary antibodies and developed 
as described above (Section 2.6.4).  
2.6.6. Antibody purification from crude sera 
Principle of antibody purification is illustrated in Figure 3-12. Sulfhydryl-groups of peptides (see 
Table 2-8) were reduced using Bond-Breaker™ TCEP Solution (Thermofisher Scientific). 
Reactions were all performed at RT. 200µg of peptide were mixed with coupling buffer (50mM 
Tris HCl pH 8.5, 5mM EDTA in H2O) and 25mM TCEP to a final volume of 2ml and incubated 
at RT for 30min. To couple reduced peptides to SulfoLink™ Coupling Resin (Thermofisher 
Scientific), 200µl of pure resin (400µl slurry) was washed in coupling buffer at RT and then 
incubated with 2ml of reduced peptide solution. The mix was incubated at RT on a rotating wheel 
for 15min and then for another 30min, this time standing upright without rotation. Resin was then 
spun down gently at 800rpm for 2min ad washed 3x in coupling buffer. To block unspecific 
binding, resin was incubated in quenching reagent (50mM L-cysteine in coupling buffer) at RT 
on a rotating wheel for 15min and then for another 30min, this time standing upright without 
rotation. Resin was then washed 3x in wash buffer (1M NaCl in H2O) and 2x in storage buffer 
(0.05%(w/v) NaN3 in 1xTBS). Resin could now be stored at 4°C until usage. Before usage resin 
was washed 3x in 1xTBS. 5ml of crude sera were spun down at full speed for 10min and 
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supernatant was moved into fresh 15ml falcon. Resin was then added and the coupling reaction 
was incubated at RT on a rotating wheel for 1h. Resin was then washed 4x in 1xTBS. To elute 
the antibodies off the resin 200µl of elution buffer (0.2M glycine HCl pH 2.5) were added and 
tube was quickly flicked and directly microcentrifuged at 800rpm for 1min. Supernatant was 
moved to a fresh tube and placed on ice. Immediately 10µl of ice-cold neutralisation buffer (1M 
Tris HCl ph 8.8) were added and mixed thoroughly to neutralise the pH to 7. Elution step was 
repeated 2-3 times. Beads were restored by washing 6x in binding/wash buffer and stored in 
storage buffer at 4°C. 
2.6.7. Antibodies 
The following antibodies were used in the listed concentrations for western blot, 
immunoprecipitation and immunofluorescence assays (Table 2-7). 
Table 2-7 Primary antibodies. 
Antibody Description Concentration 
  WB IP ChIP 
HP1β Rabbit polyclonal, Abcam 1:1000   
HP1γ Rabbit polyclonal, Abcam ab1080 1:2000   
HP1γ Mouse monoclonal, Millipore clone42s2 1:1000 5µg 5µg 
GAPDH Rabbit polyclonal Abcam ab9485 1:1000   
β-Tubulin Rabbit Polyclonal, Abcam ab6046 1:1000   
H3 Rabbit polyclonal, Abcam; ab1791 1:1000   
H3S10ph Rabbit Polyclonal, Abcam ab5176 1:1000   
H3K4me3 Rabbit Polyclonal, Abcam ab8580   2µg 
H3K36me3 Rabbit Polyclonal, Abcam ab9050   2µg 
H3R2-Cit Rabbit polyclonal, Abcam ab176843 1:1000   
Citrulline Rabbit Millipore clone 07-377 1:1000   
HA Rabbit Polyclonal, Abcam ab9110 1:1000   
GAPDH Rabbit Polyclonal, Abcam ab8245 1:1000   
Cleaved PARP1 Rabbit polyclonal, Abcam ab3251 1:5000   
GFP Rabbit polyclonal, Abcam ab290    5µg 
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Table 2-8 Secondary antibodies. 
Antibody Description Concentration 
Rabbit IgG H&L Goat anti-rabbit HRP conjugated, Abcam 
ab6721 
 1:20000  
Mouse IgG H&L Rabbit anti-mouse HRP conjugated, Abcam 
ab6728 
 1:5000  
Sheep IgG H&L Rabbit anti-sheep HRP conjugated, Abcam 
ab6747 
 1:10000  	
2.6.8. Immunoprecipitation from mammalian cell extracts (IP) 
Approximately 10x106 cells were washed twice in 1xPBS. Cells were pelleted and resuspended in 
ice-cold IPH lysis buffer (see Table 2-1) or ice RIPA lysis buffer with protease inhibitor cocktail 
(CompleteTM, Roche) and incubated on ice for 20 minutes and vortexed every 5min. IPH lysis 
buffer was used for co-immunoprecipitation assays and RIPA lysis buffer for standard 
immunoprecipitation assays. Extracts were cleared of debris by centrifugation (15 minutes, 
13000rpm, 4°C). Extracts were then incubated with 3-5µg of antibody, on a rotating wheel at 4°C 
for a minimum of 2 hours or o/n. 20µl protein A/protein G sepharose beads (1:1 mix) were added 
and the incubation continued for 4h. The sepharose beads were pelleted in a cooled micro-
centrifuge (4000rpm, 1 min, 4°C) and washed 3 times with ice-cold IPH. After the final 
centrifugation, the beads were resuspended in 1xSDS loading buffer and resolved by SDS-PAGE 
and immunoblotting.   
2.6.9. Fractionation of mammalian cells  
Approximately 5x106 cells were washed twice in 1xPBS. Cells were pelleted and resuspended in 
ice-cold IPH lysis buffer (see Table 2-1) with protease inhibitor cocktail (CompleteTM, Roche) 
and incubated on ice for 20 minutes and vortexed every 5min. Extracts were centrifuged for 
15min at 13000rpm and 4°C. The supernatant contains the nucleo- and cytoplasmic fraction and 
the insoluble pellet is composed primarily of chromatin and associated proteins.  
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2.6.10.    Production of recombinant fusion proteins from E. coli 
Protein coding sequences for each of the HP1β and γ domains were cloned into the relevant 
vector so that the region was in frame with the fusion. These constructs were transformed into the 
relevant E. coli as described (Section 2.2.1). Table 2-4 details the primers used to clone each of 
the HP1β and γ variants into pGEX-2T using the restriction enzyme sites for BamH1 and EcoRI. 
For GST fusion proteins, 10ml overnight cultures were set up in LB/antibiotic and then diluted 
1:10 into 100ml LB/antibiotic the following morning. Cultures were grown at 37°C until OD600 
reached 0.6-0.8 (log-phase). Protein expression was induced at log-phase by the addition of IPTG 
to 1mM final concentration and cultures grown for a further 4 hours at 37°C.  The bacteria were 
pelleted by centrifugation and resuspended in ice-cold 5ml TBS containing 1% (v/v) Triton-X-
100 and protease inhibitor cocktail. The cell suspension was sonicated with a probe sonicator for 
3min at high settings with 30 seconds on and 30 seconds off (Bioruptor, Diagenode) and 
centrifuged (5000 rpm, 15 minutes, 4°C).  The supernatant was poured into a 15ml Falcon tube 
containing 300µl of Glutathione linked sepharose beads slurry (Amersham), and rocked for 1 
hour at 4°C.  The beads were washed twice with 1xTBS, 1% (v/v) Triton-X-100 and twice with 
1xTBS.  The fusion proteins were either stored frozen on the beads in an equal volume 1xTBS 
with 20% (v/v) glycerol or eluted from the beads using 300µl glutathione solution (25mM 
reduced glutathione, 50mM Tris pH 8.0). 
2.7.  In vitro assays 
2.7.1. In vitro binding assays 
The GST-fusion proteins and biotin-conjugated peptides (Table 2-9) were incubated with 
glutathione agarose beads or streptavadin sepharose beads respectively in binding buffer (150mM 
NaCl, 50mM Tris-HCl pH 8.0, 5mM EDTA and 0.2% NP-40) for 1 hour at room temperature. 
After washing three times in binding buffer the beads were incubated with their potential binding 
proteins for 1 hour at room temperature. The beads were then washed 4 times with binding 
buffer, following which the bound protein was eluted with hot 2x SDS loading buffer and 
resolved by SDS-PAGE for western blot analysis or coomassie-blue staining.  
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2.7.2. In vitro citrullination assays 
Recombinant human PADI4-GST was expressed from pGEX6p constructs in LB media, induced 
with 0.1mM IPTG at 25oC, purified using glutathione-sepharose resin, eluted using a 25mM 
glutathione solution. PADI4-GST was used fresh. In vitro deimination of HP1γ wildtype and 
HP1γ R38/9A mutant protein was carried out in deimination buffer [50mM HEPES, pH 7.5; 
2mM DTT; in the presence of absence of 10mM CaCl2] at 37°C for 1h, using the active enzyme. 
Samples were eluted with hot 2xSDS loading buffer and analysed by immunoblotting. 
Table 2-9 Peptide sequences. 
	
2.8. Mammalian cell culture  	
2.8.1. Cell culture media, reagents and maintenance 
All tissue culture manipulations were carried out in sterile conditions in a standard laminar flow 
hood. Human cell lines (see Table 2-10, row 1-4) were maintained in 10cm culture dishes in 
DMEM (Gibco), 10% FCS, 1% penicillin/streptomycin, 2mM L-glutamine. MCF10A were 
cultured in DMEM/F12, 5% horse serum, 20ng/ml human EGF, 0.5mg/ml hydrocortisone, 
100ng/ml cholera toxin, 10µg/ml human insulin and 1% penicillin/streptomycin. All cell cultures 
were stored in incubators at 37°C in 5% CO2 (100% humidity) and passaged between 1:3 and 1:5 
every 2-3 days. Cells were passaged using conventional cell culture techniques.  
Name Peptide sequence 
H3 (1-16) Biotin-ARTKQTARKSTGGKAPGGC 
H3 (1-16) K9me3 Biotin-ARTKQTARK(me3)STGGKAPGGC 
HP1γ (34-44) KVLDRRVVNGKC 
HP1γ (34-44) R38-Cit  KVLD(Cit)RVVNGKC 
HP1γ (34-44) R39-Cit KVLDR(Cit)VVNGKC 
HP1γ (34-44) R38/9-Cit KVLD(Cit)(Cit)VVNGKC 
HP1γ (104-111)  SKKKRDAADKC 
HP1γ (104-111) R108-Cit SKKK(Cit)DAADKC 
HP1α (103-112)  SKKKREQSNDC 
HP1α (103-112) R107-Cit SKKK(Cit)EQSNDC 
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Mouse embryonic stem (ES) cell lines were cultured in standard serum and mouse leukemia 
inhibitory factor (mLIF) conditions. DMEM (Gibco) supplemented with 15% FCS, 0.1mM non-
essential amino acids (Gibco), 1% penicillin/streptomycin, 2mM L-glutamine (Gibco), 1mM 
sodium pyruvate (Gibco), 0.1mM beta-mercaptoethanol (Life tech) and 106 units/L mLIF 
(ESGRO, Millipore). E14 ES cells were stored in incubators at 37°C in 7.5% CO2 (100% 
humidity) and maintained in 0.1% gelatine coated 10cm culture dishes with 1:10 passaging every 
2 days. Media was changed on a daily basis.  
Table	2-10	Cell	lines.	
	
2.8.2. Transient transfection of MCF7 using FuGENE® 
MCF7 cells were seeded into 6-well dishes 24h prior to transfection. Dishes contained 
approximately 4x105 cells or were 80% confluent on the day of transfection. Media was replaced 
with 2ml of antibiotic-free DMEM (Gibco) media with 10% FCS. 6µl of FuGENE® was mixed 
with 72µl of Opti-MEMTM (Gibco). 2µg of DNA was mixed with 40µl of Opti-MEMTM (Gibco), 
then added to the mix and incubated for 20min at RT. The transfection mix was dropped onto the 
cells and 6-16 hours later 2ml of normal media were added.  
2.8.3. Transient transfection of mESCs using Lipofectamine 2000® 
5µl of Lipofectamine 2000® was mixed with 245µl of Opti-MEMTM (Gibco). 2µg of DNA was 
mixed with 250µl of Opti-MEMTM (Gibco), then added to the mix and incubated for 20min at 
RT. The transfection mix was mixed with 5x105 mESCs in 1.5ml antibiotic-free ESC media. The 
Name Cell type Details 
MCF7 
Human mammary adenocarcinoma  
ER+/PR+/Her2-, p53 wildtype, 
Luminal A type breast cancer 
cells 
MDA-MB-231 
Human mammary adenocarcinoma 
p53 mutant chemotherapy 
resistant, metastatic breast 
cancer cells  
HEK293T Human embryonic kidney cells Used for lentiviral packaging  
MCF10A Human mammary gland Immortalised, non-transformed 
mESC Mouse embryonic stem cells  E14 cell clone 
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mix was seeded into 0.1% gelatin coated 6-well dishes. Media was replaced carefully with 2ml of 
antibiotic-free ESC media 4h post transfection.  
2.8.4. Transient transfection with siRNAs using Dharmafect® (reverse) 
2µl of Dharmafect® or DharmafectDuo® was mixed with 198µl of Opti-MEMTM (Gibco). siRNAs 
were used at a final concentration of 100nM.10µl of siRNAs (20µM stock, Dharmafect) were 
mixed with 190µl of Opti-MEMTM (Gibco), then added to the mix and incubated for 20min at 
RT. The transfection mix was mixed with 5x105 MCF7 or MDA-MB-231 cells in 1.6ml 
antibiotic-free DMEM media with 10% (v/v) FCS. 12-16h later 2ml of normal media were added. 
siRNAs were ordered from Dharmacon. A list of siRNAs used in this study is summarised in 
Table 2-11. 
Table 2-11 siRNA sequences. 
 
2.8.5. Production of lentiviral particles 
5x10^6 HEK293T cells were seeded onto L-polylysine (1µg/ml) coated 10cm dishes 24h prior to 
transfection in antibiotic-free DMEM media with 10% (v/v) FCS. Cells were 80% confluent on 
the day of transfection. For production of lentiviral particles, the 3rd generation packaging system 
was used. 50µl Lipofectamine 2000® was added to 450µl of Opti-MEMTM (Gibco). 4µg of 
pCMV-VSVG (Addgene#8454) encoding viral envelope proteins, 12µg of psPAX2 
(Addgene#12260) encoding viral gag, pol, rev and tat proteins, 8µg of pLKO.1_shRNA vectors 
or lenti_CRISPR_V2 vectors were mixed with Opti-MEMTM (Gibco) to a final volume of 500µl. 
The DNA mix was added to the Lipofectamine 2000® mix and incubated for 20min at RT. The 
Name Sequence Target 
siHP1γ_1 AUCUGACAGUGAAUCUGAU hsCBX3, CDS 
siHP1γ_2 GAGGCAGAGCCUGAAGAAU hsCBX3, CDS 
siHP1γ_3 UCAGAAAGCUGGCAAAGAA hsCBX3, CDS 
siCtrl UCUCGACCCUGAACGAAUAAU Non-targeting control 
(Dharmacon) 
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transfection mix was dropped onto the cells and 12-14h later 6ml of normal media were added. 
Cells were incubated and handled under Cat.2 safety conditions. 24h after the media change 
cellular supernatant containing lentiviral particles was harvested and sterile filtered using 0.45µm 
syringe filters (Millipore). Aliquots of lentiviral supernatants were stored at -80°C. Titer of 
lentiviral particles was determined using MCF7 cells. 5x10^5 cells were seeded into 6-well 
dishes 24h prior to infection. Media was removed and replaced by 5 serial dilutions of viral 
supernatant (SN) in a total volume of 1ml starting from undiluted SN (1000, 100, 10, 1, 0.1 µl of 
viral supernatants). Cells were incubated at 37°C. As the pLKO.1 shRNA constructs contain a 
puromycin resistance gene cassette, puromycin was used for positive selection of transduced cells 
at 1µg/ml. Puromycin supplemented media was replaced every 3 days. After 8 days and the 
number of colonies was determined. Therefore, cells were washed once with 1xPBS and stained 
and fixed with a crystal violet solution (0.05% (w/v) crystal violet, 20% (v/v) EtOH in ddH2O) 
for 1h in the dark at RT. Cells were then washed twice in ddH2O. Plates were dried over night 
and colonies were counted. Titers of viral SN were calculated according to the following formula: 
Titer SN TU ml = 2 ∙ (𝑛𝑢𝑚𝑏𝑒𝑟 𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑 𝐷𝐴𝑌1)1000 µ𝑙𝑉𝑜𝑙𝑢𝑚𝑒 (𝑣𝑖𝑟𝑎𝑙 𝑆𝑁)[µ𝑙]  ∙ 𝑛𝑢𝑚𝑏𝑒𝑟 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 
2.8.6. Lentiviral infection 
MCF7, MCF10A or MDA-MB-231 cells were seeded into 6-well dishes 24h prior to infection. 
Dishes contained approximately 4x105 cells or were 80% confluent on the day of infection. 
pLKO.1 shRNA containing lentiviral particles were produced as described in Section 2.8.5. A list 
of shRNA sequences used in this study is summarised in Table 2-12. Lentiviral supernatants were 
added to cells at an estimated MOI of 10 together with 8µg/ml of transduction enhancer 
polybrene (Sigma Aldrich). 12h later 2ml of normal media were added. 24h post infection cells 
were cultured in puromycin selection media (MCF7: 1µg/ml, MDA-MB-231: 0.5µg/ml, 
MCF10A: 2µg/ml). 
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Table 2-12 shRNA and guideRNA (sgRNA) sequences. 
 								
2.8.7. Proliferation assay 
Proliferation of human cell lines was assessed using the CyQUANT® proliferation assay 
(ThermoFisher Scientific) according to the manufacturer’s instructions. At day 0, cells were 
seeded at a density of 500 cells per well into wells of a 96 well plate. Per condition and per time 
point 18 wells were seeded. Proliferation was measured at 5 time points (day 0 (=12h post 
seeding), 2, 4, 6, 8). Cell were prepared for analysis by removing media, washing the wells twice 
with 1xPBS and freezing the plates at -80°C until analysis. 200µl of 1x cell lysis buffer 
supplemented with 2x QUANT® GR DNA intercalating dye were added per well and incubated 
in the dark until measurement. Fluorescence was measure using a Clariostar® plate reader at 
520nm. Values were blank corrected and both the three highest and lowest fluorescence values 
were regarded as outliers and not included into further data analysis. In order to correct for 
seeding variability, all fluorescence values were normalised to the average of all fluorescence 
values of day 0 of the respective condition and plotted using GraphPad Prism software 
(GraphPad Software Inc. (La Jolla, United States of America)). 
2.8.8. Cell cycle analysis by flow cytometry 
MCF7 and MDA-MB-231 cells were seeded into wells of 6 well plate 2 days after infection with 
shRNA vectors. At the day of analysis, cell at approximately 80% confluency were trypsinised 
and washed twice in 1xPBS. After the last wash cell pellet was resuspended in 100µl of 1xPBS. 
200µl of staining solution were added (6% (v/v) NP-40, 50 µg/ml propidium iodide, 0.1 mg/ml 
Name Sequence Target 
shHP1γ_1 GCGTTTCTTAACTCTCAGAAA hsCBX3, CDS 
shHP1γ_2 CTGGCGAAAGAGGCAAATATG hsCBX3, CDS 
shCtrl CAACAAGATGAAGAGCACCAA Non-targeting (Sigma) 
sgCBX3 #79 CACCGGGCCTCCAACAAAACTACAT hsCBX3 exon 2 
sgCBX3 #81 CACCGAGAGCCTGAAGAATTTGTCG hsCBX3 exon 3 
sgCBX3 #83 CACCGAGAAACGCTTCAATCAATTC hsCBX3 exon 4 
sgCtrl CACCGGCGAGGTATTCGGCTCCGCG Non-targeting 
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RNase in 1xPBS) and incubated at RT in the dark for 15min. The propidium iodide stained cells 
were then analysed by flow cytometry on a Becton Dickinson FACS CaliburTM system.  
Flow cytometry analysis was performed through a custom R script. Briefly, raw FCS acquisition 
files were imported in R taking advantage of the package flowCore177. Acquired events were 
manually gated by the physical parameters Forward Scatter (FSC) and Side Scatter (SSC) in 
order to filter out and minimise the cellular debris, characterised by low intensity values. The 
G0/G1 and G2/M populations were fitted by two Gaussian distributions by first finding the local 
maxima of the FL2-A intensity distribution (Filter: 564-606nm) closest to the expected values of 
200 and 400, respectively; then, relative weights and the standard deviations of each distribution 
were calculated from their FWHMs (Full widths at half maximum). The fraction of each cell 
cycle state was computed as the fraction of the area under the curve of the corresponding 
population (see Figure 4-6C: as an example plot of the analysis). Values of S population were 
derived by subtracting the fitted areas of G0/G1 and G2/M populations from the global intensity 
distribution.  
2.8.9. Annexin V and propidium iodide staining  
MCF7 and MDA-MB-231 cells were seeded into wells of 6 well plate 2 days after infection with 
shRNA vectors. At the day of analysis at approximately 80% confluency, detached cells were 
collected and attached cells trypsinsed. Detached and trypsinsed cells were recombined and 
washed twice in 1xPBS. To measure the proportion of viable and apoptotic cells AnnexinV-FITC 
Apoptosis staining/detection kit (Abcam ab14085) was used at manufacturer’s instructions. Cells 
were then resuspended in 300 µl of the staining solution containing 5µl Annexin V-FITC 
detection reagent and 5µl of propidium iodide (PI) (final concentration: 50µg/ml) and incubated 
for 5min at RT in the dark. PI staining was used to distinguish between live and dead cells. 
Annexin V-FITC as a marker for apoptotic cells. Cells were analysed by flow cytometry on a 
Becton Dickinson FACS CaliburTM system. Properties of fluorophores are: FITC (ex = 488nm, 
em = 530nm), PI (ex = 488nm, em = 617nm).  
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2.8.10. Transwell migration assay 
MDA-MB-231 or MCF7 cells were transfected with siRNAs (Section 2.8.4, Table 2-10) and 
incubated for 44h (MDA-MB-231) or 24h (MCF7) at 37°C, after which cells were prepared for 
the transwell migration assay. 2h before the assay the bottom side of 24-well Corning® 
BioCoat™ Control Inserts (8.0µm pores) were incubated in 1µg/ml human fibronectin solution 
and washed in 1xPBS right before cells were added. Cells were trypsinsed and washed twice in 
1xPBS. To obtain a single cell solution, the cell solution was strained through a 40µm nylon filter 
mesh cell strainer. Cell numbers were determined by bromophenol blue staining using a Countess 
II FL cell counter (Thermofisher scientific). The migration chamber was assembled by placing 
the fibronectin coated transwell inserts into dishes of a 24-well plate containing 750µl of DMEM 
media supplemented with 15%(v/v) FBS. 50.000 cells in 500µl FBS free DMEM were then 
added drop-wise on top of the transwell. Migration assays was performed for for 4h (MDA-MB-
231) or 24h (MCF7) at 37°C. Transwells were the washed carefully 2x in 1xPBS from both sides 
and cells in the upper side of the transwell were removed with cotton buds. Migrated cells on the 
bottom side of the transwell were stained and fixed in a crystal violet staining solution (5mg/ml 
crystal violet, 25%(v/v) EtOH in H2Odest) for 60min at RT in the dark. Cells were then washed 2x 
in H2Odest. Cells were counted using a Brightfield microscope. At 20x magnification, cells within 
15-20 fields of view were counted manually.  
2.8.11.   Wound healing ‘scratch assay’ using Incucyte®ZOOM system 
MDA-MB-231 cells were transfected with siRNAs (Section 2.8.4, Table 2-10) and incubated for 
24h at 37°C, after which cells were seeded into wells of a 96-well plates specialised for the 
IncuCyteZOOM® system (Essenbioscience) at a density of 30.000cells/well, 32 wells per 
condition. 12h later a wound of defined size was introduced into the cell monolayer using the 
Essenbioscience 2D WoundMaker™ tool. Cells were washed 2x in completed DMEM media to 
remove cell debris and were then placed into IncuCyteZOOM® incubator system. Cells were 
imaged every 45min for 48h. Images were then used to calculate the relative wound healing 
density (RWD in%) for each timepoint using the IncuCyteZOOM® software. The algorithm is 
based on measuring the spatial cell density in the wound area relative to the spatial cell density 
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outside of the wound area at every time point. It is designed to be zero at t=0, and 100% when the 
cell density inside the wound is the same as the cell density outside the initial wound, which was 
achieved for control cells after 48h of incubation.  
2.9. Single molecule localisation microscopy (SMLM)  	
2.9.1. mES cell line generation 
ES cells expressing mouse HP1 constructs tagged at the N- or C-terminus with the mEos3.2-
HaloTag were generated by transfecting a plasmid expressing the tagged protein, followed by 
selection in 600µg/ml geneticin (Life tech, cat. 10131019). After 2 weeks of geneticin selection, 
cells were sorted using a Sony SH800 cell sorter to ensure that they were labeled with the 
mEos3.2 fluorophore (excitation at 488nm, emission at 515nm).  
2.9.2. Microscope setup 
An IX73 Olympus inverted microscope was used with circularly polarized laser beams aligned 
and focused at the back aperture of an Olympus 1.40 NA 100× oil objective (Universal Plan 
Super Apochromat, 100×, NA 1.40, UPLSAPO100XO/1.4). Continuous wavelength diode laser 
light sources used include a 561nm (Cobolt, Jive 200, 200mW) and a 405nm laser (Stradus, 
Toptica, 405-100, 100mW). Total internal reflection was achieved by aligning the laser off axis 
such that the emergent beam at the sample interface was near-collimated and incident at an angle 
greater than the critical angle θc ~ 67° for a glass/water interface for TIRF imaging and slightly 
less than θc for oblique-angle illumination imaging. This generated a ~50µm diameter excitation 
footprint. For TIRF, the power density at the coverslip for the 561 nm laser was in the range 0.5-
100 W/cm2. For oblique-angle illumination, the power of the collimated beams at the back 
aperture of the microscope was 10 kW/cm2 and 10-100 W/cm2 for the 561nm and 405 nm laser 
beams respectively. The lasers were reflected by adichroic mirrors, which also separated 
collected fluorescence emission from the TIR beam (Semrock, Di01- R405/488/561/635). The 
fluorescence emission was collected through the same objective and then further filtered using a 
combination of long-pass and band-pass filters (BLP01-561R and FF01-587/35 for 561 nm 
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excitation). The emission signal was projected onto an EMCCD (Photometrics, Evolve 512 
Delta) with an electron multiplication gain of 250 ADU/photon operating in a frame transfer 
mode. The instrument was automated using the open-source software micro-manager 
(https://www.micro-manager.org) and the data displayed using the ImageJ software. 
2.9.3. Mammalian live-cell single-molecule imaging 
ES cells expressing mEos3.2-HaloTag-tagged HP1 were passaged two days before imaging onto 
35 mm glass bottom dishes No 1.0 (MatTek Corporation P35G-1.0-14-C Case) in phenol red-free 
serum and LIF conditions. Just before single-particle tracking (SPT) imaging experiments, cells 
were labeled with 0.5nM HaloTag-JF549 ligand for at least 15 minutes, followed by two washes in 
PBS and a 30 minute incubation at 37 °C in media, before imaging the cells in fresh phenol red-
free serum and LIF conditions. Cells were under-labeled to prevent overlap of fluorophores 
during SPT. Using 561 nm excitation, fluorescence images were collected as movies of 10,000 
frames at 15ms or 1,000 frames at 500ms exposure. Mammalian cell image processing and 
analysis 
Live-cell single-molecule traces were analyzed using software that detects single-molecule 
trajectories from SPT movies178. Briefly, the code detected puncta positions in each image frame 
using a brightness-weighted centroid after applying a band-pass filter to remove low-frequency 
background and high-frequency noise from the image data. To track the HP1 single-molecules, 
only fluorescent puncta smaller than 3 pixels and with a signal-to-noise greater than 8 were 
analyzed. Fluorescent puncta were considered to be the same molecule if they were within 6 
pixels (936 nm) between frames. 
2.10. Chromatin immunoprecipitation 
2.10.1. ChIP and RT-PCR analysis 
2x10^7 MCF7 cells (~ confluent 15cm dishes) were cross-linked on the dish with 1% [v/v] 
formaldehyde for 10 minutes at room temperature and cross-linking stopped by the addition of 
0.125M glycine for 5min. To pre-extract the chromatin fraction, cells were then lysed in ice-cold 
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IPH chromatin extraction buffer supplemented with EDTA-free protease inhibitors (Roche) and 
incubated for 20min on ice intermitted by vortexing every 5min. Lysates were micro centrifuged 
at full speed for 20min. Supernatant was discarded and chromatin pellet was then lysed in ChIP 
lysis buffer (1% [v/v] SDS, 10mM EDTA, 50mM Tris-HCL pH8.0 and EDTA-free protease 
inhibitors). Cells were sonicated in a QSonica sonicator for 1.5h 5s ON/ 5s OFF to achieve a 
mean DNA fragment size of 500bp. An equal volume of protein A and G agarose beads (GE 
Healthcare), equilibrated in modified RIPA buffer (1% [v/v] Triton-X-100, 0.1% deoxycholate, 
0.1% SDS, 90mM NaCl, 10mM Tris-HCL pH8.0 and EDTA-free protease inhibitors) and was 
used to pre-clear chromatin for 1h prior to immunoprecipitation. After pre-clearing 2% of 
chromatin was stored as input material. Immunoprecipitation was performed for a minimum of 
12 hours at 4°C in modified RIPA buffer.  An equal volume of protein A and G agarose beads, 
equilibrated in modified RIPA buffer were used to bind the antibody and associated chromatin 
for a minimum of 2 hours. The beads were then washed twice with wash buffer (0.1% [v/v] SDS, 
1% [v/v] Triton-X-100, 2mM EDTA, 20mM Tris pH8.0, 150mM NaCl) and once with final wash 
buffer (0.1% [v/v] SDS, 1% [v/v] Triton-X-100, 2mM EDTA, 20mM Tris pH8.0, 500mM NaCl). 
Beads and input samples were then mixed with 200µl of elution buffer (1% [v/v] SDS, 100mM 
NaHCO3) and 5µl RNase (DNase free [Roche]) for 1h at 37°C. To reverse the cross link, the 
same mix was incubated at 65°C for at least 4h or o/n. Reverse crosslinking of DNA was 
followed DNA purification using the ChIP DNA Clean & Concentrator™ kit (Zymo Research) 
according to manufacturer’s instructions. DNA was eluted in 100µl nuclease free H2O when 
analysed by RT-PCR and 40µl when analysed by ChIP sequencing. Immunoprecipitated DNA 
was analysed on an ABI 7300 real-time PCR machine (as described in Section 2.5.3). Primers 
used for RT-PCR analysis are summarised in Table 2-13. 
2.10.2.   ChIP-sequencing library preparation 
ChIP libraries used for parallel sequencing were prepared using the NEXTflex Illumina ChIP-Seq 
library prep kit (Bioo Scientific) designed for ultra-low DNA input Illumina® sequencing. 
Following chromatin immunoprecipitation and DNA purification, DNA was quantified using 
Qubit fluorimetric quantification technology.10-50ng of DNA (including 1% of total input) was 
 68 
used to perform end repair of the ChIP DNA. Libraries were generated exactly according to 
manufacturer’s instrusctions. Size selection of library samples was performed with AMPure® XP 
beads (Agencourt) as dictated in the NEXTflex Illumina ChIP-Seq library prep kit protocol. 2µl 
of NEXTflex™ ChIP-Seq Barcodes (#1-24, #514122) were used per library, they were ligated 
onto individual libraries in the adapter ligation step of the protocol. PCR conditions for the final 
library amplifications are summarised in Table 2-14. The completed library was then tested for 
both size selection and quantity of DNA using a D1000 DNA tape analysed on the Tapestation® 
system. DNA was additionally quantified by Qubit fluorimetric quantification technology. 
Libraries were multiplexed at equal molarities. The final ChIP-seq library, with an average size 
of 300-450bp (at 10-15nM), was submitted for 50bp, paired-end sequencing on an Illumina 
HiSeq 1500®.  
          Table 2-13 ChIP pPCR primers. All primers are designed against human genes.  
Target gene Primer sequence 
ZNF37A 3’UTR Fwd: TGAGAAGACACACAGGGGAG 
Rev: TTAGGGCTGACTTCTGACGG 
ZNF221 3’UTR Fwd: TGAGAAGACACACAGGGGAG 
Rev: TTAGGGCTGACTTCTGACGG 
ZNF594 3’UTR Fwd: TTCTCCGACGTTGAATAAGG 
Rev: CACCTTGTCACACACCAGAA 
ZNF709 3’UTR Fwd: CTCCAGGAATGTCTGGTCAC 
Rev: CTTGATGCTGGGTCTCATCT 
ZNF788 3’UTR Fwd: GCACTCGGGACAGATCTCTT 
Rev: CACGGCTTCCATTTCCATGT 
ZNF75A 3’UTR Fwd: CATCAGCAGGCGTCATATCA 
Rev: GGTGCCATTTTCCCACTCTG 
ZNF174 3’UTR Fwd: CAGCTCCCCAAATGCTCAAA 
Rev: TCTCTCAGTGGGTGGCTTTT 
ZSCAN32 3’UTR Fwd: AACCTGGATGTTGTGCTTGC 
Rev: CTTTGTAACCCAGCCACCAC 
α-SAT 3’UTR Fwd: ATCGAATGGAAATGAAAGGAGTCA 
Rev: GACCATTGGATGATTGCAGTCA 
ZNF3 3’UTR Fwd: TGTGGATTCTCTGGTGCTGA 
Rev: TACGCCTGCAATGAATGTGG 
ZNFX1 TSS 
 
Fwd: CGGCCTGGACAACTACTAGA 
Rev: CGAAACGCTCTCTTTCCCG 
ZHX1 TSS Fwd: CCTTGACGTTCACTCCCCA 
Rev: GGATTAATGTGGCTCAGCGG 
ZBTB43 TSS Fwd: GCAACCACGCTCAGCTAATT 
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Rwd: GAGGCTAGGAGTTCGAGACC 
ZNF229 TSS Fwd: AGAAGCAATCAAGGTGACGC 
Rwd: GGAGGGTTCTGGGAAAGGTA 
ZMAT1 TSS Fwd: TGCGATCTCACTCACTGCTA 
Rev: TGCCTGTAATCCCAGCTACT 
ZNF124 TSS Fwd:ACTGTGTCTCTGTGAACCCT 
Rev:GGAATGCGGAAAGAAGCCAT 
 
Table 2-14 PCR program for final ChIP-seq library amplification. 
 
 
  
2.10.3.  Analysis of ChIP-Seq data 
After adaptor trimming with trim galore, unique reads were mapped against the reference genome 
sequence (GRCh38) using bwa (v0.7.12)179. Biological replicates were then combined and used 
for peak calling with MACS2180 with a p-value cutoff of 0.01 (peak calling against Input sample). 
The resulting peaks were then filtered to only retain those with a q-value less than 0.05 and all 
peaks overlapping an IgG peak were discarded. We then used bedtools to identify Ensembl genes 
with a peaks in the gene body or in the promoter (defined as TSS+/-2kb).  
To produce metagene coverage profile and heatmaps the bwa BAM files were first converted to 
bedGraph format using bedtools181 (genomeCoverageBed, v2.26.0, scaling each sample 
proportionally to the mapped library depth) and subsequently to bigWig using the UCSC 
Genome Browser tool bedGraphToBigWig182. The bigWig files were then used to produce signal 
coverage matrices using deepTools computeMatrix (v2.5.1)183 using as reference transcripts all 
Ensembl transcripts overlapping a peak and scaled to a uniform size of 5kb (+2kb upstream of the 
TSS and downstream of the TES). Heatmaps and profile plots were rendered in R using ggplot2. 
Open access to ChIP-data presented in this thesis is currently being prepared.  
 
98oC, 2 min 
98oC, 30 sec           Repeat 11 cycles* 
65oC, 30 sec 
72oC, 1 min 
72oC for 4 min 
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2.11. RNA-sequencing 
2.11.1.   Depletion of ribosomal RNA 
Whole transcriptome analysis was performed using RNA-sequencing (RNA-seq) technology. As 
input material for RNA-seq analysis total RNA depleted from ribosomal RNA (rRNA) was used. 
Total RNA was extracted (see Section 2.5.1). rRNA using the Ribo-Zero® rRNA Removal Kit 
(Illumina) according to manufacturer’s instructions with the following adjustments: Due to a 
generally low efficiency of this kit, 500ng of total RNA was used at conditions suggested for 2.5-
5µg of input RNA (10µl of Removal solution per sample). The RNA Clean & Concentartor™-5 
kit (Zymo Research) was used to clean up the rRNA depleted RNA sample. RNA was eluted in 
40µl nuclease free H2O. Efficiency of rRNA removal was confirmed RNA ScreenTape assay 
(Agilent) analysed on an Agilent 2200 Tapestation® system. In total RNA, peaks for small (18S) 
and large (28S) ribosomal subunits were detected, reflected in a RNA integrity number (RIN) >8. 
RIN is a measure of RNA integrity ranging from 1-10, with 10 describing the most intact RNA 
profile. The RIN algorithm is based on the ratio of 18S and 28S RNA fragments detected in a 
given RNA sample184. Accordingly, upon ribo-depletion of the same sample, the RIN was 
reduced to <3. 1-10ng of RNA were used for RNA-seq library preparation. 
2.11.2.   RNA-seq library preparation 
10 ng of ribo-depleted RNA was subjected to RNA seq library preparation using the NEXTflex® 
Rapid Illumina Directional RNA-Seq Library Prep Kit (Bioo Scientific) according to 
manufacturer’s instructions. This kit uses the deoxy-UTP (dUTP) strand-marking methodology in 
order to preserve the information on a transcript’s directionality185. Figure 2-1 depicts a 
schematic illustration of the library preparation protocol using this method. In brief, cDNA first 
strand synthesis is performed using random hexamers. For second strand synthesis, dUTP is used 
instead of dTTP. In the next steps, adaptors (containing individual barcodes) are ligated to both 
ends of the double stranded (ds) cDNA. The adaptor sequences have a Y-shaped structure, which 
retain directionality of the cDNA molecules. Next Uracil-DNA glycosylase (UDG) is added to 
degrade the second strand. All remaining first strand cDNAs, ligated to Y-shaped adapter 
sequences, allow directional sequencing of all molecules while retaining the strand information of 
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each RNA molecule185. NEXTflex® RNA-Seq Barcodes (#1-24 NOVA-512913) were ligated 
onto individual libraries during adapter ligation step. PCR conditions for final library 
amplification are summarised in Table 2-14. 
Table 2-14 PCR program for final RNA-seq library amplification. 
 
 
 
The average size of final libraries was measured using a DNA ScreenTape (Agilent) assay 
analysed on an Agilent 2200 Tapestation® system and DNA concentrations were determined 
using the Qbit fluorimetric quantitation system®. Libraries were multiplexed at equal molarities. 
The final multiplexed library, with an average size of 300-450bp (at 15-20nM) was submitted for 
125bp, paired-end sequencing on an Illumina HiSeq 4000® instrument. 
2.11.3.   Analysis of RNA-seq data 
Fastq files from technical replicates were merged and then mapped against the reference genome 
sequence (GRCh38) using STAR (v2.5.0)186 with indexes built with the Ensembl187 reference 
transcriptome GTF file. The number of reads mapping to each Ensembl annotated gene were 
counted with STAR and then imported into DESeq2188 for differential expression analysis. The 
DESeq2 workflow was run with default parameters using a one-factor design representing the 
treatment condition. The resulting p-values were corrected using the Benjamini-Hochberg 
method as implemented in DESeq2. 
GO and KEGG enrichment analysis were realised using the BioConductor GAGE package189. 
The input gene list to GAGE was ordered by log2 fold change in the comparison of interest, and 
Entrez IDs for each gene were retrieved from the corresponding ENSEMBL IDs using biomaRt. 
Open access to RNA-data presented in this thesis is currently being prepared. 
 
37oC, 30min 
98oC, 2 min 
98oC, 30 sec           Repeat 15 cycles* 
65oC, 30 sec 
72oC, 1 min 
72oC for 4 min 
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Figure 2-1 Deoxy-UTP (dUTP) strand-marking methodology for RNA-seq library 
preparation. Image was adapted from reference 165. For description, see main text. 
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  Chapter 3
Citrullination – a novel post-translational modification of   
HP1γ 
 
3.1. Introduction 
Citrullination describes the conversion of peptidyl-arginine to the non-coding amino acid 
peptidyl-citrulline. This modification results in loss of a positive charge that can change the 
overall charge of a protein and affect the ability of hydrogen bonding with neighbouring proteins 
or nucleic acids80. Reactions are catalysed by calcium-dependent enzymes called peptidylarginine 
deiminases (PADIs). PADI1, 2 and 4 have been reported to be nuclear and regulate gene 
expression by directly citrullinating histones48,85,86 (compare Section 1.1.8). 
3.1.1. A role for citrullination in pluripotency 
Work from our laboratory recently identified a role for PADI4 during reprogramming and ground 
state pluripotency190. It showed that expression and enzymatic activity of PADI4 are induced 
during reprogramming and that knockdown of the protein reduces reprogramming efficiency. 
Active PADI4 binds to regulatory elements of key stem cell genes and activates their 
transcription. To understand the molecular mechanism of gene regulation by PADI4, stable 
isotope labeling of amino acids in cell culture (SILAC) was used to find PADI4 substrates in 
mouse embryonic stem cells (mESCs). The experimental setup is illustrated in Figure 3-1. In 
brief, mESCs overexpressing PADI4 were labeled with 13C6 L-lysine (heavy), whereas cells 
expressing an empty control vector were labeled with 12C6 L-lysine (light). The chromatin 
fraction was then analysed by mass spectrometry. As citrullination results in a mass change of ~ 
1Da it can be reliably detected using this method191. This approach identified linker histone H1 
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variant 2 (H1.2) as a main PADI4 target, and that it was citrullinated within its DNA binding 
domain. H1 isoforms are regarded as important drivers of facultative chromatin formation97. 
They can be incorporated in a localised manner, facilitating local chromatin condensation and 
transcriptional repression. PADI4 mediated citrullination impairs H1.2 binding to DNA in 
pluripotent stem cells which leads to H1 eviction from chromatin, resulting in extensive 
chromatin decondensation. The ‘loosened’ chromatin structure, in return, facilitates gene 
expression of stem cell genes190. Besides citrullination of linker histone H1.2, this paper 
identified more than 700 non-histone citrullinated proteins, 20% of which were directly 
associated with chromatin. The list of citrullinated proteins included heterochromatin proteins 
HP1α and HP1γ. Citrullination of HP1α was detected at residue R107 within the hinge region. 
HP1γ was found to be citrullinated at residue R108 (the equivalent site to R107 in HP1α) again in 
the hinge region and additionally at residues R38 and R39 located within its chromodomain (CD) 
(Figure 1-4). 
 
3.1.2. Dynamics of HP1 
The maintenance and de novo formation of heterochromatin involves the transient binding and 
dynamic exchange of HP1 molecules on chromatin. The dynamics of HP1 have mainly been 
studied using Fluorescence after photo-bleaching (FRAP) and fluorescence correlation 
spectroscopy (FCS) technologies. Both analyses identify that the mobility of all three HP1 
	
Figure 3-1 Proteomic approach to identify citrullinated proteins in mESCs. 
 75 
paralogues is significantly lower in heterochromatin when compared to euchromatin. Diffusion 
measurements in mammalian cells imply that in euchromatin and heterochromatin at least two 
HP1 populations with different diffusion modes exist - one slow moving population, bound to 
chromatin and one freely diffusing population. In this chapter single molecule localisation 
microscopy (SMLM) is used to study HP1 dynamics in mESCs. 
3.1.2.1. The principle of SMLM in live cells 
Two variations of SMLM are photo-activated localisation microscopy (PALM) and stochastic 
optical reconstruction microscopy (STORM). PALM uses photo-activatable fluorescent proteins, 
whereas STORM uses organic dyes to label the protein of interest. Both techniques rely on 
photo-switchable fluorophores that modulate their fluorescence between an ‘on’ and ‘off’ state to 
separate fluorophores temporally so that their point spread functions (PSF) do not overlap (Figure 
3-2)192. Each fluorophor can be identified and its centre localised with high precision. Single 
molecules can then be tracked over several consequent image frames (~movie). Compared to 
conventional microscopy techniques, SMLM is therefore not dependent on the diffraction limit of 
the microscope, but on stochastic activation of single molecules, their density and the size of the 
fluorophore. 
 
 
	
Figure 3-2 General principle of single molecule localisation microscopy. 
PSF: point spread function.  
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SMLM allows super resolved imaging of proteins within mammalian nuclei at a spatial resolution 
of ~10-20nm193. Live-cell SMLM approaches allow single-particle tracking (SPT) of proteins on 
chromatin to obtain information on diffusion coefficients of proteins and their residence time on 
DNA. By adapting a total internal reflection fluorescence (TIRF) microscope to achieve oblique-
angle illumination, a 2D plane through a cell’s nucleus is illuminated, enabling detection of all 
molecules within that plane per image frame.  
This chapter aims to characterise, in vitro and in vivo, the citrullinated sites within the CD of 
HP1γ. To further explore the function of HP1γ residues R38 and R39, I will present my results 
from studying the dynamics of HP1γ molecules during mESC differentiation using SMLM. I 
performed a comparative analysis of HP1γ wildtype and R38/9A mutant proteins in mESCs in 
order to dissect the role of residues R38/9 on protein dynamics during differentiation. 
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3.2. Aims of this chapter 
This chapter has the following aims related to characterising citrullination of HP1γ at residues 
R38 and R39 
1. To determine whether HP1γ residues R38 and R39 are important for HP1γ binding to 
H3K9me3 in vitro 
2. To identify HP1γ citrullinated at residues R38 and R39 in vitro 
3. To determine whether HP1γ is citrullinated in mESCs 
4. To determine the effects of mutations in HP1’s chromo- and chromo-shadow domains upon the 
dynamics of HP1 molecules in mESCs 
5. To measure the dynamics of HP1γ molecules in mESCs upon differentiation
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3.3. HP1γ CD residues R38 and R39 are citrullinated  
Whilst sharing only ~ 70% protein sequence homology, the CDs of all three HP1 paralogues 
are structurally highly conserved. Residues R38/9, located within the β1-sheet of the CD, are 
absolutely conserved between all three homologues (Figure 1-5). Citrullination of these 
residues, however, was exclusively detected in HP1γ. In 3-dimensional space, R38/9 are in 
close proximity to amino acids F30, W51 and F53, which form the ‘hydrophobic cage’ that 
specifically recognises N-methyl groups of H3K9 in H3 tails106. The X-ray crystal structure of 
HP1γ’s CD in complex with H3K9me3 illustrates that R38/9 are actually on the opposite side 
to the H3K9me3 binding pocket, and facing away from it, suggesting that these residues are 
not in direct contact with the histone tail (Figure 3-3). Nevertheless, neutralising the positive 
charge of R38/9 by citrullination may affect the β1-sheet structure and allosterically hinder 
binding of HP1γ to H3K9me2/3.  
 
 
 
 
	
Figure 3-3 X-ray crystal structure of the CD of HP1γ in complex with H3K9me3.  
PDB file ‘5t1i’ was adapted using Pymole software. Residues forming the hydrophobic 
pocket are highlighted in light blue, V23 residue in green, citrullinated residues in pink and 
H3K9me3 tail in yellow. 
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3.4. Bacterial protein expression of HP1 isoforms 
In order to study the contribution of R38/9 to binding H3K9me2/3 in vitro, both arginines 
were mutated to alanine. Like citrullination, this removes the positive charge associated with 
these residues and I will refer to the mutant as R38/9A. Single mutations of either R38 or R39 
to alanine were also generated. As controls, HP1β wildtype (WT), HP1β V23M mutant and 
the corresponding mutation in HP1γ, V32M, were also analysed. HP1β V23M is a well-
characterised mutation that abolishes binding to H3K9me2/3 in vitro37 and in vivo194. A 
summary of the mutants is illustrated in Figure 3-4.  
 
	
Figure 3-4 Schematic illustration of HP1β and γ mutants.          
Changes in amino acid and DNA sequence are indicated.  
A Summary of HP1β mutants used in this study. 
B Summary of HP1γ mutants used in this study. 
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Full-length WT HP1γ and WT HP1β, and the CD mutants, were cloned into the bacterial 
expression vector pGEX-2TK. This generates a fusion protein with GST at the N-terminus. 
E.coli were transformed with plasmids encoding GST-HP1γ (WT, R38/9A, R38A, R39A and 
V32M) and GST-HP1β (WT and V23M). Proteins were affinity purified using glutathione 
sepharose beads and analysed by SDS-PAGE and Coomassie blue staining (Figure 3-5B-D).  
All proteins were expressed at equivalent and high levels. In order to estimate protein 
amounts, Coomassie stained GST-fusion proteins were compared to a BSA protein standard 
of known concentration (Figure 3-5A).  
 
	
Figure 3-5 HP1β and γ - GST fusion protein expression.      
Proteins were resolved by SDS-PAGE and gels stained with Coomassie blue. Eluate 1 and 2 
of each GST-protein preparation were loaded. 
A BSA protein standard ranging from 25-3200ng was used as a reference.  
B Wildtype and mutant HP1β proteins and GST were loaded at 1µl per well.  
C Wildtype and mutant HP1γ wildtype, loading as indicated.  
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3.5. HP1γ R38/9A has impaired binding to H3K9me3 
To test binding of HP1γ and its various mutants to H3K9me3, an in vitro peptide pulldown 
assay was used. C-terminally biotinylated H3 (1-16) peptides, methylated or not at K9 (Figure 
3-6A) were immobilized on streptavidin sepharose beads and incubated with 1µg of GST-
HP1 fusion proteins. Equal amounts of input proteins were determined by comparing various 
dilutions of the GST-tagged proteins by SDS-PAGE and Coomassie blue staining to a BSA 
standard (Figure 3-5A). As a proof of principle, the assay was initially performed with HP1β 
WT and the V23M mutant. Pulldowns were performed at physiological salt conditions 
(150mM NaCl). As expected, the wildtype protein does not bind to unmethylated H3 
peptides, but it specifically binds to the methylated peptides (Figure 3-6B). The V23M 
mutation abolished binding completely. The same result was obtained for HP1γ WT and the 
V32M mutant respectively (Figure 3-6C).  
 
These proof of principle experiments, using known CD mutants V23M/V32M, indicate 
effective assay conditions for both HP1β and HP1γ (Figure 3-6). Next, the HP1γ double 
R38/9A mutant was analysed using the same methodology and compared to WT HP1γ 
	
Figure 3-6 Proof of principle H3K9me3 peptide pulldown assay with HP1β and HP1γ. 
1µg of GST or the indicated GST-HP1 fusion proteins were incubated with methylated or 
unmethylated H3 (1-16) peptides immobilised on streptavidin beads in buffer containing 
150mM NaCl. Bound proteins were eluted off with 2x SDS loading buffer. Proteins were 
resolved by SDS-PAGE and gels stained with Coomassie blue staining solution. Images of 
representative pulldown assays are illustrated.  
A Sequence of biotin coupled H3 (1-16) peptide trimethylated at lysine 9. 
B Result of HP1β wildtype (WT) and V23M mutant pulldown. 
C Result of HP1γ WT and V32M mutant pulldown. 
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protein. At physiological salt conditions (150mM NaCl) the R38/9A mutant showed 
approximately 50% less binding to the methylated H3 peptide compared to WT HP1γ protein. 
At 300mM NaCl, 70% less R38/9A mutant protein was bound compared to WT HP1γ protein 
(Figure 3-7). These results indicate that the R38/9A mutation impairs binding of HP1γ to 
methylated H3K9 peptides. Binding of the R38/9A mutant is more sensitive to increased salt 
concentration than that of the WT protein.  
 
In	order	 to	understand	whether	both	R38	and	R39	residues	are	equally	 important	 for	HP1γ	 to	 bind	 methylated	 H3K9	 peptides,	 the	 experiment	 was	 repeated	 with	 single	mutants	 R38A	 and	 R39A	 (here	 at	 physiological	 salt	 conditions).	 Whilst	 binding	 to	H3K9me3	peptides	 is	 equally	 reduced	 in	both	R38A	and	R39A	when	compared	 to	 the	wildtype	 protein,	 binding	 is	 significantly	 reduced	 in	 the	 double	 38/39	 alanine	substituted	HP1γ	(Figure	3-8A).	Importantly however, mutating both R38 and R39 to lysine 
(R38/9K) restored binding back to WT levels, suggesting that the positive charges at positions 
38 and 39 are required to maintain the local structure of the chromodomain and/or the 
electrostatic interaction(s) between H3K9me3 and the chromodomain of HP1γ (Figure	3-8B). 
	
Figure 3-7 H3K9me3 peptide pulldown assay of HP1γ R38/9A mutant protein. 
1µg of indicated GST-HP1γ fusion proteins were incubated with methylated or unmethylated 
H3 (1-16) peptides immobilised on streptavidin beads in buffer containing 150mM or 300mM 
NaCl. Bound proteins were eluted off with 2x SDS loading buffer. Proteins were resolved by 
SDS-PAGE and gels stained with Coomassie blue staining solution. Images of representative 
pulldown assays are illustrated (left panel). Intensities were quantified using ImageJ and 
values were normalised to input (25%) (right panel).  
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In summary, my results suggest that a positive charge at either position 38 or 39 within 
HP1γ's CD is important for it to interact with methylated histone H3 tails in vitro. Mutating 
both residues to alanine reduces binding significantly, whereas the R38/9K mutant, which 
maintains a positive charge at both sites, has full binding capacity. My data indicate that the 
charge loss accompanied by citrullination of residues R38/9 may interfere with HP1γ’s 
binding to chromatin. 
 
3.6. HP1γ citrullination in vitro  
In order to investigate if HP1γ is a direct target of PADI4, an in vitro citrullination assay 
using recombinant human PADI4 was used.  Full length human PADI4 was cloned into the 
bacterial expression vector pGEX-6p to generate a N-terminal tagged GST-PADI4 fusion 
construct. Recombinant proteins were affinity purified, resolved by SDS-PAGE and 
	
Figure 3-8 H3K9me3 peptide pulldown assay of HP1γ mutant protein. 
1µg of indicated GST-HP1γ fusion proteins were incubated with methylated or unmethylated 
H3 (1-16) peptides immobilised on streptavidin beads in buffer containing 150mM NaCl. 
Bound proteins were eluted off with 2x SDS loading buffer.  Proteins were resolved by SDS-
PAGE and gels stained with Coomassie blue staining solution. Images of representative 
pulldown assays are illustrated.  
A Peptide pulldown performed with GST-HP1γ wildtype (WT) and R38A, R39A and R38/9A 
mutant proteins. 
B Peptide pulldown performed with GST-HP1γ WT, R38/9A and R38/9K mutant proteins. 
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visualised by Coomassie blue staining (Figure 3-9A). In vitro citrullination assays were 
performed as previously described190. In brief, 100ng GST-PADI4 enzyme was incubated 
with an equal amount of substrate in deimination buffer in the presence or absence of 10mM 
CaCl2 for 1h at 37°C. Citrullination was assessed by immunoblotting using an α-citrulline 
antibody. As a positive control, human recombinant histone H3.1 (NEB) (Figure 3-9B) - a 
known substrate of PADI449 was used. Citrullination of H3.1 was assessed using an α-H3R2-
cit antibody. As expected, citrullination of H3.1 was exclusively detected in the presence of 
Ca2+ indicating that the enzymatic activity of PADI4 depends on Ca2+.  
 
To optimise citrullination assays for GST-HP1γ, titrations of either enzyme or substrate were 
performed (Figure 3-10). Equivalent input protein amounts, as judged from Coomassie blue 
stained SDS gels, were confirmed by Ponceau S staining of transferred proteins (data not 
shown). First, the amount of HP1γ was kept constant  (1µg) and increasing amounts (50-
400ng) of PADI4 were added (Figure 3-10A). Citrullinated HP1γ was detected only in the 
presence of PADI4 and Ca2+. The strongest signal relative to background was obtained when 
assaying 100ng of PADI4. Interestingly, adding more than 200ng of PADI4 appeared to alter 
	
Figure 3-9 In vitro citrullination assay of H3.1 with PADI4.              
In vitro citrullination assays were performed with a recombinant PADI4-GST fusion protein 
for 1h at 37°C in the presence and absence of Ca2+. Reactions were resolved by SDS-PAGE 
and analysed by immunoblotting. 
A SDS-PAGE of GST-PADI4 fusion proteins, stained by Coomassie blue solution. Eluate 1 
(EL1) and 2 (EL2) of each GST-PADI4 preparation were loaded at the indicated amounts.  
B Immunoblotting of in vitro citrullination reaction with 1µg of H3.1 as a substrate and 100ng 
PADI4 with a α-H3R2-cit antibody. 
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its substrate specificity as citrullination of HP1γ diminished, whilst PADI4 autocitrullination 
increased. 
 
 
	
Figure 3-10 In vitro citrullination of HP1γ with PADI4.          
In vitro citrullination assays of HP1γ were performed with a recombinant GST-PADI4 fusion 
protein for 1h at 37°C in the presence or absence of Ca2+. Reactions were resolved by SDS-
PAGE and analysed by immunoblotting with an α-citrulline antibody. 
A Titration of PADI4 ranging from 50-400ng with a constant amount of HP1γ WT (1µg). 
B Titration of HP1γ WT ranging from 0.5-4µg with a constant amount of PADI4 (200ng).  
C Reaction of 1µg HP1γ WT and R38/9A mutant with 200ng PADI4. 
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In the next step, the amount of enzyme was kept constant (200ng) and increasing amounts 
(0.5-4µg) of HP1γ were added (Figure 3-10B). The strongest signal was achieved with 1µg 
HP1γ in the presence of PADI4 and Ca2+. Increasing HP1γ protein input above 2µg 
completely inhibited the citrullination reaction, indicating a substrate-mediated inhibition of 
the enzyme.  
In order to investigate whether PADI4 catalyses citrullination of HP1γ residues R38/9, in 
vitro citrullination assays were performed using WT HP1γ compared to the R38/9A mutant 
protein. 200ng of PADI4 was incubated with 1µg of WT HP1γ and R38/9A mutant protein 
respectively. Compared to WT HP1γ, the signal for R38/9A, in presence of PADI4 and Ca2+, 
is considerably reduced, suggesting that in vitro citrullination of residues R38/9 is mediated 
by PADI4 (Figure 3-10C). The residual signal observed for the reaction of R38/9A mutant 
protein and PADI4 could be due to the citrullination of residue R108 or other, yet undetected 
citrullination sites within HP1γ.  
My results show that HP1γ is citrullinated by recombinant PADI4 in vitro in a Ca2+ dependent 
manner and that mutating R38/9 to alanine notably reduces citrullination of HP1γ. 
Furthermore, the data show that, as with many enzymes, the activity of PADI4 in vitro 
strongly depends on concentration of substrate and enzyme. 
3.7. Generation of site-specific antibodies against HP1γ R38/9-
citrulline 
In the previous section, I showed that mutation of R38/9 to alanine leads to significantly 
reduced citrullination of HP1γ in in vitro citrullination assays. This suggests very strongly that 
PADI4 citrullinates HP1γ at residues R38/9, at least in vitro. Therefore, in order to study this 
modification in more physiologically relevant settings, I decided to raise antibodies that 
would specifically recognise HP1γ citrullinated at R38/9. A peptide immunogen was designed 
based upon the mouse HP1γ protein sequence, with the citrullinated residues 38/9 in the 
centre, flanked by 4-5 amino acids each side (HP1γ 34-44) and with a C-terminal cysteine 
(Figure 3-11A). Peptides were covalently bound to the carrier protein keyhole limpet 
hemocyanin (KLH) via their C-terminal cysteine. KLH is highly immunogenic and is 
therefore used to help initiate an immune response in the animal. 4mg of immunogen, 
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homogenized in complete Freund’s adjuvant, were injected subcutaneously into one sheep. 
The complete immunisation schedule is illustrated in (Figure 3-11B).  
 
A total number of 4 sheep were immunised with the same immunogen. Sera were collected 
after 4 weeks (1st bleed), 8 weeks (2nd bleed) and 12 weeks (3rd bleed and final bleed). Crude 
sera of all three bleeds were initially screened in dot blots against mouse HP1γ unmodified 
(34-44) and the double citrulline R38/9-cit peptides (data not shown). Bleeds showing the 
most specific recognition of citrullinated peptides were subjected to affinity purification as 
illustrated in Figure 3-12 (compare also Section 2.6.6). Purification was performed with 
R38/9-cit peptides and antigen-specific antibodies were serially eluted using low pH (0.1M 
glycine pH 2.5) and neutralized with ice-cold Tris HCl pH8.0 buffer. A representative 
methylene blue staining of purified antibodies (here S780D) pre-dialysis indicates the relative 
amount of protein obtained in each elution step (Figure 3-13A). After dialysis the antibody 
was resolved in a SDS gel and Coomassie blue stained (Figure 3-13B). Bands for both heavy 
and light chains of purified antibodies were detected in each elution step.  
	
Figure 3-11 Sheep immunisation to produce HP1γ R38/9-citrulline antibodies.      
A Sequence of HP1γ (33-44) R38/9-citrulline antigen coupled to KLH used for sheep 
immunisation. 
B Immunisation schedule.  
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Figure 3-12 Scheme of antibody affinity purification strategy.  
Compare Section 2.6.6 for further technical details. 
A Peptides (Figure 3-11A) are coupled to Sulfolink™ beads via disulfide bridge. 
B Peptides are incubated with crude serum. 
C Serial washes to remove unbound serum constituents. 
D Affinity purification using use low pH (0.1M glycine pH 2.5). Purified antibodies were 
neutralized using ice-cold Tris HCl pH8.0. 
	
Figure 3-13 Quality control of purified HP1γ R38/9-citrulline antibodies. 
A 2µl of purified antibody eluates were immobilized on humidified PVDF membrane, dried 
and stained with 2% [w/v] methylene blue solution.  
B SDS-PAGE of purified antibody eluates (elution 1-2 and 3-4 were combined). 2µl were 
loaded per well. Proteins were stained by coomassie staining solution. Heavy and light chains 
of antibodies are indicated. 
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3.8. Dot blot analysis of HP1γ R38/9-citrulline antibodies  
Four affinity-purified polyclonal antibodies against HP1γ R38/9-citrulline, referred to as 
S780D, S781D, S923D and S924D, were further tested in dot blots. They were tested against 
increasing amounts of various HP1γ peptides. Peptides screened were HP1γ (34-44) 
unmodified peptide (HP1γ UM), double citrulline R38/9-cit (HP1γ-R38/9-cit), single 
citrulline R38-cit (HP1γ-R38-cit), single citrulline R39-cit (HP1γ-R39-cit), R108-cit (HP1γ-
R108-cit) and R107-cit (HP1α-R107-cit) (Figure 3-14). Peptide sequences are summarised in 
Table 2-9 (Section 2.7.2). All antibodies specifically recognise the HP1γ-R38/9-cit peptides 
with very low binding to unmodified peptides. S780D was the most specific antibody with no 
specificity against any other peptides tested (Figure 3-14A). S781D showed moderate 
specificity against the R39-cit peptide (Figure 3-14B).  
S923D recognised the R39-cit to the same extend as the R38/9-cit peptide, suggesting that this 
polyclonal antibody contains an equal amount of reactive antibodies recognising R39-cit or 
R38/9-cit (Figure 3-14C). At this point, I decided to exclude this antibody from further 
characterisation, although it may prove useful in the future if the laboratory decides to 
specifically study citrullination of HP1γ R39-cit.  
S924D showed high specificity against R38/9-cit with low to moderate sensitivity to both 
R38-cit and R39-cit (Figure 3-14D). To enrich S924D for clones recognising only the doubly 
modified R38/9-cit peptide, the antibody preparation was sequentially passed over R38-cit 
and R39-cit peptide columns to remove antibodies that recognise each single modification. In 
each case, the column flow through was recovered. Dot blot results using the antibody after 
these additional purification steps confirmed that S924D was successfully depleted of 
antibodies specifically recognizing R38-cit and R39-cit, whilst it still recognised R38/9-cit 
(Figure 3-14E). This additionally purified antibody, S924D, together with antibodies S870D 
and S871D were used for further characterisation.  
In summary, my results demonstrate that I successfully generated three polyclonal antibodies 
with high specificity for the modified HP1γ R38/9-cit peptide. 
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Figure 3-14 Dot blot analysis of HP1γ R38/9-citrulline antibodies.               
(Figure legend is located on the next page). 
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3.9. HP1γ R38/9-citrulline antibodies tested in in vitro citrullination 
assays 
In order to test whether the antibodies recognise the epitope within full-length HP1γ, I 
performed in vitro citrullination assays (see Section 3.6) using 1µg of HP1γ WT and R38/9A 
mutant proteins. Equivalent input protein amounts, as judged from Coomassie blue stained 
SDS gels compared to a BSA standard (Figure 3-5) were used and confirmed by Ponceau S 
staining of transferred proteins (data not shown). S871D recognised both HP1γ WT and 
R38/9A in the absence of PADI4 enzyme (Figure 3-15A). This signal did not increase upon 
addition of PADI4, indicating the antibody recognised the backbone of HP1γ, with no 
specificity for citrullinated residues R38/9. 
Two antibodies S870D (Figure 3-15B) and S924D ((Figure 3-15C), did not recognise WT 
HP1γ in the absence of PADI4 but did so when PADI4 was included in the reaction. This 
indicates that the antibodies do indeed specifically recognise citrullinated HP1γ. Intriguingly 
though, both recognised the HP1γ R38/9A mutant protein even in the absence of PADI4, 
though S924D did less so than S870D. However, unlike with WT HP1γ, the antibodies’ 
recognition of HP1γ R38/9A was unaffected by addition of PADI4 to the reaction (Figure 
3-15B/C). Based on these results, I concluded that both S870D and S924D specifically 
recognise an epitope surrounding R38/9, which they bind to only when the two arginines 
(and/or the associated positive charges) are replaced by other amino acids (either citrulline or 
alanine).  In other words, the fact that the antibodies showed no specificity against HP1γ WT 
indicates that they exclusively recognise their epitope only once the arginines (and their 
positive charges) are lost either through citrullination or mutating the residues to alanines.  
 
Figure 3-14 Dot blot analysis of HP1γ R38/9-citrulline antibodies.              
HP1γ-R38/9-cit antibodies were tested against various peptides: HP1γ (34-44) unmodified 
peptide (HP1γ UM), double cit R38/9-cit (HP1γ-R38/9-cit), single cit R38-cit (HP1γ-R38-
cit), single citR39-cit (HP1γ-R39-cit), single cit R108-cit (HP1γ(104-111)-R108-cit) and 
single cit R107-cit (HP1γ(103-112)-R107-cit). Peptides were immobilised on PVDF 
membranes at indicated amounts (1-125ng) and incubated with purified HP1γ-R38/9-cit 
antibodies at 1:500 dilution.  
A S870D, B S871D, C S923D, D S924D 
E S924D antibody was repurified against single peptides HP1γ-R38-cit and R39-cit. 
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To further test whether loss of charge within the region is required to allow antibody 
recognition, I repeated the experiment using a HP1γ R38/9K mutant protein. The results for 
both antibodies, S870D (top panel) and S924D (bottom panel), are summarized in Figure 
3-16. Indeed, antibody recognition of R38/9K in absence of PADI4 was significantly weaker 
compared to recognition of HP1γ R38/9A protein. Importantly, addition of PADI4 had no 
further influence on the signal which is consistent with my hypothesis that the antibodies 
cannot recognise their epitopes if positive charges are present. 
 
	
Figure 3-15 Test of HP1γ-R38/9-cit antibodies using in vitro citrullination of HP1γ.  
In vitro citrullination assays with 1µg of HP1γ WT or R38/9A mutant protein were 
performed with 200ng of GST-PADI4 fusion protein for 1h at 37°C in the presence or 
absence of Ca2+. Reactions were resolved by SDS-PAGE and analysed by immunoblotting 
with indicated HP1γ-R38/9-cit antibodies. 
A: S871D, B: S780D, C: S924D 
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In conclusion, in vitro citrullination data demonstrate that both antibodies, S870D and S924D, 
specifically recognize their epitopes within HP1γ when arginines 38 and 39 are converted to 
citrulline or alanine. Crucially, a robust PADI4 dependent increase in signal is observed with 
HP1γ WT protein, indicating that the antibody can be used to detect citrullination of HP1γ at 
R38 and R39. 
3.10. Detection of HP1γ R38/9-citrulline in mESCs lysates 
Dot blot and in vitro citrullination data suggest that antibodies S780D and S924D specifically 
recognise PADI4 dependent citrullination of HP1γ residues R38/9. To understand whether 
this modification occurs in vivo, I transiently overexpressed HA-PADI4 in mESCs. As a 
comparison, I also included PADI2, another nuclear PADI enzyme86. Extracts were then 
analysed by immunoblotting using S780D and S924D antibodies. In order to enrich for HP1γ 
protein, chromatin was extracted using IPH chromatin extraction buffer. Protein expression of 
HA-PADI4 and PADI2 was observed by immunoblotting using a α-HA or PADI2 antibody 
respectively (Figure 3-17A).  
	
Figure 3-16 Test of HP1γ-R38/9-cit antibodies S870D and S924D using in vitro 
citrullination of HP1γ.  
In vitro citrullination assays of 1µg of HP1γ WT, R38/9A or R38/9K mutant proteins were 
performed with 200ng of GST-PADI4 fusion protein for 1h at 37°C in the presence or 
absence of Ca2+. Reactions were resolved by SDS-PAGE and analysed by immunoblotting 
with HP1γ-R38/9-cit S870D (upper panel) and S924D (lower panel) antibodies. HP1γ WT 
reaction was performed in duplicate.  
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Both enzymes were detected within the chromatin fraction. The enzymatic activity of both 
enzymes was tested by detection of citrullinated H3 by immunoblotting using a commercially 
available H3R2-cit antibody (Figure 3-17B). H3R2-cit was only detected in PADI4 and not in 
PADI2 overexpressing cells, which indicates that overexpressed PADI2 was not 
enzymatically active (at least towards H3). Notably, a weak signal at the molecular weight of 
HP1γ was observed using the S870D antibody, only upon overexpression of PADI4 (Figure 
3-17B). Immunoblotting with antibody S924D showed no significant signal.  
To enhance the HP1γ R38/9-cit signal detected with the S870D antibody, I repeated the 
immunoblotting experiment with double the amount of protein loaded per well, increased the 
polyacrylamide concentration of the gel and increased the antibody concentration. The 
	
Figure 3-17 Detection of HP1γ R38/9-cit in mESCs upon PADI4 overexpression.  
mESCs were transfected with pCDNA3.1-HA-PADI4 or pCMV6-PADI2 constructs and 
harvested 48h post transfection. Cellular fractionation of mESCs was performed using IPH 
chromatin extraction buffer. Immunoblotting was performed with the indicated antibodies.  
A Equivalent protein lysates of each fraction (from 40000 cells) were loaded per well. Chr: 
chromatin fraction; n+c: nucleo- and cytoplasmic fraction. 
B Chromatin fractions (from 40000 cells) from cells overexpressing PADI4, PADI2 or 
control cells were resolved in a 12.5%(w/v) SDS PAG. Immunoblotting was performed with 
antibodies as indicated (S870D was used at 1:1000 dilution). Blue arrow indicates molecular 
weight of HP1γ. 
C Chromatin fractions (from 80000 cells) from cells overexpressing PADI4 or control cells 
were dissolved in a 17.5%(w/v) SDS PAG. Immunoblotting was performed with S870D 
antibody at 1:500 dilution. Blue arrow indicates molecular weight of HP1γ. 
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previous HP1γ R38/9-cit signal observed after overexpression of PADI4 (Figure 3-17B) was 
significantly enhanced (Figure 3-17C). By resolving the proteins on a 17.5% SDS gel a 
second band at a molecular weight approximately 2-3kDa smaller than that of HP1γ was 
detected.  
To conclude, immunoblotting experiments using the site-specific HP1γ R38/9-cit antibody 
S870D suggest HP1γ is citrullinated at residues R38/9 upon overexpression of PADI4 in 
mESCs. Although the S924D antibody showed very promising results in in vitro assays, no 
specific signal was detected in mESC lysates.  
3.11.  Single molecule localisation microscopy (SMLM) of HP1 
To further explore the role of residues R38 and R39 on HP1γ’s function in mESCs, I studied 
the dynamics of HP1γ wildtype and R38/9A mutant molecules using 2D single molecule 
localisation microscopy (SMLM) in live mESCs during differentiation. I performed a 
comparative analysis in undifferentiated mESCs of the dynamics of HP1γ and HP1β wildtype 
and different CD and CSD mutants. This part of the project is an ongoing collaboration with 
Dr. Srinjan Basu (Prof. Ernest Laue laboratory, Department of Biochemistry, University of 
Cambridge).  
In order to measure the diffusion of single HP1 molecules, 2D imaging at 15ms time 
resolution was performed using high laser excitation powers. To measure the residence time 
of proteins bound to DNA, imaging was performed at lower laser excitation powers at 500ms 
time resolution because longer exposures lead to motion blurring of freely diffusing 
molecules as previously described195. Fluorescence images were collected as movies of 
10,000 frames at 15ms or 1,000 frames at 500ms exposure. Single-molecule traces were 
analysed using software that detects single-molecule trajectories from SPT movies. High 
excitation laser powers are necessary to achieve high-precision localisation at 15ms exposures 
and thereby accurately determine diffusion coefficients of single molecules. However, high 
excitation laser powers can lead to photobleaching, therefore low excitation powers with 
longer exposures are used to ensure long track lengths that are ideal for determining the 
residence times of proteins bound to chromatin. A detailed description of the data analysis is 
given in Section 2.9.4. 
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3.11.1.    Generation of mESC lines expressing mEos3.2-HaloTag -HP1 
proteins 
In order to measure both fast diffusion and residence times of HP1 proteins on chromatin, 
mammalian expression vectors were used encoding HP1 proteins N-terminally tagged to a 
fusion protein consisting of mEos3.2ref.86 and a HaloTag196 (Figure 3-18A). mEos3.2 is a 
widely used photo-convertible fluorophore. In the fluorescent ‘off’ state mEos3.2 is a green 
fluorescent protein that can be excited at 488nm, emitting light at 516nm. It can be activated 
to a fluorescent ‘on’ state with a 405nm laser triggering a conformational change of the 
protein. In the fluorescent ‘on’ state mEos3.2 is a red fluorescent protein, which can be 
excited at 561nm and emits light at 587nm86. mEos3.2 has limited photostability as it can only 
be activated once or twice before molecules are irreversibly bleached.  
HaloTag is a bacterial enzyme used to label proteins with organic dyes that are introduced 
into cells. HaloTag is a hydrolase with a genetically modified active site, which binds 
specifically to reactive chloroalkane ligand forming a covalent alkyl-enzyme adduct197. The 
ligand is coupled to the fluorophore of choice. In this study a HaloTag chloroalkane ligand 
coupled to Janelia Fluor (JF549) was used198. In order to avoid overlaps of PSFs (point spread 
functions) of single molecules, molecules were labeled using low concentrations of HaloTag-
JF549 ligand (0.5nM). JF549 (excitation maximum: 549nm; emission maximum: 571nm) is a 
photostable dye enabling imaging of molecules for longer, before irreversible photobleaching. 
In this study, the HaloTag-JF549 ligand labeling was used to measure both fast diffusion and 
residence time of HP1 molecules on chromatin.  
mESCs were transfected with pSB7 mammalian expression vectors containing mEos3.2-
HaloTag in frame with mouse HP1β or γ cDNA sequences (Figure 3-18A). Both HP1β or γ 
wildtype proteins were compared to CD mutants (HP1β V23M; HP1γ V32M and R38/9A) 
and CSD mutants (HP1β I161M; HP1γ I165K). As described before, mutations in the CD 
abolish binding to H3K9me3 of HP1β and γ proteins.  
Isoleucine residues in the chromo-shadow domain are conserved residues located within the 
PxVxL motif of HP1β and γ. Their mutation abolishes homo- and hetero dimerisation of HP1 
and interaction with other proteins118,199. A summary of all HP1β and γ mutants is illustrated 
in Figure 3-4.  
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pSB7 vectors contain a neomycin resistance cassette to generate stable cell lines. After 48h, 
cells were cultured in medium supplemented with geneticin. 14 days later mEos3.2 positive 
cells (excitation: 488nm; emission: 516nm) were sorted in bulk. Protein expression of HP1β 
and γ fusion proteins in stable cell lines was confirmed by immunoblotting (Figure 3-18B/C). 
HP1 fusion proteins have a molecular weight of approximately 70kDa. mEos3.2-HaloTag-
HP1γ wildtype, R38/9A, V32M and I165K mutant proteins were expressed at higher levels 
than endogenous HP1γ protein (Figure 3-18B). HP1γ R38/9A fusion proteins were expressed 
at approximately 50% lower levels than HP1γ wildtype fusion proteins. Also mEos3.2-
	
Figure 3-18 Stable expression of mEos3.2-HaloTag - HP1 constructs in mESCs.  
mESCs were transfected with pSB7 mammalian expression vectors encoding mEos3.2-
HaloTag-HP1 fusion proteins. After 14 days of geneticin selection, mEos3.2 positive cells 
were enriched by cell sorting. Immunoblotting using the indicated antibodies was performed 7 
days after cell sorting. Whole cell lysates from 50000 cells were loaded per well. 
A Schematic illustration of mEos3.2-HaloTag-HP1 fusion proteins. X-ray crystal structure of 
green EosFP (PDB identifier 1ZUX) and HaloTag (PDB identifier 5UXZ) were used to 
generate this image. Chemical structure of JF549 dye coupled to HaloTag-chloroalkane ligand 
and its approximate binding pocket is illustrated.   
B Immunoblotting, with the indicated antibodies, of HP1γ WT and mutant fusion proteins. 
C Immunoblotting, with the indicated antibodies, of HP1β WT and mutant fusion proteins. 
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HaloTag-HP1β wildtype, V23M and I161M mutant proteins were expressed at higher levels 
than endogenous HP1β protein levels (Figure 3-18C).  
3.11.2.    Diffusion of HP1 molecules in mESCs 
mESCs stably expressing mEos3.2-HaloTag-HP1β and γ fusion proteins were subjected to 
live-cell SMLM as described in Section 2.9.3. mEos3.2 green fluorescence images confirmed 
nuclear localisation of HP1 fusion proteins in each cell line (Figure 3-19A). Clear differences 
were observed in the sub-nuclear localisation of HP1β and γ constructs. Whilst wildtype 
HP1β proteins form clear heterochromatic foci, the signal for both HP1β I161M and V23M 
was more diffuse, indicating that molecules were less tightly associated with chromatin 
(Figure 3-19A, left panel). HP1γ wildtype proteins also formed foci. However, the signal was 
more diffuse than that of HP1β wildtype. No foci formation was observed with HP1γ mutant 
proteins (Figure 3-19A, right panel).  
In order to quantify diffusion of HP1 proteins, diffusion coefficients (DCs) of single 
molecules and the percentage of molecules with a specific diffusion mode were determined. 
Therefore, 2D imaging at 15ms time resolution with 67 frames per second (fps) was 
performed. Fluorescence images were collected as movies of 10,000 frames per cell and 
single-molecule traces were analysed using software that detects single-molecule trajectories 
from SPT movies (see Section 2.9.3). For each cell line, an average of 300 trajectories per 
movie were recorded. Up to 10 cells were imaged per cell line. Jump-distance analysis was 
performed as previously described178 and showed that HP1 proteins have two major DCs 
(compare Section 1.2.9). The data represent an average of all molecule trajectories within a 
2D plane, independent of their spatial distribution within the nucleus, as we did not 
distinguish between euchromatic and heterochromatic regions. As expected HP1 molecules 
exhibit one slow fraction (0.1 µm2s-1) and one fast diffusing fraction (> 0.5 µm2s-1) (Figure 
3-19B, left panel). DCs of the slow fraction were similar across samples. As slow molecules 
show similar diffusion to that observed for histone H2B200 they are regarded as stably bound 
to chromatin. The fast diffusing HP1β wildtype 50.2% fraction diffused at 0.6 ± 0.12 µm2s-1, 
whereas both V23M (61.7%; 1.01 ± 0.34 µm2s-1, p-value = 0.0016) and I161M (61.7%; 1.24 ± 
0.16 µm2s-1, p-value = 0.0001) moved significantly more quickly (Figure 3-19B/C).  
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Figure 3-19 Diffusion of HP1 molecules in mESCs. 
Stable mESC lines expressing the indicated mEos3.2-HaloTag-HP1β and γ proteins were 
labeled with 0.5nM HaloTag-JF549 ligand and subjected to live-cell SMLM. Using 561nm 
excitation, fluorescence images were collected as movies of 10,000 frames at 15ms exposure 
times. Approximately 10 cells were imaged per cell line. 
A Representative fluorescent images of mESC nuclei expressing mEos3.2-HaloTag-HP1 
proteins as indicated. Signals of mEos3.2 (em: 515nm) green fluorescence are shown. 
B Diffusion coefficients of indicated mEos3.2-HaloTag- HP1β and γ molecules [µm2s-1] are 
illustrated (left panel). Each data point represents an average of ~300 molecules tracked per 
cell. Percentages of molecules in fast and slow fraction are indicated (right panel). SEM are 
indicated.  SEM of single cell data is indicated. Significance of diffusion data was assessed 
using Students T-test. Significance of percentages was assessed using two-way ANOVA tests 
(****: p-value =0.0001, **: p-value < 0.0023). 
C Tabulated summary of results shown in B.  
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These results indicate that fast diffusion of HP1β molecules is affected when mutating the 
chromo and chromo-shadow domains. Compared to HP1β, HP1γ wildtype molecules diffused 
quicker (70.2%; 0.78±0.26 µm2s-1, p-value = 0.0577). For HP1γ, 20% more molecules were 
detected in the fast diffusing fraction compared to HP1β (p-value = 0.0001), indicating that 
HP1γ molecules are less tightly associated with chromatin. Interestingly, diffusion of both 
HP1γ CD mutants was similar to that of wildtype molecules (p-value < 0.7), suggesting that 
fast diffusion of HP1γ is less dependent on their ability to bind H3K9me3. Similar to HP1β, 
HP1γ I165K mutant molecules moved significantly faster than wildtype molecules (1.5±0.01 
µm2s-1, p-value = 0.0001). The clear differences in diffusion of wildtype compared to chromo-
shadow domain mutants for both HP1 paralogues, may indicate that HP1 moves within bigger 
complexes inside the nucleus.  
In summary, single molecule particle tracking of mEos3.2-HaloTag-HP1β and γ fusion 
proteins revealed that HP1 molecules show two major diffusion modes, which are 
characteristic for HP1 dynamics. The slow DC refers to molecules stably bound to chromatin 
and the fast DC to freely diffusing molecules. HP1γ wildtype molecules in the fast diffusing 
fraction appear to move significantly quicker than HP1β wildtype molecules. Furthermore, 
diffusion of HP1β molecules seems to be more dependent on its ability to bind H3K9me3 
than that of HP1γ molecules. However, mutating the PxVxL domain significantly increases 
fast diffusion of both paralogues. 
3.11.3.    Dynamics of HP1 during mESC differentiation  
I previously demonstrated that HP1γ R38/9A mutant proteins show impaired binding to 
H3K9me3 peptides in vitro (see Section 3.5) and provided evidence that HP1γ is citrullinated 
by PADI4 at residues R38/9 (see Section 3.9 and 3.10). During reprogramming PADI4 
enzymes are activated and citrullinate linker histone H1.2, which results in their eviction from 
chromatin and global chromatin decondensation190. Conversely, stem cell differentiation is 
accompanied by facultative heterochromatin formation and global chromatin condensation, 
which involves the association of structural chromatin proteins such as histone H1 and HP1 
with chromatin176,201. Given the independent functions of both citrullination and HP1 during 
stem cell homeostasis (compare Section 1.2.8.4), I decided to extend the analysis to 
characterise the dynamics of HP1γ R38/9A mutant compared to HP1γ and HP1β wildtype 
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proteins during mESCs differentiation. mES cell lines stably expressing mEos3.2-HaloTag-
HP1β and γ fusion proteins (see Section 3.11.1) were subjected to live cell SMLM before and 
after cellular differentiation, which was induced by withdrawing LIF for 72h. The same 
protocol was previously shown to induce differentiation in mESCs at high efficiency176. 
Diffusion coefficients (DCs) of single molecules with the percentages in each fraction were 
determined (compare Section 3.11.2). Again, two major DCs were detected for HP1 
molecules. In general, the diffusion coefficients of HP1 molecules remained unchanged upon 
mESC differentiation. However, percentages of the slow fraction of HP1γ both wildtype (48.6 
± 7.0%; 0.09 ± 0.014 µm2s-1, p-value = 0.0004) and R38/9A mutant (44.5 ± 7.6%; 0.08 ± 
0.017 µm2s-1, p-value = 0.002) molecules increased upon differentiation by approximately 
20% and 15%, respectively. Conversely, the percentages of slow HP1β even decreased by 
approximately 8% upon differentiation (41.8 ± 7.0 %; 0.07 ± 0.02 µm2s-1, p-value = 0.0143) 
(Figure 3-20A/B). Whilst in undifferentiated cells both HP1γ wildtype (p-value = 0.0001) and 
R38/9A mutant (p-value = 0.0001) molecules showed significantly more molecules in the fast 
moving population when compared to HP1β. These differences decreased upon differentiation 
for both HP1γ wildtype (p-value = 0.174) and R38/9A mutant (p-value = 0.0619) molecules. 
These results indicate that HP1γ showed a striking redistribution towards the slow moving 
fraction upon differentiation, whereas percentage of HP1β slow moving molecules even 
decreased, which would suggest that HP1γ is more critical in establishing heterochromatin 
during differentiation in this system. However, a similar increase of stably bound molecules 
was observed for HP1γ R38/9A mutant molecules.  
To measure the residence time of proteins on chromatin in differentiated versus 
undifferentiated cells, imaging was performed at 500ms time resolution with 2 fps. 
Fluorescence images were collected as movies of 1000 frames per cell and single-molecule 
traces were analysed using software that detects single-molecule trajectories from SPT movies 
(HP1γ). For each cell line, an average of ~200 trajectories per movie were recorded. Up to 10 
cells were imaged per cell line. Figure 3-20C depicts the average residence times of HP1 
molecules before and after differentiation. Single particle tracking at 500ms time resolution 
only detects movement of molecules bound to chromatin, as faster moving molecules cannot 
be detected in more than one frame. The average residence times therefore refer to molecules 
stably bound to chromatin.  
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Figure 3-20 Dynamics of HP1 upon mESC differentiation.  
Stable mESC lines expressing the indicated mEos3.2-HaloTag-HP1β and γ proteins were  
differentiated by 72h LIF withdrawal. Differentiated and undifferentiated cells were labeled 
with 0.5nM HaloTag-JF549 ligand and subjected to live-cell SMLM. Using 561nm excitation, 
fluorescence images were collected as movies of 10,000 frames at 15ms for diffusion and 
1000 frames at 500ms for residence data.  
A Diffusion coefficients of indicated mEos3.2-HaloTag- HP1β and γ molecules [µm2s-1] are 
illustrated (left panel). Each data point represents an average of ~300 molecules tracked per 
cell. Percentages of molecules in fast and slow fraction are indicated (right panel). 
Approximately 10 cells were imaged per cell line. SEM of single cell data is indicated. 
Significance of diffusion data was assessed using Students T-test. Significance of percentages 
was assessed using two-way ANOVA tests (****p-value = 0.0001, ***p-value = 0.0004, 
**p-value = 0.002, *p-value = 0.0143). 
B Tabulated summary of results depicted in A. 
C Average residence time of indicated mEos3.2-HaloTag- HP1β and γ molecules [s] are 
illustrated. Each data point represents an average of ~200 molecules tracked per cell. 
Approximately 10 cells were imaged per cell line. SEM of exponential fit are indicated. 
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In agreement with the increase of molecules in the slow moving population in differentiated 
cells (Figure 3-20A/B), HP1γ WT molecules show an increased average residence time (tres) 
of approximately 3s upon differentiation (tres[+LIF] = 4.10±0.05s; tres[-LIF] = 7.37±0.24), 
while the residence time of HP1β molecules only increased slightly (tres[+LIF] = 4.33±0.08s; 
tres[-LIF] = 5.13±0.11s).  
Intriguingly, although the percentage of immobilised HP1γ R38/9A mutant molecules 
increased in differentiated cells (Figure 3-20A/B), their average residence time did not change 
significantly (tres [+LIF] = 4.1±0.07s; tres [-LIF] = 4.96±0.11s). Hence, upon differentiation, 
the overall percentage of slow moving and chromatin associated HP1γ R38/9A molecules 
increases similar to WT molecules. However, the average time these molecules remain stably 
bound to chromatin is lower than that of WT HP1γ molecules.  
In summary, upon differentiation the diffusion of fast and slow moving HP1β or γ molecules 
remains unchanged, however the percentage of slow moving molecules significantly increases 
for HP1γ (WT and R38/9A), but not for HP1β molecules. These results suggest that HP1γ’s 
contribution to local and global chromatin condensation during differentiation is higher than 
that of HP1β. While the percentages of slow moving molecules of HP1γ WT and R38/9A are 
similar in differentiated cells, their average residence on chromatin is lower, which suggests 
that the residues R38 and R39 are not necessarily important for HP1γ’s recruitment to 
chromatin during differentiation, but influence the stable binding of HP1γ molecules on 
chromatin.  
3.12. Discussion 
Mass spectrometry analysis in mESCs identified citrullination of HP1γ in the hinge region at 
residue R108 and in the CD at residues R38/9. My PhD project focused on citrullination of 
residues R38/9 since these were within a domain of well-characterised function. This chapter 
documents my efforts to characterise these modifications using in vitro and in vivo assays.  
3.12.1.    R38/9A mutant shows impaired binding to H3K9me3 peptides 
Residues R38/9 are located within the β1-sheet of the CD (Figure 1-5). As they are on the 
opposite side and facing away from the H3K9me2/3 binding pocket they probably do not 
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directly contact the H3 tail. However, correct folding of the β1-sheet is important for H3 
recognition106 and losing the positive charge of two adjacent arginines due to citrullination, 
may affect CD structure and hence the affinity of HP1 to H3K9me2/3. To test this hypothesis, 
I performed in vitro pulldown assays with H3K9me3 peptides using recombinant HP1γ 
wildtype and R38/9A mutant proteins (see Section 3.5). The R38/9A mutant showed impaired 
binding to H3K9me3 peptides compared to wildtype, suggesting positive charges at residues 
R38/9 are important for HP1γ to efficiently bind methylated H3 tails. The fact that the 
R38/9K mutant restores binding indicates that positive charges at position 38 and 39 are 
critical for HP1γ’s CD to interact with H3K9me3. When comparing different pulldown 
experiments, it became apparent that the efficiency varied from experiment to experiment. 
This might be due to experimental variants such as GST-preparations, peptide batches or 
temperature fluctuations in the lab. Despite this variability the results presented here were 
qualitatively highly reproducible.  
The R38/9A mutant was designed to mimic the loss of charge accompanied with 
citrullination. Previous work from our lab showed that linker histone H1.2 R54A mutant 
phenocopies citrullinated R54 in in vitro nucleosome binding assays190. However, the effect 
of mutating two adjacent, relatively long arginine residues to short alanine tails may interfere 
with the protein structure of HP1γ more than citrullination of these residues. Here, nuclear 
magnetic resonance (NMR) spectroscopy of wildtype and mutant CDs could provide more 
insight into the impact of R38/9A mutations on the overall doain structure.  
In conclusion, my results show that maintaining positive charges at residues R38/9 is 
important for HP1γ to bind H3K9me3 in vitro and suggest that citrullination may influence 
this interaction.  
3.12.2.  HP1γ R38/9-citrulline antibodies and potential applications 
In order to characterise these modifications in vivo, I generated site-specific antibodies against 
HP1γ R38/9-citrulline. Antibodies were validated using in vitro assays (see Section 3.8 and 
3.9) and finally tested on mESCs whole cell extracts (see Section 3.10). Out of four antibodies 
tested, S870D and S924D appeared the most specific for HP1γ R38/9-cit. In vitro 
citrullination assays revealed binding of S870D or S924D to R38/9A, but not to the R38/9K 
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mutant. This suggests that antibody recognition of its epitope is inhibited by positive charges 
at positions 38 and 39 within HP1γ's CD, although steric hindrance due to the lysine side-
chain may also be involved in blocking antibody access to its epitope. Most importantly 
though, the signal on wildtype HP1γ notably increased upon addition of PADI4, confirming 
that citrullination of R38/9 promotes epitope recognition. Indeed, recognition of the 
citrullinated form of HP1γ is even stronger than the HP1γ R38/9A mutant indicating that both 
antibodies prefer citrulline at these positions for full binding activity. 
The S870D antibody detected an increase in HP1γ R38/9-cit in mESCs upon overexpression 
of PADI4, suggesting that the modification can exist in vivo. To verify that the signal is 
specific for HP1γ, it is crucial to test the antibody on lysates obtained from cells depleted 
from endogenous HP1γ in the presence or absence of HA-PADI4 over-expression. Signal 
reduction in HP1γ knockdown cells over-expressing PADI4 would confirm that S780D 
specifically recognises PADI4 dependent citrullination of HP1γ at residues R38/9. 
The signal for HP1γ R38/9-cit was weak and was only detected upon PADI4 overexpression 
indicating that the overall levels of this modification are low in untreated mESCs. To gain 
further insight into the role of HP1γ citrullination it will be very important to determine where 
citrullinated HP1γ is located in the cell. Immunostainings or cellular fractionations analysed 
by immunoblotting would be useful in this regard.  
Besides HP1, other chromatin associated proteins have been described to be 
citrullinated202,203. Hormone induced nuclear receptors (NRs) regulate expression of target 
genes by association with coactivator proteins to remodel chromatin structure and assemble 
the transcription machinery204. The important coactivators of NRs, histone acetyltransferases 
CBP/p300202, have been shown to be regulated by citrullination. PADI4 citrullinates p300 on 
R2142, which in turn enables the protein to interact with the coactivator complex that 
activates estrogen receptor-mediated transcription205. Similarly, citrullination of HP1γ could 
generate new binding sites for proteins affecting HP1γ localisation or function. Since HP1γ 
seems to be the only paralogue which is part of NR complexes139,140, it would be very 
interesting to test whether this interaction is regulated by citrullination. Furthermore, in vitro 
pulldown assays with unmodified or R38/9-cit modified HP1γ peptides using mESC whole 
cell lysates, analysed by mass spectrometry could be a way of identifying readers of these 
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modifications. The HP1γ R38/9-cit antibody would be a valuable tool in helping to dissect the 
role of potential interaction partners. 
Citrullinated H1.2 is evicted from chromatin in mESCs190. My in vitro data indicate that 
binding of HP1γ R38/9A to H3K9me3 is significantly reduced compared to WT HP1γ 
suggesting HP1γ’s binding to chromatin may also be regulated by citrullination. In mESCs, 
the amount of citrullinated HP1γ seems to be low, suggesting that citrullination only affects a 
small subset of HP1γ molecules per cell. ChIP experiments using the HP1γ R38/9-cit 
antibody would be a crucial experiment to determine whether citrullination affects HP1γ’s 
binding to chromatin and, if so, which genomic loci are affected. To gain more insight into the 
role of PADI4 mediated HP1γ citrullination, these data could be cross-compared with ChIP 
data from cells overexpressing PADI4, using HP1γ and PADI4 antibodies. An interesting 
starting point would be to study the potential interplay of HP1γ and PADI4 in regulating 
expression of the stem cell gene Nanog. In differentiated cells, HP1γ binds to the Nanog 
promoter via H3K9me3 and represses gene expression. Furthermore, loss of HP1γ increases 
reprogramming efficiency by de-repressing Nanog expression, indicating a role for HP1γ in 
regulating cell fate decisions172. During reprogramming, expression of PADI4 is induced, 
which leads to activation of stem cell genes, including Nanog190. It would therefore be very 
interesting to understand whether HP1γ’s displacement from the Nanog promoter during 
reprogramming is regulated by PADI4. 
3.12.3.    Single molecule localisation microscopy of HP1 
SMLM was used to determine the dynamics of HP1β and γ wildtype and mutant proteins in 
mESCs. For that purpose, stable cell lines expressing mEos3.2-HaloTag-HP1 proteins were 
generated. All constructs were expressed at levels higher than those of the respective 
endogenous proteins (Figure 3-18B). However, we deliberately chose cells with lower 
expression to decrease the likelihood of overexpression artefacts (Figure 3-19A). 
Furthermore, the analysis to determine diffusion parameters for single molecules is corrected 
for the overall fluorescence intensity. Therefore, individual expression levels of fusion 
proteins should not influence the measurements dramatically. 
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SPT of mEos3.2-HaloTag-HP1β and γ fusion proteins detected two characteristic diffusion 
modes of HP1 molecules, which confirms results from previous studies using complementary 
technologies (FRAP and FCS)109,173-175. FCS is based on the observation of single molecules 
or several molecules within one diffraction-limited spot. Also FRAP measures kinetics of 
molecule diffusion within one region of interest. Data acquisition is therefore limited to single 
regions within a nucleus. On the other hand, 2D SMLM allows one to detect every molecule 
within a 2D plane within a nucleus. SPT is a much more quantitative technique, as diffusion 
of hundreds of molecules can be determined simultaneously. 
The two major diffusion modes of HP1 relate to molecules that are either stably bound to 
chromatin (slow) or freely diffusing molecules (fast). In contrast to published data stating that 
HP1 paralogues share similar dynamics109,168,174, we observed clear differences between HP1β 
and γ. HP1γ wildtype molecules in the fast diffusing fraction appear to move significantly 
quicker than HP1β wildtype molecules. Furthermore, diffusion of HP1β molecules seems to 
be more dependent on its ability to bind H3K9me3 than that of HP1γ molecules. This 
observation is interesting in the sense that HP1γ is the only paralogue predominantly found in 
H3K9me3 deprived regions of the genome143. Mutations within the CD were previously 
shown to result in complete loss of HP1 from heterochromatin, as mutations completely 
abolish heterochromatic foci formation109. Conversely, our data suggest that a significant 
proportion of CD mutant molecules is still stably bound to chromatin. It is likely that HP1 
recruitment to chromatin is not entirely regulated by its ability to bind H3K9me3 and/or that 
the molecules we detect interact with chromatin via their CSD or hinge region. Mutating the 
PxVxL domain significantly increases fast diffusion of both HP1β and HP1γ, which suggests 
that HP1 molecules move in dimers or even in bigger complexes. The mechanisms of HP1 
recruitment to chromatin are largely unknown. Given HP1’s multipartite nature, recruitment 
of HP1 via association with larger protein complexes seems highly likely. 
Both HP1γ170-172 and PADI4ref.190 are associated with stem cell homeostasis. To understand 
whether the residues R38 and R39 of HP1γ influence the proteins dynamics during stem cell 
differentiation, we compared the dynamics of HP1γ R38/9A mutant to WT HP1γ and HP1β 
molecules in mESCs before and after LIF withdrawal. The first interesting observation from 
this experiment is that, upon differentiation the percentage of slow moving molecules 
significantly increases for HP1γ (WT and R38/9A), but not for HP1β molecules. This 
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suggests that, at least in our system, HP1γ’s contribution to chromatin remodeling during 
differentiation is greater than that of HP1β. Conversely, data derived from FRAP experiments 
reported no apparent difference between HP1 paralogues169,176. SPT is a more quantitative 
method and more sensitive than FRAP. It is possible that functional differences between HP1 
paralogues have not been detected yet, due to limitations of other technologies.  
Secondly, we observed that although the percentages of slow moving molecules of HP1γ WT 
and R38/9A are similar in differentiated cells, their average residence time on chromatin is 
lower. These data suggest that residues R38 and R39 are not necessarily critical for HP1γ’s 
recruitment to chromatin during differentiation, but they influence the stability of HP1γ 
binding on chromatin. This hypothesis is supported by in vitro data, which showed that 
interaction of HP1γ R38/9A with methylated H3K9 peptides is less stable than that of WT 
proteins. Binding of HP1γ R38/9A is significantly impaired under physiological salt 
conditions and seems to be more sensitive to increasing salt concentrations when compared to 
WT proteins, indicating that the interaction of the mutant protein with H3K9me3 peptides is 
weaker.  
The diffusion data presented here represent an average over all molecule trajectories, 
independent of their spatial distribution within the nucleus. Therefore, our analyses do not 
distinguish between euchromatic and heterochromatic regions. Data derived from FRAP and 
FCS experiments suggest differential dynamics of HP1 in heterochromatin and euchromatin. 
To understand the plasticity of HP1γ and the R38/9A mutant during differentiation, it will be 
crucial to determine the diffusion and residence time of molecules in euchromatin versus 
heterochromatin. It is also possible to determine association rates of single molecules in 
different regions of the nucleus. This work is currently ongoing. In the future, we are planning 
to analyse DNA residence time data of HP1 in 3D to understand how the bound molecules are 
moving. In particular, it will be possible to determine whether molecules are sliding along the 
DNA or are bound to specific sites. This information will be very valuable to understand how 
HP1 molecules are interacting with chromatin and which domains or residues are necessary.  
In this chapter, I presented my results characterising a novel post-translational modification of 
HP1γ. I showed that HP1γ is citrullinated by PADI4 in vitro and in vivo at residues R38/9. 
The mutant R38/9A, which is designed to mimic the loss of charge accompanied with 
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citrullination, affects HP1γ’s binding to H3K9me3 peptides and reduces the residence time of 
HP1γ molecules on chromatin in differentiated cells. This suggests a role for citrullination in 
regulating HP1γ binding to chromatin during differentiation.  
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   Chapter 4
Functional characterisation of HP1γ in breast cancer 
cells 
 
4.1. Introduction 
Gene regulation is tightly controlled at different levels to ensure correct transcriptional 
programming of a cell. Deregulation of these processes may result in many phenotypic 
changes including aberrant cell growth and oncogenesis. It is well documented that cancer 
progression is a multistep process involving many changes in chromatin structure and gene 
expression165. Given their widespread role of telomere and centromere stability and gene 
regulation, it is not surprising that HP1 proteins have links to cancer progression160,206. High 
protein levels of HP1γ have been associated with enhanced cell proliferation and oncogenesis 
in various cancers such as colorectal155,156, non-small cell lung157, prostate158, cervical and 
breast159,160 (compare Section 1.2.8.3). However, the involvement of HP1γ in tumorigenesis 
remains unclear. 
In this chapter, I will present data on the physiological role of HP1γ in breast cancer cells. I 
have taken advantage of two breast cancer cell line models, one with less invasive 
characteristics (MCF7) and one with a more invasive phenotype (MDA-MB-231). This 
chapter describes the changes to the phenotype of these cells upon HP1γ depletion using 
assays that assess cell growth, cell cycle progression, cell viability and motility. 
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4.1.1. The MCF7 breast cancer cell model  
The MCF7 (Michigan cancer foundation 7) cell line is a widely used human breast cancer cell 
line generated from a 69- year old Caucasian woman in 1973ref.207 with an invasive ductal 
breast carcinoma. The cells express estrogen receptor α (ERα) and progesterone receptor 
(PR), and are receptor tyrosine kinase ERBB2 (HER2) negative. Therefore, they are regarded 
as a model for luminal A type breast cancer. Luminal A type breast cancer is the most 
common type of breast cancer with the best prognosis208. 
MCF7 cells are adherent cells that have retained characteristics of the mammary epithelium, 
and they therefore display an epithelial-like morphology.  In culture, MCF7 cells grow as a 
monolayer, are 20-25µm in diameter (Figure 4-1) and have a doubling time of 30-40h.  
													
	
Figure 4-1 Morphology of MCF7 cells.  
Brightfield microscopy image of adherent MCF7 cells at 80% confluency, captured with a 
Leica EC3 digital camera at 10x magnification. Scale bar indicated (50µm). 
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4.1.2. The MDA-MB-231 breast cancer cell model  
The MDA-MB-231 cell line is a human breast cancer cell line generated from a 51- year old 
Caucasian woman in 1973209 with a poorly differentiated invasive ductal breast carcinoma. 
This cell line is an example of triple negative breast cancer due to lack of the molecular 
markers ERα, PR and HER2. It further lacks expression of tight junction proteins including 
claudin 3 and E-cadherin, but it shows high expression of mesenchymal markers and therefore 
classifies as a model for the Claudin-low (CL) breast cancer subtype210. CL tumors are poorly 
differentiated and are frequently found in residual mammary tumour tissue after hormone 
therapy or chemotherapy, and consequently patients overall have a poor prognosis211.  
MDA-MB-231 cells are adherent cells that form loose networks of round or short, spindle-
shaped cells, they are 15-20µm in diameter (Figure 4-2) and have a doubling time of 35-40h. 
The cells are used as model for chemotherapy resistant metastatic breast cancer cells. 
												
	
Figure 4-2 Morphology of MDA-MB-231 cells. 
Brightfield microscopy image of adherent MDA-MB-231 cells at 60% confluency, captured 
with a Leica EC3 digital camera at 10x magnification. Scale is bar indicated (50µm). 
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4.2. Aims of this chapter 
This chapter has the following aims related to characterising the phenotype of HP1γ depletion 
in the two breast cancer models MCF7 and MDA-MB-231. 
1. To determine the effects of HP1γ depletion on cell proliferation and cell cycle 
progression 
2. To determine the effects of HP1γ depletion on cell viability  
3. To investigate whether loss of HP1γ affects cellular mobility 																													
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4.3. Phenotype changes upon HP1γ depletion in MCF7 cells 
4.3.1. Expression of HP1γ in MCF7 cells 
HP1γ is a ubiquitously expressed nuclear protein associated with chromatin. In order to 
determine HP1γ protein levels and subcellular localisation in MCF7 cells, cellular 
fractionation using a 0.5% (v/v) NP-40 lysis buffer (IPH buffer) was performed to separate 
chromatin from the nucleo- and cytoplasmic fraction. Cellular equivalents from each fraction 
were resolved by SDS PAGE and analysed by immunoblotting using antibodies against HP1γ, 
the cytoplasmic marker GAPDH and the chromatin marker histone H3 (Figure 4-3). GAPDH 
was absent from the chromatin fraction and only a small amount of H3 was detected in the 
nucleo-cytoplasmic fraction, indicating cellular fractionations were performed successfully. 
As expected, the strongest signal for HP1γ was observed in the chromatin fraction. However, 
when compared to total HP1γ as shown in the whole cell lysate, approximately 33%, of the 
protein was detected in the nucleo- and cytoplasmic fraction. My results suggest that, in 
MCF7 cells, the majority of HP1γ is associated with chromatin but a significant fraction is 
also present within the nucleoplasm and/or cytoplasm.  
 
 
 
Figure 4-3 Cellular fractionation of MCF7 cells.   
Immunoblotting of MCF7 lysates using indicated antibodies. MCF7 cells were lysed directly 
in 2x Laemmli buffer to prepare whole cell lysates (WCL). Cellular fractionation was 
performed using IPH chromatin extraction buffer. Nuc+Cyt: nucleo- and cytoplasmic 
fraction. Cellular equivalents (representing 40000 cells) of each fraction were loaded per 
well. 
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4.3.2. shRNA mediated knockdown of HP1γ 
To analyse HP1γ function in MCF7 cells, I generated stable knockdown cell lines using 
lentiviral vectors that express small hairpin RNAs (shRNAs) targeting the CDS of the human 
HP1γ gene CBX3. shRNAs against HP1γ and a non-targeting control shRNA were cloned into 
lentiviral vector pLKO.1 and lentiviral particles were produced in 293T cells using the 3rd 
generation packaging system212. MCF7 cells were then infected with lentiviral supernatant. 
24h post infection cells were cultured in puromycin selection media. HP1γ knockdown 
efficiency was determined by measuring HP1γ mRNA and protein levels for two shRNAs: 
shHP1γ_1 and 2 versus the control shCtrl over a 6 day time course. HP1γ mRNA levels were 
measured by RT-PCR and protein level by immunoblotting using a HP1γ antibody (Figure 
4-4). Protein levels were quantified using ImageJ and signal intensities normalised to the 
loading control GAPDH. 2 days post infection, a 95% reduction of HP1γ mRNA was 
observed with shHP1γ_1 and a 50% reduction with shHP1γ_2, as compared to shCtrl control 
levels (Figure 4-4A). At the same time point, protein levels were reduced by 75% with 
shHP1γ_1 and remained unchanged with shHP1γ_2. After 6 days, the most efficient 
knockdown of HP1γ protein was observed for both shRNAs. shHP1γ_1 resulted in nearly 
complete protein depletion and shHP1γ_2 reduced the protein level by 80% (Figure 4-4B). 
Based on these results, day 4 and 6 time points were chosen for functional assays. 
4.3.3. HP1γ depletion affects proliferation of MCF7 cells 
Previous studies using different cancer cell lines showed that loss of HP1γ inhibits tumour 
cell growth155,159. To understand whether loss of HP1γ affects cell growth of MCF7 cells, I 
performed shRNA-mediated knockdown of HP1γ and assessed cell proliferation using the 
CyQUANT® cell proliferation assay. The CyQUANT® assay uses a fluorescence dye that 
intercalates into DNA and RNA. The fluorescence signal is directly proportional to the 
number of cells and is therefore used as an estimate for cell proliferation. 4 days after 
infection with lentiviral vectors encoding shRNAs (shCtrl, shHP1γ_1 and shHP1γ_2), cells 
were seeded at equal densities into wells of a 96-well plate (t = d0) and fluorescence was 
measured every 2 days for a total of 8 days. HP1γ protein knockdown at d0 was confirmed by 
immunoblotting using a HP1γ antibody (Figure 4-5A).  
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With both shRNAs the fluorescence signal was significantly lower compared to shCtrl cells, 
indicating cell proliferation was impaired upon HP1γ depletion (Figure 4-5B). To 
independently confirm the CyQUANT® assay results, I performed a single counting 
experiment for one shRNA (shHP1γ_1) (Figure 4-5C). Cells infected with shCtrl vector grew 
exponentially, whereas HP1γ depleted cells merely doubled over the time course of 8 days. 
Hence, a cell counting assay confirmed the results obtained from CyQUANT® assays. To 
further confirm that this effect is dependent on HP1γ protein levels, a rescue experiment was 
performed. MCF7 cell lines expressing HA-HP1γ or an empty control construct were 
generated using the lentiviral vector pHIV-Zsgreen, which expresses HA-HP1γ and GFP 
linked via an IRES sequence. GFP positive cells were sorted 5 days post infection and 
propagated to generate a cell line. HA-HP1γ overexpressing and control cells were infected 
 
Figure 4-4 Time course for knockdown of HP1γ in MCF7 cells.                         
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA vectors and processed 2, 4 
and 6 days post infection.  
A Immunoblot of MCF7 whole cell lysates, using indicated antibodies (left panel). Signal was 
quantified using ImageJ and normalised to GAPDH (right panel). Protein lysates representing 
40000 cells were loaded per well. 
B HP1γ mRNA level assessed by RT-PCR relative to shCtrl samples. Graph shows relative 
mRNA expression after normalisation to TUBB expression. The fold change over shCtrl 
samples is shown. An average of duplicates is shown. SEM are indicated.  
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with shCtrl and shHP1γ_1 vectors and 4 days after infection cells were subjected to one 
CyQUANT® proliferation assay as described above. Expression of endogenous and 
exogenous (HA) HP1c protein levels were confirmed by immunoblotting (Figure 4-5D). 
Preliminary results showed that proliferation of MCF7 was partially rescued in cells 
expressing HA-HP1γ (Figure 4-5D, green line).  
 
Figure 4-5 legend is located on the following page. 
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To test whether impaired proliferation upon HP1γ depletion is a general cellular response, or 
more specific for cancer cells, I assessed cell proliferation in the non-tumorigenic breast 
epithelial cell line MCF10A - a model cell line for normal mammary epithelial cells. 4 days 
post infection with shRNA vectors (t = d0), HP1γ protein knockdown was confirmed by 
immunoblotting (Figure 4-6A). CyQUANT® results summarised in Figure 4-6B indicated that 
proliferation of MCF10A was not affected in HP1γ depleted cells. For both shRNAs, the 
measured fluorescent signals were similar to those of the control. 
In summary, loss of HP1γ significantly affects MCF7 cell proliferation, whereas proliferation 
of the non-tumorigenic mammary epithelial cell line MCF10A was unaffected. My results 
indicate that proliferation of breast cancer cells is dependent upon HP1γ, whereas 
proliferation of normal breast epithelia cells is not. 
Figure 4-5 Proliferation of MCF7 cells.                                          
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA vectors and processed 4 
days post infection (t = d0).  
A Immunoblot of MCF7 whole cell lysates at d0 using indicated antibodies. Protein lysates 
from 40000 cells loaded per well.  
B CyQUANT® proliferation assays over an 8 day time course. Cells were seeded at 500 
cells/well in a 96 well plate at d0. Fluorescence was measured at 520 nm in a Clariostar® 
microplate reader at the indicated time points. Fluorescent units were normalised to signals 
measured at d0. Graph includes results from 3 independent experiments, each performed with 
12 wells per condition. Significance was assesses using one-way ANOVA test (* p-value = 
0.0001). SEMs are indicated. 
C Cell proliferation assessed by cell counting. 1.0*10^5 cells were seeded in wells of a 12-
well dish at d0. Cells were trypsinsed and counted over the course of 8 days. Graph includes 
data from one experiment with 2 replicates per condition. SEMs are indicated. 
D	Immunoblot	of	MCF7	stably	expressing	HA-msHP1γ or empty vector (Ctrl)	whole	cell	lysates	at	d0	using	indicated	antibodies.	Protein	lysates	from	40000	cells	loaded	per	well.	
E CyQUANT® proliferation assays over an 8 day time course. Cells were seeded at 500 
cells/well in a 96 well plate at d0. Fluorescence was measured at 520 nm in a Clariostar® 
microplate reader at the indicated time points. Fluorescent units were normalised to signals 
measured at d0. Graph includes results from 1 experiment performed with 12 wells per 
condition. SEMs of technical replicates are indicated. 
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4.3.4. Cell cycle analysis of MCF7 cells 
To help understand whether the impaired cell proliferation observed in HP1γ depleted MCF7 
cells is due to cell cycle progression defects, I performed cell cycle analysis in HP1γ 
knockdown cells. Knockdown was confirmed by immunoblotting (Figure 4-7A). Data from 
studies in colorectal cancer cells suggest that HP1γ regulates expression of the cyclin-
dependent kinase inhibitor p21 by directly repressing the promoter activity of the CDKN1A 
gene155. Consequently, HP1γ depletion causes an increase of p21 expression in colorectal 
cancer cells, which then accumulate in G1 phase of the cell cycle155. 
 
 
Figure 4-6 Proliferation of MCF10A cells.                  
MCF10A cells were infected with shCtrl and shHP1γ_1 and 2 shRNA vectors and processed 
4 days post infection (t = d0).  
A Immunoblot of MCF10A whole cell lysates at d0 using indicated antibodies. Protein lysates 
from 30000 cells were loaded per well.  
B CyQUANT® proliferation assays over an 8 day time course. Cells were seeded at 500 
cells/well in a 96 well plate at d0. Fluorescence was measured at 520 nm in Clariostar® 
microplate reader at the indicated time points. Fluorescent units were normalised to signals 
measured at d0. Graph includes results from 2 independent experiments. SEMs are indicated. 
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Figure 4-7 Cell cycle analysis of MCF7 cells. 
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA lentiviral vectors and 
processed 4 or 6 days post infection.  
A Immunoblot of MCF7 whole cell lysates at day 6 using indicated antibodies. Protein lysates 
from 40000 cells were loaded per well.  
B mRNA level of CDKN1A encoding p21 at 6 days post infection, assessed by RT-PCR. 
Graph contains data from 3 experiments. Data normalised to TUBB. Significance was 
assessed using one-way ANOVA tests (* p-value <0.002; ns. p-value <0.095). SEM are 
indicated 
C Cell cycle analysis of MCF7 cells by flow cytometry. Unsynchronised cells were stained 
with propidium iodide (PI) to assess DNA content. A total of 30000 cells were recorded per 
sample. Representative image of histograms are shown; curves were fitted using a custom R 
script (top panel). Percentages of cells in each cell cycle phase are shown (bottom panel). 
Plots contain results from 2 independent experiments performed in triplicate. Significance 
was assessed using one-way ANOVA tests (* p-value <0.008, ns. p-value <0.882). SEM are 
indicated. 
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I assessed p21 mRNA level by RT-PCR in MCF7 cells 6 days after infection with HP1γ 
shRNA vectors. For both shRNAs, an increase in p21 expression was observed compared to 
shCtrl cells (Figure 4-7B). However, the results varied significantly between the two shRNAs. 
Notably, the most potent shRNA, shHP1γ_1, which results in almost complete depletion of 
HP1γ protein (Figure 4-7A), resulted in less than a 2-fold increase in p21 mRNA compared to 
shCtrl, whereas shHP1γ_2 that less efficiently depletes of HP1γ protein (Figure 4-7A), 
increased p21 mRNA levels approximately 4-fold compared to shCtrl cells. These results 
indicate that p21 mRNA levels are increased in HP1γ knockdown cells, however, p21 
expression does not directly correlate with HP1γ protein levels. To analyse cell cycle 
progression, unsynchronised MCF7 cells were stained with propidium iodide and DNA 
content per cell was assessed by flow cytometry. Cell cycle analysis was performed 4 and 6 
days after infection with shRNA vectors. Results are summarised in Figure 4-7C. The results 
differed significantly between HP1γ shRNAs. At both time points, shHP1γ_1 showed no 
effect on cell cycle progression (p-value >0.882), whereas shHP1γ_2 significantly increased 
the number of cells in G1 phase by approximately 20% (p-value <0.002) with a concomitant 
decrease of cells in G2/M and S phase.  
Cell cycle analysis showed that shHP1γ_2 treated cells, which express higher levels of p21, 
arrest in the G1 phase of the cell cycle, whilst shHP1γ_1 treated cells remain unaffected. 
However, effects on cell cycle could not be directly correlated with HP1γ protein levels, as 
cells treated with the more effective shRNA cycled normally.  
4.3.5. Morphology of HP1γ depleted MCF7 cells  
MCF7 cells undergo morphological changes upon HP1γ knockdown. Representative 
brightfield images of cells 6 days after infection with shRNA vectors are depicted in Figure 
4-8. ShCtrl cells showed normal MCF7 morphology (compare to Figure 4.1), whereas both 
knockdown cell lines showed signs of apoptosis such as membrane blebbing, cell 
condensation and detachment (highlighted by red arrows), indicating cell viability was 
affected in HP1γ depleted cells. However, morphological differences were evident between 
cells infected with shHP1γ_1 or shHP1γ_2 vectors. Cells infected with shHP1γ_1 were 
rounded (middle panel), whereas shHP1γ_2 cells were flat and showed condensation of 
cellular organelles (bottom panel).  
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4.3.6. HP1γ affects cell viability of MCF7 cells  
To measure viability of MCF7 cells upon HP1γ depletion, I performed annexin V/propidium 
iodide (PI) staining, analysed by flow cytometry. Annexin V is a phospholipid-binding 
protein with high affinity for the phospholipid phosphatidylserine (PS). In viable cells PS is 
located in the inner leaflet of the plasma membrane. Upon early stages of apoptosis, PS 
translocates to the outer leaflet of the plasma membrane, where it can be detected by annexin 
V coupled to a fluorophor (here FITC was used)213. Whilst annexin V is used as a marker for 
apoptotic cells, PI staining distinguishes between viable and dead cells. Assay conditions 
were optimised using MCF7 cells treated with 5 mM hydrogen peroxide (H2O2) as a positive 
control.   
	
 
Figure 4-8 Morphology of HP1γ depleted MCF7 cells.       
Brightfield microscopy images of MCF7 cells 6 days post infection with lentiviral shRNA 
vectors as indicated. Images were captured with a Leica EC3 digital camera at 10x 
magnification. Scale bar indicated (50 µm). Regions of interest are 3-fold magnified and red 
arrows highlight cell aberrations. 
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The excessive exposure of cells to reactive oxygen species (ROS) is well known to induce 
apoptotic pathways214. Flow cytometry results for annexin/PI stainings are summarised in 
Figure 4-9A. Gatings were adjusted manually using control (shCtrl) cells as a reference. A 
representative plot showing cells detected in FITC and PI channels, for H2O2 treated versus 
untreated MCF7 cells is depicted in Figure 4-9. As expected, H2O2 treatment clearly increased 
the number of annexin V positive and annexin V/PI double positive cells, indicating an 
increase in apoptotic and dead cells. Figure 4-9B shows the results of one representative 
experiment using MCF7 cells 4 days after infection with shCtrl and shHP1γ_1 and 2 shRNA 
lentiviral vectors.  
With shRNA_1, a significant 20% decrease of viable cells compared to shCtrl cells was 
observed (p-value <0.0001), indicating that cell viability was affected (Figure 4-9C).  
Furthermore, an approximate 10% increase of dead cells (p-value <0.0001) and 5% increase 
of apoptotic cells (p-value <0.06) were observed with shHP1γ_1. The number of PI positive, 
necrotic cells remained unchanged. With shRNA_2 a modest non-significant increase of 5% 
of dead cells (p-value >0.224) and 5% decrease of live cells (p-value >0.231) were observed. 
In summary, these results demonstrate that compared to control cells, shHP1γ_1 cells show 
increased cell death with an increase in apoptosis as determined by annexin V staining. The 
effects on cell viability were less robust with shHP1γ_2, which depletes HP1γ less efficiently 
than shHP1γ_1. 
4.3.7. Detection of apoptosis in MCF7 cells 
The majority of annexin V positive cells detected in HP1γ knockdown cells, co-stained with 
PI, indicating cells were in late stages of apoptosis or already dead. To further investigate the 
apoptotic process in my system, I analysed the levels of cleaved poly (ADP-ribose) 
polymerase-1 (PARP1). PARP1 is a known substrate of cysteinyl-aspartate proteases 
(caspases)215. Caspases are important mediators of signaling cascades involved in apoptosis. 
They initiate cell death by cleaving and activating other, so called, effector caspases, which 
drive the process of apoptosis. Effector caspases then activate DNA nucleases resulting in 
DNA fragmentation, another key feature of apoptosis216.  
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Figure 4-9 Annexin V-FITC/PI staining of MCF7 cells.               
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA lentiviral vectors and 
processed 4 days post infection. Cells were trypsinsed and stained with annexin V-FITC and 
propidium iodide (PI) and analysed by flow cytometry. Gating was adjusted manually using 
shCtrl cells as a reference. A total of 30000 cells were recorded per sample. 
A Flow cytometry results of cells treated with 5mM H2O2 for 30min compared to untreated 
cells.  
B Flow cytometry results of HP1γ knockdown cells compared to control cells. Representative 
plots of one experiment are shown. 
C Summary of flow cytometry results (left panel). Gating of cell populations and their 
definition are summarised in the right panel. Plots contain results from 3 independent 
experiments performed in duplicate. Significance was assessed using one-way ANOVA tests 
(* p-value <0.0001, ns. p-value >0.224). SEM are indicated. 
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Caspase-mediated PARP1 cleavage is considered a hallmark of apoptosis. It results in 2 very 
specific fragments of 24 and 89kDa in size215,217. To detect PARP1 cleavage upon HP1γ 
depletion in MCF7 cells a specific antibody against the 24kDa fragment of PARP1 was used. 
Figure 4-10A summarises the results of a time course monitoring the level of cleaved PARP-1 
after 2, 4 and 6 days after infection with shRNA vectors. An increase of cleaved PARP1 
protein was observed 4 days after infection in both HP1γ knockdown cell lines compared to 
shCtrl cells. The most effective knockdown of sHP1γ was observed at day 6 with both 
shRNAs, which correlated with a further increase of cleaved PARP1 levels, indicating that 
apoptotic signaling cascades were activated upon HP1γ depletion. Higher levels of PARP1 
were detected for cells treated with the more effective shRNA shHP1γ_1. Notably, a slight 
increase in cleaved PARP1 levels was also observed in shCtrl cells, which may be due to 
puromycin selection mediated stress. 
In summary, elevated levels of cleaved PARP-1 were observed in HP1γ depleted MCF7 cells 
compared to control cells. This indicated that cells activate caspase dependent apoptotic 
pathways.  
 
 
Figure 4-10 Apoptosis detection in MCF7 cells.  
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA lentiviral vectors and 
processed 2, 4 or 6 days post infection. Immunoblotting of whole cell lysates using indicated 
antibodies. Protein concentrations were determined using a BCA protein quantification 
assay.10 µg of protein were loaded per well.  
 
 126 
4.3.8. Migration of MCF7 cells  
To study the migratory response of cells towards a serum gradient, a standard membrane-
based transwell assay was used for MCF7 cells upon siRNA-mediated knockdown of HP1γ 
(principle of transwell assay is explained in Section 2.8.11).  
The duration of migration was optimised for MCF7 cells so that approximately 100 cells were 
counted per window at 20x magnification. As MCF7 cells are epithelial cells with low 
intrinsic motility, an optimal migration period of 24h was determined. 24h after transfection 
with siRNAs, MCF7 cells were seeded into transwell chambers and incubated for 24h. HP1γ 
knockdown with 2 independent siRNAs was confirmed by immunoblotting (Figure 4-11A) 
and RT-PCR (Figure 4-11B). On average, 120 migrated cells were counted for cells 
transfected with control siRNA and siRNA_3, whereas cells transfected with siHP1γ_1 
migrated approximately 40% less effectively (Figure 4-11C). However, this result was not 
statistically significant (p-value >0.08). To conclude, these results indicated that HP1γ 
depletion induced no consistent effects upon MCF7 cell migration. 
4.4. Phenotype changes upon HP1γ depletion in MDA-MB-231 cells 
4.4.1. Expression of HP1 in MDA-MB-231 cells 
To determine HP1γ protein levels in MDA-MB-231 cells, cellular fractionation was 
performed using IPH chromatin extraction buffer (compare Section 4.3.1). Cellular 
equivalents from each fraction were resolved by SDS PAGE and analysed by immunoblotting 
using antibodies against HP1γ, GAPDH and histone H3 (Figure 4-12). No GAPDH was 
detected in the chromatin fraction and only a small amount of H3 was present in the nucleo-
cytoplasmic fraction, indicating cellular fractionations were performed successfully. The 
highest signal for HP1γ was observed in the chromatin fraction. Similarly to my results in 
MCF7 cells (Figure 4-3) approximately 33% of the protein was detected in the nucleo- and 
cytoplasmic fraction, indicating that, also in MDA-MB-231 cells, a significant fraction of 
HP1γ is not tightly associated with chromatin.  
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4.4.2. shRNA mediated knockdown of HP1 γ in MDA-MB-231 cells 
Stable knockdown of HP1γ in MDA-MB-231 cells was achieved using lentiviral vectors 
expressing shRNA shHP1γ_1 or shCtrl. HP1γ knockdown efficiency was determined by 
measuring HP1γ mRNA and protein levels over the course of 6 days (Figure 4-13). HP1γ 
mRNA levels were more than 95% down-regulated after two days in shHP1γ_1 cells 
 
Figure 4-11 Migration of MCF7 cells.      
MCF7 cells were transfected with siRNA vectors (siHP1γ_1, 3 and siCtrl). 24h post 
transfection, 5*10^4 cells were seeded into transwell chambers, which were then placed into 
24 wells containing 15% (v/v) FBS culture medium. Cells were incubated for 24h and 
migrated cells were fixed and stained with crystal violet. Cells were counted manually at 20x 
magnification with the transwell area divided into 15 windows. Each dot represents an 
average of cells counted per window. 
A HP1γ protein level 48h post transfection with siRNAs assessed by immunoblotting using 
indicated antibodies. Whole cell lysates from 40000 cells were loaded per well. 
B HP1γ mRNA levels 24h post transfection with the indicated siRNAs assessed by RT-PCR, 
normalised to B2M. Results of PCR replicates are shown. 
C Quantification of migration assays (left panel). Results of 5 independent experiments are 
shown. Significance was assessed using one-way ANOVA tests. Results were not significant 
(p-value >0.08). SEM are indicated. Representative images of migrated cells in each 
condition are shown (right panel). 
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compared to shCtrl cells (Figure 4-13B). 4 days post infection, HP1γ protein level was 
reduced by 85% (Figure 4-13A) and almost complete depletion was observed after 6 days. 
 
 
  
Figure 4-12 Cellular fractionation in MDA-MB-231 cells. 
Immunoblotting of MDA-MB-231 lysates using indicated antibodies. MDA-MB-231 cells 
were lysed directly in 2x Laemmli buffer to prepare whole cell lysates (WCL). Cellular 
fractionation was performed using IPH chromatin extraction buffer. Nuc+Cyt: nucleo- and 
cytoplasmic fraction. Cellular equivalents (representing 50000 cells) of each fraction were 
loaded per well. 
 
Figure 4-13 Time course of HP1γ knockdown in MDA-MB-231 cells.  
MDA-MB-231 cells were infected with shCtrl and shHP1γ_1 shRNA vectors and processed 
2, 4 and 6 days post infection.  
A Immunoblot of MDA-MB-231 whole cell lysates, using indicated antibodies (left panel). 
Signal was quantified using ImageJ and normalised to GAPDH (right panel). Protein lysates 
representing 50000 cells were loaded per well. 
B HP1γ mRNA levels assessed by RT-PCR relative to shCtrl samples. Graph shows relative 
mRNA expression after normalisation to TUBB expression. The fold change over shCtrl 
samples is shown. An average of duplicates is shown. SEM are indicated.  
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4.4.3. HP1γ depletion affects proliferation of MDA-MB-231 cells 
Previous results showed that loss of HP1γ significantly affects cell proliferation of MCF7 
cells, but not of normal breast epithelial cells (Section 4.3.3). To study the effect of HP1γ 
depletion on MDA-MB-231 cell growth, CyQUANT® cell proliferation assays were 
performed with HP1γ knockdown cells. 4 days after infection with shRNA vectors, cells were 
seeded into 96-well plates at equal densities  (t = d0). HP1γ protein knockdown at d0 was 
confirmed by immunoblotting (Figure 4-14A). The fluorescence signal was significantly 
reduced in HP1γ knockdown cells compared to shCtrl cells, indicating MDA-MB-231 cell 
proliferation was impaired upon HP1γ depletion (Figure 4-14B). The average signal detected 
at day 8 in HP1γ knockdown cells was approximately 50% lower than at day 0, indicating that 
initial cell numbers were reduced. 
In conclusion, similarly to MCF7 cells, depletion of HP1γ from MDA-MB-231 cells 
significantly impairs their proliferation and viability (initial number reduced). 
	
	
Figure 4-14 Proliferation of MDA-MB-231 cells. 
MDA-MB-231 cells were infected with shCtrl and shHP1γ_1 vectors and processed 4 days 
post infection (t = d0).  
A Immunoblot of MDA-MB-231 whole cell lysates at d0 using indicated antibodies. Protein 
lysates from 40000 cells were loaded per well.  
B CyQUANT® proliferation assays over an 8 day time course. Cells were seeded at 500 
cells/well in a 96-well plate at d0. Fluorescence was measured at 520 nm in a Clariostar® 
microplate reader at indicated times. Fluorescent units were normalised to signals measured at 
d0. Graph includes results of 2 independent experiments, each performed with 12 wells per 
condition. Significance was assesses using one-way ANOVA test (* p-value > 0.0001). SEMs 
are indicated. 
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4.4.4. Cell cycle analysis in MDA-MB-231 cells 
To analyse cell cycle progression, unsynchronised MDA-MB-231 cells were stained with PI 
and DNA content per cell was assessed by flow cytometry. Cell cycle was analysed after 4 
days of infection with shCtrl and shHP1γ_1 vectors. HP1γ protein knockdown was confirmed 
by immunoblotting (Figure 4-15A). Cell cycle analysis revealed no significant difference 
between HP1γ knockdown and shCtrl cells (Figure 4-15C). In addition to analysing cell cycle 
profiles, I measured the levels of phosphorylated serine 10 of histone H3 (H3S10ph), a well-
established histone modification of mitotic chromosomes catalysed by Aurora kinase B218. 
Immunoblotting of whole cell lysates of MDA-MB-231 cells, 4 days after infection with 
shHP1γ_1 and shCtrl vectors was performed using an α-H3S10ph and α-H3 antibodies 
(Figure 4-15B). H3S10ph levels were normalised to total H3 levels for each sample. On 
average a reduction of H3S10ph signal of approximately 40% was observed in HP1γ 
knockdown samples.  
To summarise, cell cycle profiles of MDA-MB-231 cells depleted of HP1γ by its knockdown 
did not differ from control cells, indicating that cells were not arrested in a particular phase of 
the cell cycle. The reduction of H3S10ph in HP1γ knockdown cells suggests that either fewer 
cells were in M-phase or that cells simply had less of the modification as they progressed 
through this phase of the cell cycle. 
4.4.5. Morphology of HP1γ depleted MDA-MB-231 cells 
Loss of HP1γ also causes MDA-MB-231 cells to undergo morphological changes. 4 days 
after infection with shRNA vectors, HP1γ knockdown cells were aggregated into clusters and 
began to round up and detach from the culture dish. In contrast, shCtrl cells showed normal 
MDA-MB-231 morphology (Figure 4-16). After 6 days, more than 80% of knockdown cells 
were detached (not shown).  
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Figure 4-15 Cell cycle analysis of MDA-MB-231 cells.               
MDA-MB-231 cells were infected with shCtrl and shHP1γ_1 shRNA lentiviral vectors and 
processed 4 post infection.  
A Immunoblot of MDA-MB-231 whole cell lysates at day 4 using the indicated antibodies. 
Protein lysates from 40000 cells loaded per well.  
B Immunoblot of MDA-MB-231 whole cell lysates at day 4 in triplicates per condition, using 
indicated antibodies. Protein lysates from 40000 cells were loaded per well. H3S10-ph blot 
was stripped and re-blotted with an α-H3 antibody (left panel). H3S10ph signal was 
quantified using ImageJ and normalised to H3 (right panel). 
C Cell cycle analysis of MDA-MB-231 cells by flow cytometry. Unsynchronised cells were 
stained with PI to assess DNA content. A total of 30000 cells were recorded per sample. 
Representative images of histograms are shown, curves were fitted using a custom R script 
(left panel). Percentages of cells in each cell cycle phase are summarised in the right hand 
panel. Plots contain results from 3 independent experiments performed in triplicates. SEM are 
indicated. 
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4.4.6. HP1γ depletion affects cell viability of MDA-MB-231 cells 
To determine cell viability of HP1γ depleted MDA-MB-231 cells, annexin V/PI staining was 
performed. Cells were analysed by flow cytometry. Results from two experiments are 
summarised in (Figure 4-17). Upon HP1γ knockdown, an increase of approximately 14% of 
dead and apoptotic cells together with a 10% decrease in viable cells was observed compared 
to shCtrl cells. However, these results were not statistically significant (p-value > 0.15), 
which suggests that the experiment should be repeated. 
4.4.7. Detection of apoptosis in MDA-MB-231 cells 
To understand whether cells were detaching due to apoptosis, I divided HP1γ depleted cells 
into attached and detached cells and tested the levels of cleaved PARP1 by immunoblotting. 
Both fractions were depleted of HP1γ (Figure 4-17A). Interestingly, cleaved PARP1 was only 
detected in detached and not attached HP1γ knockdown cells suggesting that caspase 
dependent apoptotic pathways were activated after cells detached (Figure 4-17B).  
 
 
Figure 4-16 Morphology of HP1γ depleted MDA-MB-231 cells.     
Brightfield microscopy images of MDA-MB-231 cells 4 days post infection with lentiviral 
shRNA vectors (as indicated). Images were captured with a Leica EC3 digital camera at 10x 
magnification. Scale bar indicated (50 µm). Regions of interest are 3-fold magnified and red 
arrows highlight cell aberrations. 
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In conclusion, MDA-MB-231 cells detached from culture dishes upon HP1γ depletion. 
Increased levels of PARP1 were observed in detached cells, suggesting that detached cells 
were less viable than attached MDA-MB-231 cells. Assessment of cell viability and apoptosis 
in MDA-MB-231 cells indicated an increase of apoptotic cells together with a decrease in the 
number of viable cells.  
	
	
 
 
Figure 4-17 Viability and apoptosis assessment in MDA-MB-231 cells.            
MDA-MB-231 cells were infected with shCtrl and shHP1γ_1 lentiviral vectors and processed 
4 days post infection. Cells were stained with annexin V-FITC/PI and analysed by flow 
cytometry. A total of 30000 cells were recorded per sample. Gating was adjusted manually 
using shCtrl cells as a reference. Flow cytometry results are shown of HP1γ knockdown 
compared to shCtrl cells (left panel). Representative plots for one experiment are shown. 
Summary of flow cytometry results (right panel). Refer to Figure 4-9C for gating key. Plots 
contain results from 2 independent experiments performed in duplicate. Significance was 
assessed using Student T-tests. Results were not significant (p-value  > 0.15). SEM are 
indicated.  
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4.4.8. Migration of MDA-MB-231 cells 
MDA-MB-231 cells are of metastatic origin and therefore have intrinsically high cellular 
motility. An optimal migration period of 4h was established for this cell line. Migration 
assays were set up 44h after transfection with siRNAs. HP1γ knockdown with 2 independent 
siRNAs was confirmed by immunoblotting (Figure 4-19A). Intriguingly, both knockdown 
cell lines migrated 80% less compared to control cells (p-value <0.0001), indicating that 
depletion of HP1γ influences cell motility of MDA-MB-231 cells (Figure 4-19B). 
To further confirm that this effect is dependent on HP1γ, a rescue experiment was performed. 
Together with the siRNAs, MDA-MB-231 cells were transfected with mammalian expression 
vector pcDNA3.1 containing DNA encoding mouse HP1γ N-terminally fused to a HA-tag. An 
empty pcDNA3.1-HA vector was used as control. Protein expression was observed by 
immunoblotting using an α-HA antibody (Figure 4-19C). HA-HP1γ protein levels were 
expressed at approximately 50% of the endogenous HP1γ levels as assessed by 
immunoblotting with an α-HP1γ antibody (compare lane siHP1γ_3 + HA-HP1γ to lane siCtrl 
+ HA-Ctrl). An average of 75 control cells migrated through the membrane, whereas an 
average of 22 HP1γ knockdown cells  (siHP1γ_3 + HA-Ctrl) did so (p-value <0.0001). For 
HP1γ rescue cells (siHP1γ_3 + HA-HP1γ) an average of 42 migrated cells were counted, 
 
Figure 4-18 Apoptosis assessment in MDA-MB-231 cells.  
MDA-MB-231 cells were infected with shCtrl and shHP1γ_1 lentiviral vectors and processed 
4 days post infection. Immunoblotting of whole cell lysates using the indicated antibodies was 
performed. shHP1γ_1 cells were divided into attached (Ad) and detached (De) cells, and 
adherent shCtrl cells were used as a control. Protein lysates from 40000 cells were loaded per 
well. 
A Immunoblot of shHP1γ_1 and shCtrl cell lysates with indicated antibodies. 
B Immunoblot of shHP1γ_1 attached and detached cell lysates with indicated antibodies. 
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indicating an increase of approximately 50% compared to knockdown cells (p-value <0.031). 
These preliminary results indicate that the migratory phenotype of HP1γ knockdown cells was 
partially rescued in cells expressing HA-HP1γ. 
 
	
Figure 4-19 Migration of MDA-MB-231 cells. 
MDA-MB-231 cells were transfected with siRNA vectors (siHP1γ_1, 3 and siCtrl). 44h post 
transfection 5*10^4 cells were seeded into transwell chambers, which were placed into 24 
wells containing 15% (v/v) FBS culture medium. Cells were incubated for 4h and migrated 
cells were fixed and stained with crystal violet. Cells were counted manually at 20x 
magnification, where the transwell area was divided into 15 windows. Each dot represents an 
average of cells counted in each window. 
A HP1γ protein levels 44h post transfection with the indicated siRNAs, assessed by 
immunoblotting using indicated antibodies. Whole cell lysates from 40000 cells loaded per 
well. 
B Quantification of migration assays (left panel). Results of 3 independent experiments are 
shown. Significance was assessed using one-way ANOVA tests (p-value <0.0001). SEM are 
indicated. Representative images of migrated cells in each condition are shown (right panel). 
C HP1γ protein level 44h post transfection with the indicated siRNA and pcDNA3.1-HA 
constructs assessed by immunoblotting using indicated antibodies. 
D Preliminary results from one migration assay. Significance was assessed using one-way 
ANOVA tests (p-value < 0.031). SEM are indicated. 
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In summary, migration assays showed that HP1γ knockdown significantly affects the 
migratory response of MDA-MB-231 cells towards a serum gradient. This phenotype was 
partially rescued by reintroducing HP1γ expression, suggesting that migration of MDA-MB-
231 cells depends on HP1γ.  
4.4.9. Wound healing of MDA-MB-231 cells 
To study the effect of HP1γ depletion on MDA-MB-231 cell motility further, I performed 2D 
wound healing (scratch) assays with MDA-MB-231 cells upon siRNA mediated HP1γ 
knockdown. In contrast to transwell migration assays, which acquire endpoint measurements, 
wound healing assays measure speed and efficiency with which cells migrate to close a gap in 
a monolayer over time. Wound healing assays were performed using the Essenbioscience 
IncuCyteZOOM® system. MDA-MB-231 cells were seeded into 96-well plates and 
transfected with siRNAs.  
24h later a wound of known area was introduced into the cell monolayer of each well. Images 
were taken every 45min over a total of 34h to follow the cell movement over time. The 
images were then used to calculate the relative wound healing density (RWD in %), which 
was calculated using an algorithm based on the density of both the cell region and the wound 
region. After just 2h, a significant 2-fold decrease in the RWD of both knockdown cell lines 
compared to siCtrl cells was observed (p-value <0.0001). The difference between knockdown 
and control cells increased further over the course of 34h, indicating that cell movement of 
MDA-MB-231 cells was impaired upon HP1γ knockdown (Figure 4-20A). Representative 
lightfield images of wound healing taken at different time points illustrate the differences of 
the migration fronts in knockdown and control cells (Figure 4-20B).  
To conclude, both transwell migration and wound healing assays indicated that MDA-MB-
231 cells have impaired cellular migration upon HP1γ depletion.  
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Figure 4-20 Wound healing assay of MDA-MB-231 cells.             
Wound healing assays were performed using the Essenbioscience IncuCyteZOOM® system. 
MDA-MB-231 cells were seeded in to a 96-well plate and transfected with siRNAs (as 
indicated). After 24h a wound of known area was introduced and cells were imaged every 
45min over the course of 34h. 
A Relative wound healing density (RWD) for each time point. Graph contains results of two 
experiments performed with 16 wells per condition. Significance was assessed using one-way 
ANOVA tests (p-value <0.0001 from indicated time point (t = 2h) onwards). SEM are 
indicated.  
B Representative lightfield images of wound healing at time points t = 0, 15 and 34h. 
Representative scale bar is indicated (300 µm). Migration fronts are highlighted by yellow 
lines. 
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4.5. Discussion 
In this chapter, I presented functional data on the role of HP1γ in two the breast cancer cell 
lines, MCF7 and MDA-MB-231. The phenotype of HP1γ depletion was characterised in both 
cell lines using assays to assess cell growth, cell cycle progression, cell viability and motility. 
My data indicate that loss of HP1γ affects proliferation and cell viability of both cancer cell 
lines.  
4.5.1. Cell growth 
In both MCF7 and MDA-MB-231 cells lines loss of HP1γ impairs cell proliferation, whereas 
proliferation of non-tumorigenic epithelial breast cells remains unaffected, indicating a cancer 
cell specific function for HP1γ. In contrast to the phenotype described in the colon cancer cell 
line HCT116ref.155,156, cell cycle analysis provided no sufficient evidence that reduced 
proliferation is directly associated with a defect in cell cycle progression. In MDA-MB-231 
loss of HP1γ had no effect on cell cycle.  
MCF7 cells infected with shHP1γ_2 accumulated in G1 phase of the cell cycle, whilst 
knockdown cell line shHP1γ_1 showed no difference to control cells. Differences between 
these two shRNAs cannot be directly correlated with HP1γ protein levels, as cells treated with 
the more effective shRNA progressed through the cell cycle normally. At this stage it is 
unclear why knockdown of HP1γ with both shRNAs results in such different results. In order 
to exclude any off-target effects from either shRNA, it will be important to repeat the 
experiments with additional independent shRNAs. 
It is possible that cells are not arresting in a particular phase of the cell cycle, but rather that 
the length of each cycle is generally increased. To determine cell cycle duration one could use 
live cell imaging of synchronised cells to measure the time it takes for cells to progress 
through a cell cycle. Alternatively, one could use dual pulse labeling of cells with different 
nucleosides such as BrdU (5-bromo-2'-deoxyuridine) and EdU (5-ethynyl-2´-deoxyuridine), 
which incorporate into the DNA of growing cells. Sequential pulses of BrdU and EdU are 
useful in determining cell cycle kinetics and they provide an estimate of total cell cycle 
length219.  
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Of cause, the cell cycle may not be affected at all. Reduced proliferation rates may simply 
reflect increased cell death. 
4.5.2. Cell viability and apoptosis 
Annexin V/PI staining detected an increase of dead cells in both cell lines, indicating that 
HP1γ depletion affects cell viability. In MCF7 cells, a significant decrease of viable cells 
together with an increase of dead and apoptotic cells was observed, whilst the phenotype in 
MDA-MB-231 cells was less well defined. Furthermore, both cell lines showed elevated 
levels of cleaved PARP-1 upon HP1γ knockdown, together with an increased number of cells 
with fragmented DNA, indicating induction of apoptosis. 
MCF7 cells showed classical morphological signs of apoptosis such as membrane blebbing, 
condensation and cell shrinkage. However, these signs were not observed in MDA-MB-231 
cells. In contrast, upon loss of HP1γ, MDA-MB-231 cells rounded up and detached from the 
culture dish, with up to 80% of cells becoming detached 6 days after infection with shRNA 
vectors. Control cells remained attached. The fact that both cell lines show such different 
morphologies upon loss of HP1γ might suggest that apoptotic pathways are activated in 
different ways. Indeed, cleaved PARP-1 was only detected in detached MDA-MB-231 cells 
and not in the attached cell population, suggesting that caspases were only activated after cells 
detached.  
Apoptosis can be triggered via two major pathways, the intrinsic and the extrinsic pathway. In 
the intrinsic pathway, caspase activation occurs as a consequence of mitochondrial 
permeabilisation. This is regulated by the pro-apoptotic BH3-only protein family, which 
control formation of pores in the outer mitochondrial membrane (OMM), releasing 
proapoptotic factors such as cytochrome c. The release of cytochrome c in turn activates 
caspases. The extrinsic pathway is initiated by ligation of death receptors on the cell surface, 
such as TNF receptor or Fas, resulting in the assembly of a death-inducing signaling complex 
(DISC). DISC then recruits FADD (Fas-associated protein with death domain) and caspase 8, 
resulting in activation of the latter. Both pathways ultimately result in activation of the major 
effector caspase 3, which triggers the execution of apoptosis leading to protein and DNA 
degradation220.  
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When comparing the activation of apoptosis in MDA-MB-231 and MCF7 cells their genetic 
backgrounds have to be considered. MDA-MB-231 cells express high levels of caspases, 
whereas MCF7 cells are known to lack expression of caspase 3 and are therefore dependent 
on other caspases to trigger cell destruction221. Besides caspases, MDA-MB-231 cells express 
high levels of mutant p53222, whereas MCF7 express low levels  of wildtype p53223. p53 is an 
important activator of pro-apoptotic BH3-only proteins, hence a potent activator of the 
intrinsic pathway224. It would be interesting to understand whether HP1γ’s role in mediating 
apoptosis, either directly or indirectly, is cell type specific and whether it is linked to p53. 
Finally, it is possible that in MDA-MB-231 cells induction of apoptotic pathways is not the 
predominant consequence of HP1γ depletion. Loss of HP1γ could trigger a change of cell 
surface molecules necessary for MDA-MB-231 cells to attach and/or to interact with each 
other. A process called ‘Anoikis‘ describes the phenomenon of activating apoptosis in 
anchorage-dependent cells in response to inappropriate cell-to-cell or extra cellular matrix 
(ECM) interactions. Integrins, as major components of adherens junctions linking the 
cytoskeleton to components of the ECM play an important role in mediating survival 
signaling in many cell types225. It would be interesting to understand why MDM-MB-231 
cells lose contact and whether, for example HP1γ depletion changes expression of genes 
encoding cell adhesion molecules. Furthermore, HP1γ could indirectly affect localisation of 
adherens junction or cytoskeleton components. Immunofluorescence stainings for proteins 
involved in these processes such as integrins, focal adhesion complex members or 
cytoskeletal components could provide insights into the mechanism by which MDA-MB-231 
detachment is mediated upon HP1γ depletion. 
4.5.3. Cell migration 
Cell migration is a multistep process and a fundamental component of many biological and 
pathological processes such as tissue re-organization, angiogenesis, immune cell trafficking, 
wound healing and tumour metastasis. To understand whether HP1γ depletion affects breast 
cancer cell motility, I performed transwell migration assays in MCF7 and MDA-MB-231 
cells upon HP1γ knockdown. MCF7 cells showed no significant effect on cell migration upon 
HP1γ knockdown, whereas migration of MDA-MB-231 cells was significantly impaired. The 
effect on MDA-MB-231 cell mobility was confirmed by wound healing assays. Impairment 
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of cellular movement could be directly associated with the morphological changes observed 
in HP1γ depleted MDA-MB-231 cells. For cells to migrate they need to be attached to the 
matrix and since part of the phenotype of HP1γ depleted cells I observed is detachment from 
the surface this is likely, at least in part, to result in their reduced mobility. 
Both MCF7 and MDA-MB-231 cell lines originated from invasive ductal breast carcinomas. 
However, MCF7 cells are differentiated and retain an epithelial-like morphology, whereas 
MDA-MB-231 cells are poorly differentiated and have lost any morphological resemblance to 
epithelial cells. Furthermore, MDA-MB-231 cells are a model for Claudin-low (CL) 
metastatic breast cancer and express high levels of epithelia-to-mesenchymal transition 
markers such as vimentin. There are several ways how HP1γ could be involved in the 
regulation of cell motility. Firstly, HP1γ could be directly or indirectly involved in regulating 
genes encoding proteins involved in cell adhesion, cell-to-cell interactions or cell 
communication. Important factors associated with breast cancer metastasis include cadherins, 
selectins and integrin subunits, which are major components of adherens junctions linking the 
cytoskeleton to components of the extra cellular matrix. Intercellular adhesion molecules or 
components of tight junctions such as claudins are further factors linked to breast cancer 
metastasis226.  
Cell migration is initiated by a stimulus that activates a set of signaling pathways leading to 
cellular polarization and a rapid reorganization of actin filaments and microtubules. HP1γ 
could be either directly involved in signaling cascades or affect chromatin condensation, an 
interesting feature of cell migration. Using wound healing assays, Gerlitz el al. showed that 
upon induction of cell migration, levels of markers for facultative heterochromatin such as 
H3K27me3 or H4K20me1 are increased in cells at the migratory front227. Furthermore, 
interference with heterochromatin formation using the HDAC inhibitor TSA and the 
methyltransferase inhibitor chaetocin reduced cellular migration227. HP1γ itself is classified as 
a marker for facultative heterochromatin97 and so it may be involved in migration mediated 
chromatin condensation. The nuclear lamina is directly connected to the cytoskeleton through 
components of the so-called LINC complex, which is integrated into the nuclear 
membrane228. Interestingly, interference with the lamina or the structure of the LINC complex 
can inhibit cell migration both in vivo and in vitro229. As HP1 proteins directly interact with 
the nuclear lamina230, they may be involved in LINC mediated cell migration.  
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My findings clearly indicate that loss of HP1γ specifically affects cellular motility of more 
aggressive breast cancer cells, but not of less aggressive breast cancer cells. From a clinical 
point of view, these results are very interesting, as they suggest a role for HP1γ in breast 
cancer invasiveness. Importantly, my work highlights HP1γ as a good candidate target for 
therapeutic intervention in aggressive breast cancer. To dissect the functional differences 
between aggressive and less aggressive breast cancer cells in more detail, soft agar colony 
formation assays could be used to monitor the effect of HP1γ depletion on anchorage-
independent growth. 
To summarise this chapter, loss of HP1γ results in impaired proliferation and reduces cellular 
viability of the two breast cancer cell lines MCF7 and MDA-MB-231. In both cell lines an 
increase in apoptotic cells was observed. While MCF7 cells show classical signs of apoptosis, 
the phenotype in MDA-MB-231 cells is less defined. The analysis of cell motility revealed a 
significant impairment of cell migration in the more aggressive breast cancer cell line MDA-
MB-231, whereas less aggressive MCF7 cells remained unaffected, suggesting a role for 
HP1γ in breast cancer invasiveness. 
The following chapter includes transcriptome analysis in MCF7 before and after HP1γ 
depletion. The analysis identified pathways that may underlie the aforementioned phenotypic 
changes. 
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  Chapter 5
Transcriptomic analysis of HP1γ in breast cancer cells  
 
5.1. Introduction 
HP1γ overexpression has been linked to increased cell proliferation and oncogenesis in 
various cancers such as colorectal155,156, non-small cell lung157, prostate158, cervical and 
breast159. First mechanistic insights into how HP1γ might be involved in cancer progression 
were described for colorectal cancer. Liu et al. showed that in human colorectal cancer 
HCT116 cells elevated levels of HP1γ repress gene expression of the cell cycle regulator 
p21(Waf1/Cip1) resulting in uncontrolled cell proliferation155. Consequently, knockout of 
HP1γ in HCT116 cells leads to cell cycle arrest and impaired proliferation in vitro and in vivo. 
In addition, in the same cell line HP1γ regulates a feedback mechanism by repressing 
expression of cyclin dependent kinase Cdk6, an activator of p21(Waf1/Cip1)156. Similar 
results were observed in primordial germ cells. HP1γ knockout mice show a dramatic 
reduction in the number of primordial germ cells due to cell cycle arrest127. Cell cycle defects 
were again linked to HP1γ mediated regulation of p21(Waf1/Cip1) expression. 
In the previous chapter, I showed that HP1γ depletion impairs proliferation of the two breast 
cancer cell lines MCF7 and MDA-MB-231. In contrast to previous studies, a drecrease in 
proliferation could not directly be linked to cell cycle progression defects. However, in both 
cell lines an increase in apoptotic cells was observed, indicating that impaired proliferation 
may be a result of reduced cell viability.  
To find pathways that may underlie these phenotypic changes, I performed whole 
transcriptome analysis in MCF7 cells before and after HP1γ depletion. In this chapter I 
explore the function of HP1γ in transcriptional regulation and link the findings to the 
phenotype of HP1γ depletion. 
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5.2. Aims of this chapter 
This chapter has the following aims related to changes in gene expression in MCF7 upon 
HP1γ depletion. 
1. To detect differentially expressed genes in MCF7 cells depleted of HP1γ  
2. To identify differentially regulated pathways upon HP1γ depletion 
3. To investigate whether gene expression changes are linked to phenotypic changes 
observed in HP1γ depleted cells 
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5.3. RNA-seq in MCF7 cells upon HP1γ knockdown 
5.3.1. Preparation of RNA-seq libraries 
Whole transcriptome analysis in MCF7 cells upon HP1γ knockdown was performed using 
RNA-sequencing (RNA-seq) technology. Knockdown efficiency was confirmed by 
immunoblotting using a HP1γ antibody (Figure 5-1A) and RT-PCR (Figure 5-1B), 6 days 
after infection with shRNA vectors containing shHP1γ_1 or shCtrl sequences. The experiment 
was performed with three technical replicates for each condition. Total RNA was depleted 
from ribosomal RNA (see Section 2.11.1) and RNA-seq libraries were prepared as described 
in Section 2.11.2. Libraries were multiplexed at equal molarities and were submitted for 
125bp, paired-end sequencing on an Illumina HiSeq 4000® instrument.  
 
 
 
Figure 5-1 Preparation of RNA-seq samples from MCF7 cells following HP1γ 
knockdown.  
MCF7 cells were infected with shCtrl and shHP1γ_1 shRNA vectors and processed 6 days 
post infection.  
A Immunoblot using the indicated antibodies of MCF7 whole cell lysates expressing either 
control or HP1γ shRNAs as indicated (left panel). Signals were quantified using ImageJ and 
normalised to GAPDH (right panel). 
B HP1γ mRNA levels were assessed by RT-PCR. Data were normalised to TUBB and the 
fold change expression over the average of 3 shCtrl samples is shown. 
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5.3.2. RNA-seq analysis 
5.3.2.1. Quality control of RNA-seq data 
The sequencing data was mapped to the reference genome assembly and the total number of 
mapped reads per replicate was determined (compare Section 2.11.3). The total read counts, 
summarised in Table 5-1, show that multiplexed samples were well balanced, with no over-
represented sample in the pool. The similarity between replicates was determined by 
hierarchical clustering of normalised reads. Overall replicates clustered together, indicating a 
high degree of similarity within each sample group (shCtrl and shHP1γ_1) (Appendix I, 
Figure 1B). The gene-wise dispersion estimates were obtained with DESeq 2ref.188, and the 
dispersion-mean curve displayed the expected profile, with shrinkage of the individual gene-
wise estimates towards the fitted value (Appendix I, Figure 1A). 
In conclusion, quality control assessment detected low level of variability within the data and 
high degree of similarity across technical replicates within sample groups. 
Table 5-1 Total read counts of MCF7 RNA-seq data. Number of uniquely mapped reads 
per replicate is depicted for each sample.  	
	 rep	1	 rep	2	 rep	3	
shCtrl	 38837750	 46670329	 37493876	
shHP1γ_1	 36191074	 35948714	 33089260			
5.3.2.2. Differential expression analysis 
Differential expression analysis comparing control (shCtrl) versus HP1γ knockdown 
(shHP1γ_1) samples was performed using the Bioconductor package DESeq2. Results are 
visualised as a volcano plot (Figure 5-2A). Here, the log2 of expression fold change for each 
gene on the x-axis is plotted against log10 of the adjusted p-value on the y-axis. Each dot 
represents a single gene with significant fold change in red (adjusted p-value <0.05) and non-
significant (adjusted p-value <0.05) in black. This analysis identified a total number of 4673 
genes significantly deregulated upon HP1γ knockdown including 65% of genes with greater 
than log2 fold change. Differentially expressed genes were both up- (52.4%) and down-
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regulated (47.6%). The most significantly up-regulated genes with adjusted p-values <1E-75 
were IFI27, PARP10 DDX60L, FBX032 and RASD1. The most significantly down-regulated 
and the only gene with adjusted p-values <1E-75, was CBX3 itself. As an example, UCSC 
browser snapshots of the most up-regulated gene IFI27 and the most down gene CBX3 are 
shown in Figure 5-2B.  
 
5.3.2.3. Gene ontology analysis 
In order to understand which biological processes were affected by HP1γ depletion, gene 
ontology enrichment analysis was performed using the generally applicable gene-set 
enrichment for pathway analysis (GAGE) Bioconductor package. The results are summarised 
in Figure 5-3. GO enrichments are ranked according to the p-value corrected for multiple 
testing (q-value) ranging from red (significant) to black (non-significant). GO terms for up-
 
Figure 5-2 Differential expression analysis of MCF7 RNA-seq. 
Differential expression analysis performed using Bioconductor package DESeq2. 
A Volcano plot of differentially expressed genes. log2 fold change on X-axis plotted against 
log10 of the adjusted p-value on Y-axis. Dots represent single genes with significant fold 
change (red: p-value >0.05) and non-significant (black: p-value <0.05). 
B UCSC genome browser snapshots of normalised RNA-seq reads of most up-regulated 
gene IFI27 (top panel) and most down gene CBX3 (bottom panel). Equal scaling is used for 
shCtrl and shHP1γ _1 tracks. 
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regulated genes are depicted on the right and down genes on the left hand side. GO terms for 
up-regulated genes were predominantly linked to angiogenesis and vascular development, 
followed by regulation of immune system, metabolic processes and transcriptional regulation. 
On the other hand, among down-regulated genes, GO terms involved in transcriptional 
elongation, translation, RNA processing and DNA repair were highlighted.  
 
5.3.2.4. KEGG pathway analysis 
Next, KEGG pathway analysis was used to understand which biological pathways were 
affected. Here, KEGG pathway maps covering all known biological pathways ranging from 
metabolism, cellular processes to human disease pathways are scored according to their 
enrichment in differentially expressed genes. This analysis allows to identify biological 
networks and signaling pathways significantly affected in HP1γ depleted cells. Results are 
summarised in Figure 5-4. Here, the statistical mean for each enrichment group is illustrated. 
As the majority of genes were up-regulated, more pathways (16 in total) were identified for 
those genes (Figure 5-4A). For down-regulated genes only 3 pathways were found (Figure 
	
Figure 5-3 Gene ontology analysis of MCF7 RNA-seq data. 
GO enrichment statistics are plotted and ranked according to the q-value ranging from red 
(significant) to black (less significant). Both GO terms for up-regulated genes (right) and are 
down genes (left) are depicted. 
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5-4B). Intriguingly, among up-regulated genes several pathways indicating activation of an 
interferon mediated immune response, reacting to nucleic acid sensing, such as JAK-STAT, 
RIG-I-like receptor, cytosolic DNA-sensing, NOD-like receptor, Toll-like receptor and 
apoptosis signaling were identified. This analysis implies that upon knockdown of HP1γ, 
MCF7 cells activate pathways that, under normal circumstances, should only be triggered in 
response to acute viral or bacterial infections. Besides immune activation, pathways 
suggesting regulation of cell adhesion molecules and cell migration were identified. Among 
down-regulated genes, pathways involving down-regulation of physiological functions, such 
as ribosomal and mitochondrial processes were found (Figure 5-4B). Figure 5-5 illustrates 
two examples of the pathways RIG-I-like receptor signaling (upper panel) and ribosomal 
function (lower panel). Pathway maps for JAK-STAT, cytosolic DNA-sensing, NOD-like 
receptor, Toll-like receptor and apoptosis signaling are illustrated in Appendix I (Figures 2 to 
6). Gene expression changes of individual genes are colour-coded, where red indicates up-
regulation and green down-regulation. It illustrates clearly that many genes within the 
intracellular RNA sensing RIG-I-like pathway are up-regulated, whereas the majority of 
ribosomal genes are collectively down-regulated.  
Taken together, the KEGG pathway analysis suggests that the cells are under physiological 
stress and are in the process of shutting down biological processes that are important for cell 
homeostasis.  
5.3.2.5. Determination of differential exon usage  
Two independent reports proposed a role for HP1γ in alternative splicing143,145. By attenuating 
RNA Pol II, the protein was shown to favor alternate exon usage of all variable exons (8 in 
total) within the human CD44 gene145. Loss of HP1γ either results in reduced usage of 
alternate exons within the CD44 gene145 or a general reduction of splicing143. To determine 
whether HP1γ depletion affects differential exon usage in MCF7 cells, RNA-seq data was 
analysed using the Bioconductor tool DEXSeq231. For a p-value threshold of 0.01 a total 
number of 882 genes with at least one differentially used exon were identified. As an 
example, the result for CD44 is depicted in Appendix I (Figure 6A). Each of the 18 exons (10 
constant (C) and 8 variable (V) exons) are plotted on the x-axis against the exon usage on the 
y-axis. This value is normalised to the expression level of the gene. The only significant 
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differential exon usage for this gene was detected for exon V2, which has higher relative 
abundance in transcripts of HP1γ knockdown cells compared to controls (log2 fold change = 
1.2, adjusted p-value = 0.049). This result would suggest that loss of HP1γ causes increased 
exon usage of exon V2, which is the opposite result to published data145. However, it has to be 
noted that in general this analysis revealed highly inconclusive results. Figure 6B of the 
Appendix I depicts the result for the histone gene HISTH4H, the gene with the most 
significant changes. Virtually every exon is either significantly included (exon 1-4) or 
excluded (exon 5-6) (adjusted p-value < 0.009). For many genes similar, biologically rather 
unlikely results were observed.  
DEXSeq is a powerful method to identify differential exon usage, however, to produce 
biologically meaningful results, RNA-seq data of great sequencing depth should be used. Our 
rather inconclusive results are probably due to limited sequencing depth and the small number 
of biological replicates used in this experiment (n=3). The effect of HP1γ depletion on 
alternative splicing in MCF7 cells was not pursued any further. 
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Figure 5-4 KEGG pathway analysis of MCF7 RNA-seq data. 
KEGG pathway analysis performed using Bioconductor package for KEGG enrichment 
analysis. Input data: all differentially expressed genes (p-value <0.05). Statistical mean for 
each biological pathway class plotted, p-values indicated. 
A Up-regulated genes. B Down-regulated genes   
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5.3.3. Validation of RNA-seq in MCF7 cells 
5.3.3.1. Activation of interferon response pathways 
KEGG pathway analysis identified the most up-regulated genes to be enriched for pathways 
indicating activation of an interferon mediated immune response, such as JAK-STAT, RIG-I-
like receptor, cytosolic DNA-sensing, NOD-like receptor and Toll-like receptor signaling. All 
of these pathways are functionally linked. Normally they are activated in response to acute 
viral or bacterial infection. Components of RIG-I-like receptor, NOD-like receptor and Toll-
like receptor signaling pathways directly bind double stranded RNA or DNA and rapidly 
induce signaling cascades resulting in release of pro-inflammatory cytokines such as type I 
interferons (IFNs), interleukins and TNF ligands. These cytokines, in particular type I IFNs 
	
Figure 5-5 KEGG pathway maps.  
Examples of KEGG pathway maps. Differentially expressed genes are highlighted: Up-
regulated genes (red) and down-regulated genes (green). 
A hsa04622: RIG-I-like receptor signaling 
B hsa03010: Ribosome 
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(IFNα, β), in turn act as activators for the same pathways. Cells use these positive feedback 
mechanisms to assure immediate reaction to infections. 
The JAK-STAT signaling is downstream of the above-mentioned pathways and directly 
activated by type I IFNs. STATs are monomeric transcription factors that reside within the 
cytoplasm. Upon IFN binding to its receptor, receptor-associated Janus kinases (JAKs) are 
activated and recruit monomeric STATs. JAK mediated phosphorylation of STATs facilitates 
their dimerisation and localisation to the nucleus where they act as transcription factors232. 
JAK-STAT signaling results in activation of genes inducing growth arrest and apoptotic 
pathways - phenotypes that relate to the physiological changes observed in HP1γ depleted 
MCF7 cells. Apart from JAK-STAT signaling all of these pathways result in the release of 
IFNβ. Other common cytokines induced by these pathways include TNFα, interleukin 6, 8, 10 
(IL6, 8, 10), as well as other interleukins. To confirm activation of pathways involved in the 
interferon mediated immune response in MCF7 cells, mRNA levels of IFNβ (IFNB1), IL8 
(CXCL8), TNFα (TNF) and IL28A/B (IFNL2/3) were analysed by RT-PCR over a time 
course of 6 days after infection with HP1γ shRNA vectors. Significant increase in mRNA 
expression of these genes was detected after 4 days with further increase at day 6 for both 
shRNAs targeting HP1γ compared to shCtrl cells (p-values <0.05, Figure 5-6A, Figure 5-6B). 
Effects were more pronounced for shHP1γ_1. The fact that expression of these cytokines was 
only induced after 4 days indicates that the effects are not directly due to infection with 
lentiviral shRNA vectors. In fact, gene expression changes can be correlated with down-
regulation of HP1γ protein as assessed by immunoblotting (Figure 4-10A). 
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Figure 5-6 Expression of genes linked to interferon immune response in MCF7 cells. 
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA vectors and processed 2, 
4 and 6 days post infection. mRNA levels of indicated genes were assessed  at the 3 
indicated time points by RT-PCR. Graphs show relative mRNA expression after 
normalisation to TUBB expression and include data from 3 independent experiments. 
Significance was assessed using one-way ANOVA tests, highest p-values per panel are 
indicated. SEM are indicated. 
A Genes encoding regulatory immunity cytokines (* p-value <0.05).  
B JAK-STAT target genes (* p-value <0.05). 
C Gene encoding dsRNA sensing DEAD-box helicase DDX58 (* p-value <0.05). 
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The activity of the JAK-STAT signaling pathway was assessed by measuring expression of 
selected STAT target genes such as PIM1 and IFIT3. Both PIM1 and IFIT3 show similar 
expression patterns to genes encoding cytokines (Figure 5-6B). mRNA expression was 
induced 4 days after infection with shRNA vectors in both knockdown cell lines (p-values 
<0.05). IFIT3 encodes an interferon response protein. Differential expression analysis 
(Section 5.5.3) identified more than 10 such interferon response genes that were significantly 
up-regulated upon HP1γ knockdown (log2 >2, p-value <0.0001). Besides STAT target genes, 
up-regulation of several STAT transcription factor genes (STAT1, 2, 3 and 5A, log2 >1.5, p-
value <1E-6) was identified. I validated the mRNA levels for STAT1 (Figure 5-6B). 
Interestingly, mRNA expression of STAT1 mRNA peaked at day 4 and decreased 
significantly at day 6, indicating dynamic regulation. 
Differential expression analysis identified up-regulation of genes encoding dsRNA sensing 
proteins, which are important components of the interferon immune response. Genes such as 
DDX58 (also called RIG-I) and DDX60 both encoding DEAD box helicases recognising viral 
dsRNA were detected (log2 >2, p-value <1E-26). Furthermore, genes encoding viral dsRNA 
sensing oligoadenylate synthetases OAS1, 2, 3 (log2 > 2, p-value <1E-19) or genes encoding 
members of the toll like receptor family TLR1, 2, 3 (log2 >2, p-value <0.03) were also 
detected. TLR1 and 2 are located in the cytoplasma membrane, predominantly detecting 
bacteria in the extracellular space, whereas TLR3 located in endosomal membranes detecting 
dsRNA. mRNA expression was validated for DDX58 (Figure 5-6C), which was induced after 
4-6 days in both knockdown cell lines (p-values <0.027). 
Stimulation of an interferon immune response in MCF7 upon loss of HP1γ was further 
confirmed by immunoblotting using antibodies against phosphorylated STAT1. With both 
HP1γ targeting shRNAs an increase of STAT1 phosphorylation was observed 4 days after 
infection, whilst total STAT1 protein levels remained unchanged (Figure 5-7). 
Phosphorylation of STAT1 correlates with a decrease in HP1γ protein levels.  
In conclusion, KEGG pathway analysis indicated that MCF7 cells activate signaling pathways 
linked to an interferon-mediated antiviral response upon HP1γ depletion. I confirmed the 
activation of these pathways by measuring mRNA expression of the cytokine genes IFNB1, 
TNF, IL8 and IL28A/B. Furthermore, expression for a subset of JAK-STAT targets was 
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assessed, confirming the activation of JAK-STAT signaling, which is downstream of the IFN 
response. Induction of IFN response genes 4-6 days after infection with HP1γ shRNA vectors 
correlates with decreased HP1γ protein level.  
 
5.3.3.2. Up-regulation of pro-apoptotic genes  
Interferon mediated activation of apoptotic pathways is a well known self defense mechanism 
to prevent viral replication in virus-infected cells233. Given the clear activation of interferon-
mediated pathways, it is not surprising that up-regulation of numerous pro-apoptotic genes 
was identified in HP1γ depleted MCF7 cells. Such genes include those encoding members of 
the pro-apoptotic BH3-only protein family (BIK, BID and PUMA), apoptosis inducing 
members of tumor necrosis factor (TNF) ligand family (TNFSF10, TNF) and their receptors 
(TNFRSF10A/C), a negative regulator of the ‘inhibitor of apoptosis protein’ IAP family 
(XAF1) family and genes encoding caspases (CASP4, 10, 7). Furthermore, down-regulation of 
BCL2, encoding a member of the Bcl-2 protein family of anti-apoptotic proteins, was also 
observed. Both XAF1 and TNFSF10 (also called TRIAL) are direct targets of IFNβ234,235. 
mRNA levels of a subset of pro-apoptotic genes were followed over a time course of 6 days 
by RT-PCR using shHP1γ_1 and shHP1γ_2 mediated knockdown of HP1γ. Results are 
summarised in Figure 5-. Up-regulation of mRNAs encoding pro-apoptotic proteins BID, BIK 
and PUMA was observed after 2 days of knockdown with both shRNAs compared to shCtrl 
samples, with a significant increase after 4 days  (Figure 5-A). A non-significant down-
 
Figure 5-7 STAT1 phosphorylation in MCF7 cells upon HP1γ knockdown. 
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA vectors and processed 2 
and 4 days post infection. Immunoblot of MCF7 whole cell lysates, using indicated 
antibodies. Protein lysates representing 40000 cells were loaded per well.  
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regulation of the anti-apoptotic gene BCL2 was observed on day 6 only with shHP1γ_1 
(Figure 5-C). Expression of XAF1, TNF and TNFSF10 mRNA was induced at day 4 with both 
shRNAs (Figure 5-B/C). In comparison, reduction of HP1γ protein levels were detected after 
2 days with shHP1γ_1 and after 4 days with shHP1γ_2 (Figure 4-10A) indicating the 
observed gene expression changes can be correlated with a reduction of HP1γ protein levels. 
Notably, increased expression of pro-apoptotic genes was also observed over time in shCtrl 
cells, which may be due to puromycin selection mediated stress. To avoid selection stress, 
gene expression changes were further validated using siRNA-mediated knockdown of HP1γ 
in MCF7s cells (Figure 7, Appendix II). Gene expression changes resulted in an increase in 
protein expression for a subset of apoptosis factors. Immunoblotting of MCF7 whole cell 
lysates 4 days after infection with shRNA vectors confirmed an increase of XAF1, BID and 
PUMA protein levels (Figure 5-9).  
In summary, upon HP1γ depletion, MCF7 cells showed clear up-regulation of pro-apoptotic 
genes. Induction of apoptotic genes could be a direct result of interferon mediated signaling. 
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Figure 5-8 mRNA expression of apoptotic genes in MCF7 cells.                                  
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA vectors and processed 2, 4 
and 6 days post infection. mRNA levels of indicated genes were assessed  at the 3 indicated 
time points by RT-PCR. Graphs show relative mRNA expression after normalisation to TUBB 
levels and include data from 3 independent experiments. Significance was assessed using one-
way ANOVA tests, highest p-values per panel are indicated. SEM are indicated. 
A Genes encoding members of pro-apoptotic BH3-only protein family (*p-value <0.04).  
B Genes encoding members of family of tumor necrosis factor ligands  (*p-value <0.04). 
C Genes encoding pro-apoptotic factor XAF1 and anti-apoptotic factor BCL2 (*p-value 
<0.04). 
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5.4. Discussion 
In this chapter, I presented whole transcriptome analysis in MCF7 cells upon HP1γ depletion. 
Differential expression analysis identified 4673 de-regulated genes with an equal split 
between up- and down-regulation. Subsets of genes linked to phenotypic changes determined 
in Chapter 5 were validated by RT-PCR. 
5.4.1. Interferon response  
To confirm activation of pathways involved in the interferon mediated immune response in 
MCF7 cells, induction of genes encoding IFNβ, IL8, TNFα and IL28A/B was analysed. Gene 
expression was induced 4-6 days after infection with shRNA vectors, which can be correlated 
with a reduction of HP1γ protein levels observed at these time points. I also confirmed 
activation of a subset of JAK-STAT target genes that are downstream of interferon signaling 
pathways. Upon stimulus, STAT transcription factors are phosphorylated and activated by 
receptor-associated JAK232. Activation of the JAK-STAT pathway was confirmed by by 
immunoblotting with antibodies recognising phosphorylated STAT proteins 4 days after 
infection with shRNA vectors. Besides JAK-STAT target genes, induction of genes encoding 
STAT transcription factors was detected. In response to acute viral infection JAK-STAT 
signaling was shown to activate expression of STAT1 and 3 to reinforce the immune 
response236. This positive feedback mechanism could be an explanation for elevated STAT1 
expression and further emphasizes that MCF7 cells fully activated the interferon mediated 
immune response. 
	
Figure 5-9 Protein expression of apoptotic factors in MCF7 cells.                                  
MCF7 cells were infected with shCtrl and shHP1γ_1 and 2 shRNA vectors and processed 4 
days post infection. Immunoblot of MCF7 whole cell lysates, using indicated antibodies. 
Protein lysates representing 40000 cells were loaded per well. 
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HP1γ has been associated with regulating expression of interferon response genes in mouse 
embryonic fibroblasts (MEFs)132,141. HP1γ regulates the transcription rate of immune response 
genes, such as CXCL8, in response to bacterial infection or phorbol ester PMA treatment, by 
directly interacting with RNA Pol IIref.141. Only upon loss of HP1γ do these genes become 
hyper activated in response to stimuli, resulting in a full-blown immune response. 
Interestingly, knockdown of HP1γ alone induced selected immune related genes, however, 
did not lead to full activation of the interferon immune response. Similar results were 
observed in HeLa cells depleted of HP1γ132. My data suggests that in un-stimulated MCF7 
cells, loss of HP1γ is sufficient to induce an immune response normally activated in response 
to viral infection.  
Another recent report demonstrated a role for HP1γ in regulating the tumor immune 
environment161. In CD8 positive T cells HP1γ regulates the expression of effector T cell 
factors such as perforin, granzyme B and the inflammatory cytokine interferon γ, which are 
all necessary to kill target cells161. HP1γ deficient CD8 positive T cells express high levels of 
these factors and therefore harbor increased tumor-killing capacity. In fact tumour burden of 
mice treated with HP1γ deficient CD8 positive T cells was reduced, indicating that targeting 
HP1γ in CD8 positive T cells may be a novel therapeutic approach to control growth of solid 
tumours161. 
Both of these studies clearly link HP1γ to the regulation of immune response genes. The 
question whether HP1γ directly regulates expression of immune response genes in MCF7 
cells will be addressed in Chapter 6, which includes a genomic analysis of HP1γ in MCF7 
cells. 
5.4.2. Activation of apoptosis 
Depletion of HP1γ impairs proliferation and reduces cell viability of MCF7 cells (compare 
Section 4.2.). Besides morphological changes, MCF7 show an increase of apoptotic markers 
such as cleaved PARP1 and elevated levels of DNA fragmentation (Figure 4-10). These 
results indicate that MCF7 cells activate classical apoptotic pathways upon loss of HP1γ. In 
fact, KEGG pathway analysis identified enrichment of up-regulated genes associated with 
pro-apoptotic pathways (Figure 5-4). I validated increased expression of genes encoding 
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members of the pro-apoptotic BH3-only protein family BIK, BID and PUMA at mRNA. In 
each case expression was induced 4-6 days after infection with shRNA vectors, which 
correlates with reduced HP1γ protein levels. Similar results were obtained for the activation 
of the tumour necrosis factor ligand TNFSF10 (TRAIL). Based on this analysis it is difficult 
to conclude which apoptotic pathway is activated. Up-regulation of TRIAL indicates 
activation of the extrinsic, while up-regulation of BH3-only proteins indicates activation of 
the intrinsic apoptotic pathway. Given the plethora of signaling cascades activated in HP1γ 
depleted MCF7 cells, it is likely that both apoptotic pathways are triggered simultaneously.  
Up-regulation of pro-apoptotic genes is in agreement with the phenotypic changes observed in 
MCF7 cells upon HP1γ depletion. Both phenotypic changes and effects on gene expression 
were less robust with shHP1γ_2, which depletes HP1γ less efficiently than shHP1γ_1. 
Differences between the two shRNAs could suggest a dose dependent effect of HP1γ 
depletion. To ultimately confirm that phenotypic changes are HP1γ dependent, it will be 
crucial to perform HP1γ rescue experiments.  In addition to rescuing with wildtype HP1γ 
protein, rescue experiments with HP1γ mutant proteins would provide interesting insights into 
which domain of the protein is required for its function. 
Loss of HP1γ induces apoptosis in non-small cell lung cancer (NSCLC) cell lines237. 
Phenotypic changes in this study were correlated with increased protein levels of growth 
arrest and DNA-damage-inducible protein alpha (GADD45α) and BAX, another member of 
the BH3-only protein family. The same genes were only slightly up-regulated in MCF7 cells 
(log2=0.8 p-value <0.015, log2=0.6 p-value <0.015, respectively), indicating different 
apoptotic pathways are activated in HP1γ depleted MCF7 cells. Besides, a correlation with 
GADD45α and BAX expression data in NSCLC cell lines did not reveal any mechanistic 
insights into how HP1γ depletion induces apoptosis237.  
Given the direct link between the interferon response and activation of apoptosis, it is possible 
that MCF7 cells undergo apoptosis as a consequence of triggering interferon signaling. In 
fact, upon loss of HP1γ, I observed a clear activation of XAF1 and TNFSF10 expression both 
of which are direct targets of IFNβ234,235. In support of this hypothesis is a recent study 
analysing the influence of IFNβ, produced by adipose tissue-derived mesenchymal stem cells 
(ASCs), on MCF7 cell physiology238. It showed that ASCs release IFNβ into the culture 
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medium. Culturing MCF7 cells in this conditioned media resulted in impaired cell 
proliferation and induction of apoptosis238. This study demonstrates that IFNβ stimulation is 
sufficient to trigger the same phenotypic changes I detect in MCF7 cells upon HP1γ 
depletion. In order to understand whether apoptosis is activated via IFNβ signaling, HP1γ 
depleted cells could be treated with neutralizing IFNβ antibodies or JAK (JAK1 or JAK2) 
inhibitors to inhibit JAK-STAT downstream signaling. Alternatively, time course experiments 
with more time points between 2 and 6 days after infection with shRNA vectors could help to 
dissect the order of gene activation events in more detail. 
5.4.3. Proliferation 
Depletion of HP1γ severely impaired proliferation of MCF7 cells, however no significant 
effect on cell cycle progression was detected. Control of proliferation usually occurs during 
G1 phase of the cell cycle. Several different extrinsic and intrinsic cues influence the cell’s 
decision to enter S phase. Progression through G1 phase is controlled by members of the 
retinoblastoma (pRB) proteins, which function to repress E2F-dependent transcription. 
Phosphorylation of pRB proteins causes them to dissociate from E2F at promoters, thereby 
de-repressing E2F transcription factors and allowing them to activate expression of various 
genes whose products stimulate entry into S phase. pRB phosphorylation is regulated by three 
CDKs: cyclin-D-dependent CDK4 and CDK6 and cyclin-E-dependent CDK2239. These 
cyclin-CDK complexes are tightly controlled by CDK inhibitors (CDKIs) such as p21, p27 or 
members of the INK4 family of CDKIs (p15, p16, p18 or p19). Transcriptional regulation of 
G1 cyclin (D and E) genes adds another level of complexity, which is mediated through 
signaling cascades induced by mitogens, cytokines or other signaling molecules239.  
Differential expression analyses did not provide any clear insight into how cell proliferation is 
affected in MCF7 cells. Gene ontology analysis identified down-regulation of genes involved 
in DNA-replication, indicating that DNA duplication in S phase may be affected. In contrast, 
KEGG pathway analysis identified activation of MAPK signaling, which suggests an 
activation of pro-proliferative signaling cascades. Manual inspection of the data identified up-
regulation of genes encoding CDKIs such as CDKN1A (p21; log2=1 p-value<1E-4), 
CDKN1B (p27; log2=0.7 p-value< 0.001) and CDKN2D (p19; log2=1.6 p-value<0.001), all of 
which repress G1 to S phase transition. On the contrary, up-regulation of cyclin D and E 
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genes CCND3 (log2=1.6 p-value <1E-5) and CCNE1 (log2=0.9 p-value<0.001) was 
observed, which should have the opposite effect. Based on this differential expression 
analysis in MCF7 cells, it is unclear how cell proliferation is affected. Deregulation of genes 
could be due to feedback mechanisms and/or directly linked to the strong immune response 
that was detected in MCF7 cells upon HP1γ depletion. Overall, given these results, it seems 
likely that impaired cell proliferation is predominantly due to induction of apoptosis.  
5.4.4. Cell adhesion 
KEGG pathway analysis identified up-regulation of genes associated with cell adhesion 
molecules. Amongst these were genes encoding cell adhesion molecules such as ICAM1 and 
4; CEACAM1, 5 and 6; L1CAM and BCAM. Several genes encoding focal adherens 
components such as integrin subunits (ITGA3, 5, 9 and ITGB1, 6, 8), cadherins (CDH15, 18 
and 5) and selectin (SELE) were also significantly up-regulated. Furthermore up-regulation of 
genes encoding tight junction components such as claudins (CDLN 1, 3, 4, 23, 7 and 9) and 
occludin (OCLN1) were identified. This list of up-regulated genes strongly suggests that cell 
morphology and/or cell mobility of MCF7 cells is affected upon HP1γ depletion. However, 
migration assays with MCF7 cells showed that loss of HP1γ had no effect on their cell 
migration. As MCF7 cells have low intrinsic mobility, an effect on cell migration will be 
difficult to measure. Intriguingly, HP1γ depleted MDA-MB-231 cells, which are of metastatic 
origin, showed a clear effect on cell migration. As most of the above mentioned genes have 
direct links to cancer metastasis, it would be very interesting to determine expression of cell 
adhesion genes, identified in MCF7 cells, in MDA-MB-231 cells. Beyond this candidate 
approach, a comprehensive comparison of whole transcriptome analysis in MDA-MB-231 
and MCF7 cells upon HP1γ depletion will be very important to identify cell type specific 
roles of HP1γ and may elucidate a function for HP1γ in breast cancer invasiveness. RNA-seq 
analysis in MDA-MB-231 cells before and after HP1γ depletion is currently ongoing. 
To summarise this Chapter, whole transcriptome analysis in MCF7 cells upon HP1γ depletion 
identified differentially expressed genes. Gene enrichment analysis identified clear activation 
of IFNβ mediated signaling pathways and activation of apoptosis. Together with a down-
regulation of genes enriched for ribosomal and mitochondrial functions, this analysis indicates 
that upon HP1γ depletion, MCF7 cells are under extreme physiological stress and shut down 
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biological processes that are important for cell homeostasis. Gene expression changes are in 
agreement with phenotypic changes observed in HP1γ depleted MCF7 cells.  
In Chapter 6, I will present the results from HP1γ chromatin immunoprecipitation (ChIP) 
analysis linked to next generation sequencing (ChIP-seq) using samples isolated from MCF7 
cells. ChIP-seq data will be cross-compared with whole transcriptome data discussed in this 
chapter to understand whether gene expression changes are directly mediated by HP1γ.
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  Chapter 6
Genomic analysis of HP1γ in breast cancer cells 
 
6.1.  Introduction  
HP1γ is a versatile transcriptional regulator that can operate either as a repressor or a 
transcriptional activator. In contrast to HP1α and β, HP1γ is predominantly associated with 
euchromatin and it localises to sites of active transcription73,135,143,145. HP1γ regulates 
alternative splicing of specific gene transcripts by directly interacting with components of the 
splicing machinery135,143. Furthermore, it interacts with and mediates RNA Pol II action 
resulting in different transcriptional outcomes. It was proposed that HP1γ enhances RNA Pol 
II’s transcription rate, suggesting it functions as a transcriptional activator143. Other studies, 
however, associate HP1γ with ‘slowing down’ transcription via its interaction with the 
elongating form of RNA Pol II, which either facilitates alternate exon inclusion of nascent 
transcripts145, facilitates transcriptional termination147 or ‘fine tunes’ transcription of inducible 
immune response genes141 (see Section 1.2.8.1.2). The means by which HP1γ regulates RNA 
Pol II activity mechanistically remains, however, an unanswered question. 
In this chapter I explore the function of HP1γ in regulating gene expression in MCF7 cells. 
Whole transcriptome data presented in Chapter 5 will be cross-referenced with the genomic 
localisation of HP1γ as determined here by ChIP-sequencing. 
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6.2. Aims of this chapter 
This chapter has the following aims related to the genomic localisation of HP1γ and its role in 
regulating gene expression. 
1. To determine the genomic locations of HP1γ in MCF7 cells 
2. To determine differentially expressed genes directly bound by HP1γ 
3. To investigate whether HP1γ is involved in regulating ZNF genes 
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6.3. Using ChIP-seq to determine HP1γ bound loci in MCF7 cells  
6.3.1. ChIP protocol for HP1γ 
In Chapter 4, I showed that approximately 33% of HP1γ is located in the nucleo-cytoplasmic 
fraction of MCF7 cells indicating a significant proportion of HP1γ is not tightly associated 
with chromatin (Section 4.3.1). Furthermore, my analysis on the dynamics and subcellular 
localisation of HP1 molecules in mESCs revealed that HP1γ molecules are more dynamic and 
less tightly bound to chromatin than other HP1 isoforms (presented in Section 3.10). 
Therefore, to avoid immunoprecipitation (IP) of freely diffusing HP1γ proteins and to enrich 
for chromatin bound HP1γ, I extracted chromatin before pursuing the standard ChIP protocol. 
I cross-linked adherent cells with 2% (v/v) formaldehyde for 10 min. After neutralisation with 
125mM glycine, cells were lysed in IPH chromatin extraction buffer supplemented with 0.1% 
(w/v) SDS. Chromatin pellets were then separated from the nucleo- and cytoplasmic fraction 
by centrifugation. Chromatin was then resuspended in ChIP lysis buffer and subjected to 
sonication. Sonication conditions were optimized for MCF7 cells. To test sonication 
efficiency, sheared DNA was extracted and resolved in a 1% (w/v) agarose gel. DNA was 
visualised following ethidium bromide staining of the gel. I tested different sonication times 
ranging from 30min to 1.5h (data not shown). The best sonication result was obtained with 
1.5h of total sonication time (at 5sec ON/ 5sec OFF and 100% amplitude; Qsonica™ 
sonicator). A representative image of sonicated DNA using these conditions is depicted in 
Figure 6-1A. Compared to unsonicated, genomic DNA of high molecular weight, the 
sonicated DNA size ranged from 200 to 800bp, indicating a resolution ranging from mono- to 
tetra-nucleosomes. Sheared chromatin was then subjected to immunoprecipitation (IP) using a 
HP1γ specific antibody. The antibody was tested for IP under ChIP buffer conditions. The IP 
efficiency was confirmed by immunoblotting using the same antibody (Figure 6-1B). IP with 
the HP1γ antibody showed an enrichment of HP1γ protein over input. A mouse IgG isotype 
control was used as a negative control. The ChIP protocol using this antibody was then 
followed as described in Section 2.10.1.  
6.3.2. ChIP-seq library preparation 
For the ChIP-sequencing experiment, ChIP was performed in untreated MCF7 cells with 
antibodies against HP1γ, H3K4me3, H3K36me3 and GFP, the latter being an IgG isotype 
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control. Histone modifications H3K4me3 and H3K36me3 were selected in order to identify 
actively transcribed genes. Samples were prepared in technical replicates and 1% of total 
input was used. Library preparation was performed as described in Section 2.10.3. The 
average size of final libraries and their DNA concentrations were determined and a total of 10 
libraries were multiplexed at equal molarities. Libraries were analysed by 50bp, paired-end 
sequencing on an Illumina HiSeq 1500® system.  
 
6.3.3. ChIP-seq analysis  
Read count of uniquely mapped reads per sample are summarised in Table 6-1. Processed 
reads for each replicate were mapped against the human reference genome and peaks were 
called on combined replicates against input samples (compare Section 2.10.3). With further 
filtering, peaks were cleared from those overlapping with an IgG peak and enriched for 
significant peaks (q-value <0.05) only. A total of 7637 peaks before and 7596 after filtering 
were identified for HP1γ. In order to estimate the similarity between replicates, pairwise 
	
Figure 6-1 ChIP protocol adapted to HP1γ. 
2*10^7 MCF7 cells were cross-linked using 1% (v/v) formadehyde (10 min), neutralised with 
125 mM glycine and lysed in IPH buffer (+ 0.1% (w/v) SDS). Chromatin was separated from 
nucleo-cytoplasmic fraction by centrifugation. Chromatin was then resuspended in ChIP lysis 
buffer and sonicated for 1.5 h of total sonication time (at 5 sec ON/ 5 sec OFF and 100% 
amplitude; Qsonica sonicator). 
A Sonicated DNA was phenol-chloroform extracted and resolved on 2%(w/v) agarose gel 
stained with ethidium bromide. DNA ladder is indicated [bp].  
B Immunoblot using HP1γ antibodies of immunoprecipitated material from HP1γ and mouse 
IgG isotype antibody immunoprecipitation (IP) performed under ChIP conditions. 2% of total 
input lysate was analysed alongside IP samples.  
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correlation analysis was performed (Appendix II, Figure 8). Pearson correlation coefficients 
(R) are indicated for each sample group. For HP1γ a correlation of R=0.8 and for both histone 
modifications correlations of R>0.9 were obtained, indicating that replicates showed high 
degrees of similarity.  
To understand HP1γ’s role in direct regulation of gene expression, as a primary approach 
ChIP-seq analysis was focussed on all HP1γ promoter bound genes (n=3859). The analysis of 
genes with HP1γ binding exclusively within gene bodies is currently on going and will not be 
discussed in this chapter. 
Table 6-1 Total read count of ChIP-seq data. Number of uniquely mapped reads per 
replicate are depicted for each sample. 
Antibody Rep 1 Rep 2 
HP1γ 28940004 17711924 
H3K4me3 23395080 14518886 
H3K36me3 21830521 15089423 
IgG 
Input (1%) 
2501319 
22795178 
3580514 
24171690 
 	
6.3.4. Distribution of ChIP-seq peaks 
Distributions of HP1γ, H3K4me3 and H3K36me3 ChIP-seq signal over all genes with a HP1γ 
peak 2kb up- and/or downstream of the TSS (n = 3859) were visualised as metagene coverage 
profile plots and heatmaps (Figure 6-2). Each sample is scaled proportionally to the mapped 
library size and all transcripts overlapping a peak are scaled to a uniform size of 5kb (plus 2kb 
upstream of the TSS and downstream of the TES). Both metagene plot (Figure 6-2A) and 
heatmap (Figure 6-2B) show similar results. As expected, the signal for H3K4me3, a marker 
for active genes, peaks at the TSS. Also H3K36me3, a histone mark found in the gene body of 
actively transcribed genes, shows the expected profile of being absent at the TSS, but 
increasing over the gene body. For HP1γ the signal peaks at the TSS and, at a lower level, 
continues over the gene body. The heatmap clearly illustrates that for a subset of genes HP1γ 
binding is also enriched throughout the gene body (Figure 6-2B).  
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These data clearly show that the majority of genes bound by HP1γ, are also marked by 
H3K4me3 and H3K36me3, indicating HP1γ is predominantly marking actively transcribed 
genes. This observation is in agreement with published data sets for HP1γ using the same 
antibody but in different cell types143. 
	
Figure 6-2 Distribution analysis of ChIP-seq peaks of HP1γ bound genes.    
Metagene coverage analysis of HP1γ, H3K4me3 and H3K36me3 ChIP-seq data restricted to 
genes with a HP1γ peak 2kb up- and/or downstream of the TSS (n=3859). The signal for 
individual samples was scaled proportionally to mapped library size and log10 transformed. 
All transcripts overlapping a peak are scaled to a uniform size of 5kb (plus 2 kb upstream of 
the TSS and downstream of the TES). 
A Metagene coverage plot illustrating the mean distribution of all peaks. 
B Visualisation of all transcripts overlapping a peak as a heatmap. Colour code represents 
normalised ChIP-seq signal.  
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6.3.5. Gene ontology analysis of HP1γ bound genes  
To understand whether HP1γ bound genes are functionally related, gene ontology (GO) 
enrichment analysis was applied using the topGO Bioconductor package. Results are 
summarised in Figure 6-3. For each Molecular Function GO term, the dots indicate its 
enrichment score (x-axis), statistical significance (colour) as well as the absolute number of 
HP1γ bound genes in the category (size). Among the most significant GO terms this analysis 
identified enrichment in ‘DNA binding’ (GO: (GO:0003677, adjusted p-value<10-30), ‘metal 
ion binding’ (GO:0046872, adjusted p-value<10-30) and ‘transcription factor activity’ 
(GO:0003700, adjusted p-value<10-30). Intriguingly, the majority of genes within these 
enrichment classes encode zinc finger (ZNF) proteins. Indeed, a total number of 290 ZNF 
genes were bound by HP1γ. Therefore, I decided to study this subgroup of HP1γ bound genes 
in more detail. 
 
	
Figure 6-3 Gene ontology analysis of HP1γ bound genes.  
The plot reports the top 20 Molecular Function GO terms with the strongest enrichment for 
HP1γ promoter bound genes (n=3859) obtained with the topGO Bioconductor package. Each 
dot represents a different GO term (y-axis) with its enrichment score (x-axis). Size of dots 
indicates the absolute number of gene targets that are annotated within the given class. Colour 
coding represents adjusted p-value: significant (red), less significant (black). 
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6.3.6. HP1γ is enriched at ZNF gene clusters 
Out of 937 ZNF genes annotated in the human genome, I identified 290 (31% of total) bound 
by HP1γ. ZNF genes encode the biggest group of transcription factors with almost half of 
them (>400) encoding Krüppel-associated box (KRAB)-domain containing ZNF proteins. 
Amongst the 290 genes, ZNF genes of different classes such as C2H2- and KRAB ZNF genes 
were identified. Metagene analysis of HP1γ’s distribution over all annotated ZNF genes 
(n=937) showed that besides enrichment at the TSS, HP1γ signal is enriched throughout the 
gene body with a significant increase towards the 3’-exon. (Figure 6-4A). A closer inspection 
of the data visualised in the UCSC genome browser revealed that HP1γ is enriched across 
entire ZNF gene clusters (Figure 6-4B).  
An example of the UCSC tracks over a ZNF gene cluster located on the p-arm of 
chromosome 19 is shown in Figure 6-4B. This figure also reports Encode ChIP-seq data for 
the HP1γ interactor KAP1240, which was also described to bind ZNF genes in a very similar 
fashion241. Whereas HP1γ peaks are broad and extended over the whole locus, KAP1 peaks 
are more defined. Figure 6-4B illustrates that the signal for both factors clearly defines the 
borders of this particular locus. Both KAP1 and HP1γ predominantly bind to 3’-exons of ZNF 
genes, with additional peaks at the TSS241. Figure 6-4C depicts UCSC tracks zoomed in on 
two divergent genes located in a ZNF gene cluster on chromosome 16 (ZSCAN32 and 
ZNF174) demonstrating enrichment of both factors over the 3’-exons. However, only HP1γ 
shows additional enrichment at the TSS spanning the promoter regions of both genes. 
HP1γ ChIP-seq results were validated by RT-PCR using specific primers spanning HP1γ 
bound regions. Validation experiments were performed in wildtype MCF7 cells compared to 
HP1γ CRISPR knockout cells. HP1γ knockout cells were generated by Katharina Lindner - a 
master’s student whom I supervised during my PhD. CRISPR knockout was achieved using 
the lentiviral CRISPR_V2 vector system with two independent guide RNAs targeting exon 2 
or exon 4 of CBX3. Clonal cell lines for each guide RNA were generated from single cells. A 
summary of the cell line derivation is depicted in Appendix II (Figure 9). As a control, a non-
targeting guide RNA was used. Hereafter I refer to control cells as ‘wildtype cells’ (WT). 
Knockout of HP1γ was confirmed by immunoblotting using a HP1γ antibody. 
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Figure 6-5A shows the results from two wildtype clones (WT_1 and 2) and one knockout 
clone for each guide RNA (KO_1 and 2), all of which were used for validation experiments. 
RT-PCR primers were designed against the 3’-exon of ZNF genes. Experiments were 
performed with two biological replicates. RT-PCR results for one representative experiment 
including 9 different ZNF genes are summarised in Figure 6-5. For each gene, the percentage 
binding relative to input is plotted for HP1γ and an IgG control. As a positive control HP1γ 
enrichment at pericentric α-satellite repeats was determined (Figure 6-5B). ZNF genes were 
separated in to 3 different classes: (i.) located within Chr19 ZNF cluster (Figure 6-5C), (ii.) 
Chr16 ZNF cluster (Figure 6-5D) or (iii.) located outside of ZNF gene clusters (Figure 6-5E).  
	
Figure 6-4 HP1γ - enrichment over ZNF gene clusters.  
A Metagene coverage plots of HP1γ reads over all annotated ZNF genes (n = 937). Individual 
samples are scaled proportionally to mapped library size. All transcripts overlapping a peak 
are scaled to a uniform size of 5kb (plus 2kb upstream of the TSS and downstream of the 
TES). Colour scheme: ranging from 100% enrichment (red) to 0% enrichment (blue). 
B UCSC genome browser snapshot of normalised HP1γ, KAP1 (Encode data set), IgG peaks 
over ZNF cluster on p-arm of chromosome 19. ChIP-seq peaks of combined replicates are 
shown. Boundaries of ZNF gene cluster are indicated by black lines. 
C UCSC genome browser snapshot of HP1γ, KAP1 (Encode data set), IgG peaks over 
example genes ZSCAN32 and ZNF174 located on chromosome 16. ChIP-seq peaks of 
combined replicates are shown. 
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Figure 6-5 HP1γ ChIP-seq validation at 3’-exon of ZNF genes in MCF7 cells. 
HP1γ CRISPR knockout MCF7 cells were generated using the lentiviral CRISPR_V2 vector 
system with 2 independent guide RNAs targeting exon 2 (knockout 1 (KO_1)) or exon 4 
(knockout 2 (KO_2)) of CBX3. Cells were used for ChIP experiments using HP1γ and IgG 
antibodies and results were analysed by RT-PCR. RT-PCRs were performed in duplicates; the 
average of Ct values was used for further calculations. ChIP results are plotted as percentage 
of bound HP1γ over input.  
A Whole cell lysates of two wildtype (WT) and two knockout clones analysed by 
immunoblotting using the indicated antibodies. 
B ChIP RT-PCR of alpha-satellite repeat region as a positive control for HP1γ binding. 
C - D ChIP RT-PCR of representative genes located in ZNF gene cluster of Chr19 (C), Chr16 
(D) and outside of ZNF gene clusters (E). 
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The overall ChIP efficiency was relatively low with 1% being the highest enrichment detected 
for HP1γ at α-satellite repeats. However, in wildtype samples I detected 5-10 fold enrichment 
of HP1γ compared to IgG for all genes tested. Importantly, HP1γ signal was notably reduced 
in knockout cells. For most genes, HP1γ signal was at IgG level in knockout cells indicating 
that the enrichment of HP1γ measured in wildtype cells was specific.  
In conclusion, ChIP-seq analysis of HP1γ in MCF7 cells identified HP1γ peaks in 
approximately 30% of all ZNF genes annotated in the human genome. Unbiased metagene 
analysis of HP1γ’s distribution over all ZNF genes (n=937) showed that the signal for HP1γ 
peaks at the TSS and is further distributed over the whole gene body with a significant 
increase towards the 3’-exon. Interestingly, HP1γ seems to cover entire gene clusters of ZNF 
genes. To validate these findings I performed ChIP experiments analysed by RT-PCR in 
MCF7 wildtype cells compared to HP1γ knockout cells. RT-PCR primers were designed to 
span part of the 3’-exon of different ZNF genes. My results confirmed the ChIP-seq analysis 
for ZNF genes located within and outside of gene clusters. The majority of ZNF genes are not 
bound by HP1γ, suggesting a specific role for HP1γ at only a subset of ZNF genes. In order to 
further investigate the function of HP1γ binding to ZNF genes further, I cross-compared my 
RNA-seq data with the HP1γ ChIP-seq data. Results are summarised in the next section.  
6.4. HP1γ regulates ZNF gene expression 
To understand whether HP1γ regulates gene expression of ZNF genes, I cross-compared the 
list of all differentially regulated genes (n=4673, adjusted p-value<0.05) with all genes with a 
HP1γ peak 2kb up- and/or down-stream of the TSS (n=3859) as identified by ChIP-seq 
analysis. The results are visualized as a Venn diagram in Figure 6-6. It shows that only 14% 
of differentially expressed genes (n=665) are also bound by HP1γ, suggesting that the 
majority of genes might not be directly regulated by HP1γ at the expression level. Of those 
genes, 52% were up-regulated and 48% down-regulated upon HP1γ knockdown. Surprisingly, 
these genes were not enriched for those linked to IFNβ signaling and apoptosis pathways (as 
discussed in Chapter 5), indicating that loss of HP1γ most likely indirectly triggered 
activation of these signaling cascades. The only genes identified by this analysis were STAT1 
and STAT2.  
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Figure 6-6 Cross-comparison of HP1γ bound and differentially expressed genes upon 
HP1γ knockdown in MCF7 cells.   
List of differentially expressed genes upon HP1γ knockdown (p-value <0.05) (n=4673) was 
compared to genes identified by HP1γ ChIP-seq (n=3859). Results were visualised as a Venn 
diagram (top panel). GO enrichment analysis of genes contained within the intersection was 
performed (bottom panel) with the topGO Bioconductor package. Each dot represents a 
different GO term (y-axis), and the value (x-axis) indicates the fraction of genes in the given 
term, both differentially expressed and bound by HP1γ. Size of dots indicates the absolute 
number of gene targets that are annotated within the given class.  Colour coding represents 
adjusted p-value: significant (red), less significant (black). 
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The JAK-STAT pathway is activated downstream of the interferon response, therefore it 
seems unlikely that up-regulation of STAT transcription factors is sufficient to activate the 
immune response observed in HP1γ depleted MCF7 cells.  
Gene ontology analysis identified significant enrichment of genes associated with DNA 
binding, transcription factor binding and metal ion binding (Figure 6-6, bottom panel). A list 
of genes identified in the top GO enrichment class ‘DNA binding’ plotted against their log2 
fold change is illustrated (Figure 6-7). 40 out of 108 genes (37%) within this list are ZNF 
genes (highlighted by green box). This analysis highlights that HP1γ may be directly involved 
in regulating gene expression of a subset of ZNF genes. The majority of ZNF genes within 
this list were up-regulated with only 25% identified being down-regulated.  
As an example, Figure 6-8A, shows a UCSC genome browser snapshot of RNA-seq and 
ChIP-seq tracks for the gene ZNF778. It clearly demonstrates mRNA up-regulation of 
ZNF778 upon HP1γ depletion. HP1γ binding at the 3’-exon of this gene was validated using 
HP1γ knockout cells Figure 6-5B. I validated gene expression changes by RT-PCR using an 
additional shRNA (shHP1γ_2) for a subset of genes. Figure 6-8B summarises representative 
results for 5 up-regulated genes. I furthermore validated HP1γ binding to the TSS of ZNFX1 
and ZBTB43 genes by ChIP RT-PCR using HP1γ knockout cells (Figure 6-8D). HP1γ 
knockdown using shHP1γ_1 significantly (p-value <0.001) increased mRNA levels of all 
genes tested. A similar result was obtained for shHP1γ_2. However, the effect was less 
robust, which could be due to incomplete knockdown of HP1γ by this shRNA (compare to 
Figure 4-2). I also measured mRNA levels of the two most down-regulated ZNF genes 
(Figure 6-8C). However, due to the generally low expression levels of these genes, I was 
unable to validate the down-regulation of their mRNA with either of the shRNAs. 
In summary, I showed that 14% of genes deregulated upon HP1γ depletion are actually bound 
by HP1γ. Intriguingly, gene ontology analysis of this gene subset revealed a significant 
enrichment for ZNF genes. Hence, HP1γ might directly regulate ZNF gene expression. To 
further confirm this hypothesis, I validated the expression changes of several ZNF genes by 
RT-PCR using two independent shRNAs. HP1γ binding to a subset of genes was validated 
using HP1γ knockout cells.  
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Figure 6-7 Genes identified in ‘DNA binding’ GO class. Genes plotted against their log2 
fold change in HP1γ knockdown vs. control cells. The colour scale reports the adjusted p-
value of differential expression statistics. Colour coding: red (adjusted p-value <0.01), black 
(adjusted p-value <0.05). ZNF genes are highlighted by green box. 
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Figure 6-8 ZNF genes are deregulated upon HP1γ knockdown.  
A UCSC genome browser tracks of normalised RNA-seq and HP1γ ChIP-seq data for 
ZNF778 gene. 
B/C mRNA level of indicated genes was assessed by RT-PCR after 6 days of knockdown 
using two independent shRNAs. Relative mRNA expression normalised to TUBB is shown. 
Graphs include data from 3 independent experiments. Significance was assessed using one-
way ANOVA tests (*p-value < 0.001). SEM are indicated. B Up-regulated genes. C Down-
regulated genes. 
D HP1γ CRISPR knockout and wildtype MCF7 cells were used for ChIP experiments using 
HP1γ and IgG antibodies and data were analysed by RT-PCR. RT-PCRs were performed in 
duplicate; the average of Ct values was used for calculations. ChIP results are plotted as 
percentage of input.  
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6.5.  Discussion 
HP1 proteins are chromatin proteins functionally linked to various aspects of gene regulation. 
Whereas HP1α and HP1β are mainly involved in chromatin compaction and gene repression, 
HP1γ’s role in gene and chromatin regulation is less well defined. In this chapter I studied the 
role of HP1γ in transcriptional regulation in breast cancer cells. I cross-referenced whole 
transcriptome analysis in HP1γ depleted MCF7 cells with the genomic localisation of HP1γ.  
6.5.1. HP1γ ChIP in MCF7 cells 
Cellular fractionation in MCF7 (Figure 4-2) and MDA-MB-231 cells (Figure 4-12) showed 
that a significant amount of HP1γ was not directly associated with chromatin. Furthermore, 
single molecule localisation microscopy of HP1γ in mESCs indicated that HP1γ molecules 
have higher diffusion coefficients and are less tightly bound to chromatin compared to HP1β 
molecules (Figure 3-19). HP1γ ChIP experiments were performed on isolated chromatin after 
cross-linking to avoid IP of freely diffusing HP1γ molecules. ChIP-seq validation by RT-PCR 
showed that HP1γ enrichment was in general relatively low, indicating that ChIP efficiency 
was not optimal. However, HP1γ signal in ChIP RT-PCRs was significantly reduced in HP1γ 
CRISPR knockout cells, demonstrating specific binding of HP1γ to all analysed loci. ChIP 
efficiency could be further optimised, for example by using different cross-linking reagents. 
All ChIP experiments described in this chapter used formaldehyde, which predominantly 
cross-links protein to DNA. In order to stabilise HP1γ molecules that are not in direct contact 
to chromatin, interacting with chromatin via other proteins, an additional cross-linking step 
using protein-protein cross-linking reagents such as disuccinimidyl glutarate (DSG) or 
dimethyl adipimidate (DMA) could be used242. These cross-linkers have a much higher 
effective cross-linking length than formaldehyde. If a significant proportion of HP1γ 
molecules are located further away from chromatin, changing the cross-linking conditions 
could increase the efficiency of HP1γ ChIP. 
Nevertheless, ChIP-seq analysis of HP1γ in MCF7 cells identified 7596 significant HP1γ 
specific peaks. Further analysis showed that 3859 genes have a HP1γ peak 2kb up- and/or 
downstream of their TSS, indicating HP1γ is significantly enriched at promoters.  
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6.5.2. Regulation of gene expression by HP1γ in MCF7 cells 
6.5.2.1. IFNβ response genes are not bound by HP1γ  
In Section 6.3.5, I cross-compared HP1γ promoter bound genes in MCF7 cells with 
differentially expressed genes upon HP1γ depletion. Intriguingly, only a small subset (14%) 
of total differentially expressed genes was bound by HP1γ, indicating that the majority of 
gene expression changes may not be directly mediated by HP1γ. In Chapter 5, I showed that 
IFNβ signaling and pro-apoptotic pathways were activated in HP1γ depleted cells (Figure 5-6 
and Figure 5-). The majority of genes involved in these pathways were not directly bound by 
HP1γ, suggesting signaling cascades were triggered downstream of HP1γ depletion. This 
analysis identified STAT1 and STAT2 as direct targets of HP1γ. As the JAK-STAT pathway is 
activated downstream of the interferon response, it seems unlikely to be the trigger that 
activates the immune response observed in MCF7 cells. As discussed in Section 5.4.1, 
STAT1/3 can activate their own expression during acute viral infection236. It is therefore 
possible that up-regulation of STAT genes due to loss of HP1γ, reinforces the immune 
reaction and sensitizes MCF7 cells to activation of IFNβ signaling. It remains, however, 
unclear what triggered the immune reaction in the first place. 
Cross-comparison of ChIP-seq and RNA-seq data did not include genes bound by HP1γ 
exclusively within the gene body. As HP1γ was reported to directly regulate genes involved 
in the immune response through either mediating RNA Pol IIref.132,141 or repressing gene 
promoters161, I manually inspected HP1γ ChIP-seq reads in the UCSC browser of genes 
involved in IFNβ immune regulation. However, I detected no significant enrichment of HP1γ 
within gene bodies. A comprehensive comparison of differentially expressed genes with 
genes harbouring a HP1γ peak exclusively in the gene body is currently ongoing. 
ChIP-seq analysis of HP1γ, therefore, revealed no significant evidence that HP1γ directly 
regulates gene expression of genes that could trigger an immune response in MCF7 cells. 
6.5.3. HP1γ marks actively transcribed genes  
The first study to analyse HP1γ genome wide was published by the Ren laboratory in 
2012ref.143. The authors performed ChIP-seq for HP1γ in the colorectal cancer cell line HCT-
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116 and cross-compared it with RNA-seq data upon HP1γ knockdown. The paper describes a 
positive correlation between HP1γ binding and down-regulation of genes. They further 
confirmed that HP1γ interacts with elongating RNA Pol IIref.73. These results led them to 
define HP1γ as a transcriptional activator regulating transcriptional elongation. My ChIP-seq 
analysis in MCF7 cells indicated that HP1γ predominantly marks actively transcribed genes 
(Figure 6-2), which is consistent with these previous studies73,141,143,145. Notwithstanding the 
above, my results in MCF7 cells also show that 52% of genes bound by HP1γ are 
significantly up-regulated upon its depletion, indicating that HP1γ also plays a prominent role 
in transcriptional repression in MCF7 cells.  
6.5.3.1. Understanding HP1γ’s function in euchromatin 
How HP1γ regulates expression of genes located predominantly in euchromatin remains 
poorly understood. Several studies describe recruitment of HP1γ to specific genes resulting in 
local ‘heterochromatin’ formation and gene repression. HP1γ can be part of repressor 
complexes containing histone methyltransferases that are recruited to actively transcribed 
genes in euchromatic regions. Recruitment then results in H3K9me3 deposition and 
ultimately gene repression137,138. However, H3K9me3 is not exclusively found in 
heterochromatin, as H3K9me3 within bodies of active genes is bound by HP1γ73.  
Of course, HP1γ may affect gene expression via post-transcriptional mechanisms. Indeed, the 
protein interacts with nascent transcripts145, so it may play a role in stabilising or destabilising  
transcripts in addition to regulating alternative splicing. Although HP1γ was described as a 
general RNA binding protein243, it may selectively and perhaps only temporarily bind to its 
target gene mRNAs. RNA binding by HP1 proteins is mediated by their hinge region116. An 
interesting experiment would be to test whether mutations within, or complete deletions of the 
hinge region affect binding of HP1γ to its target genes and whether expression of these 
mutants in place of wildtype HP1γ affect transcription in the same way as HP1γ depletion. 
Alternatively, HP1γ ChIP before and after treatment with RNase could be used to test the 
dependence of RNA on HP1γ’s association to chromatin. 
Several studies suggest HP1γ is localised to chromatin via its interaction with RNA Pol II, 
which can result in different transcriptional outputs. On the one hand, HP1γ was proposed to 
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enhance RNA Pol II transcription rate, suggesting HP1γ functions as a transcriptional 
activator143. On the other hand, a role for HP1γ in retarding transcription through slowing 
down the elongating RNA Pol II was described141,145,147. How HP1 regulates RNA Pol II 
activity mechanistically remains an open question in the field. It would be important to follow 
RNA Pol II progression at a given gene, in order to understand if its rate of transcription is 
immediately affected when released from a given promoter. This could for example affect 
loading of the next polymerase. Alternatively, the rate may be affected later during the 
elongation process. RNA Pol II progression can be measured by quantifying the amount of 
nascent transcripts with technologies such as global-run-on (GRO) sequencing244 or native 
elongating transcript (NET) sequencing245. With these techniques it would be interesting to 
follow gene activation of inducible genes in the presence and absence of HP1γ. 
HP1γ has been described quite extensively to relocate to inducible genes upon stimulation by 
cytokines143, bacterial infection141,151 or phorbol ester treatment141,145. I thought it would be 
interesting to study gene induction and RNA Pol II progression upon rapid inducible HP1γ 
degradation. To achieve this, I generated homozygous knock-in HCT-116 cells introducing an 
auxin-inducible degron (AID) tag at the CBX3 locus using the CRISPR Cas9 system (as 
described in246.) HCT116 cells are deficient in NHEJ repair mechanisms and therefore they 
are the preferred cell line for CRISPR knock-in experiments246. In theory, treatment of cells 
stably expressing auxin perceptive F-box protein TIR1 (OsTIR1), which forms a functional 
SCF (Skp1–Cullin–F-box) ubiquitin ligase, should rapidly (within minutes) induce 
degradation of proteins fused to AID following addition of auxin to the culture medium. 
Unfortunately, I detected reduced HP1γ protein levels in several clones only after 24h of 
auxin treatment, which could be due to the high abundance of HP1γ and/or low protein turn-
over (data not shown). 24h is too long to detect immediate effects on transcription initiation 
and/or elongation, as I wished to do. Therefore, I decided not to pursue this investigation of 
HP1γ’s role in regulating RNA Pol II function any further.  
As both enhancing and attenuating RNA Pol II progression were proposed it would be 
interesting to investigate whether other proteins are part of the elongation machinery together 
with HP1γ. A technique to identify protein complexes on chromatin was published 
recently247. Using this technique with different antibodies against phosphorylated RNA Pol II 
to distinguish between initiation (RNA Pol II Ser2 phosphorylation) and elongation (RNA Pol 
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II Ser5 phosphorylation) complexes would be very useful to determine how complexes 
change upon HP1γ depletion. In turn, this could identify novel co-mediators of HP1γ. 
6.5.4. HP1γ - a novel regulator of ZNF genes? 
ChIP-seq analysis of HP1γ in MCF7 cells indicated that HP1γ target genes are highly 
enriched in ZNF genes. Approximately 30% (n = 290) of all ZNF genes annotated within the 
human genome are bound by HP1γ. Metagene coverage analysis of HP1γ signal over all ZNF 
genes (n = 937) showed that HP1γ signal is enriched at the TSS as well as the 3’-exon (Figure 
6-4). HP1γ binding to the 3’-exon of ZNF genes was validated for a subset of genes (Figure 
6-5), as well as binding to the TSS for another subset of genes (Figure 6-8). Cross-comparison 
of HP1γ bound genes with differentially expressed genes upon HP1γ knockdown showed that 
17% (n = 48) of all ZNF genes bound by HP1γ are significantly deregulated, with 
approximately 33% (n =14) down- and 67% (n = 34) up-regulated (Table 6-2). The majority 
of ZNF genes bound by HP1γ (n = 242), does not change expression upon loss of HP1γ. 
Furthermore, this analysis identifies a group of genes, which is differentially expressed, but 
not bound by HP1γ, indicating loss of HP1γ perturbs ZNF gene expression in multiple ways.  
Table 6-2 Summary of ZNF gene regulation by HP1γ. ZNF genes bound by HP1γ (n=290) 
are cross-compared with differentially expressed ZNF genes upon HP1γ knockdown (n=139). 
NC: not changing expression, UP/DOWN: up- and down-regulated (p-value <0.05). 	
 NC UP DOWN 
Bound 242 34 14 
Not bound x 46 45 
HP1γ might not be the only HP1 paralogue present at ZNF gene clusters. A similar 
observation was made for HP1β in the same cell line using the DamID method248. 
Furthermore, HP1γ interactor KAP1 binds to ZNF genes in a very similar fashion to HP1γ241. 
Remarkably however, loss of neither HP1β248 nor KAP1241 affects expression of its ZNF 
target genes, indicating an unique role for HP1γ in regulating ZNF gene expression. 
6.5.4.1. HP1β binding at ZNF genes 
Similarly to the binding profile of HP1γ at ZNF genes, HP1β binding was found strongly 
enriched at the 3’-exon248 with additional peaks at the TSS. Vogel et al. demonstrate that 
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knockdown of HP1β and HP1α (HP1γ knockdown was not performed) had little influence on 
gene expression of ZNF genes in MCF7 cells. Overall they observed that HP1β target genes, 
ZNF and non-ZNF genes showed slightly lower expression levels than non-target genes248. 
My results indicate that in contrast to HP1β, HP1γ might regulate ZNF gene expression. But 
what makes HP1γ exclusive? 
ZNF genes have a particularly interesting chromatin environment; genes are marked both by 
H3K9me3 and H3K36me3, indicating they are located within a state of ‘heterochromatin’ that 
is permissive for transcription241,249. A comparison of HP1γ with H3K36me3 and H3K4me3 
ChIP-seq data for all ZNF genes (n = 937), shows that the majority of ZNF genes, including 
HP1γ target and non-target genes, are transcriptionally active (metagene plots are summarised 
in Appendix III Figure 8). RNA-seq data from the same cell line confirms these results. As 
discussed above, HP1γ is the only HP1 paralogue that directly mediates RNA-Pol II 
elongation rate and might be involved in regulating loading of the next polymerase during 
transcriptional initiation. HP1γ’s direct association with transcriptional regulation could be an 
explanation why only loss of HP1γ, and not of HP1β, affects transcription of ZNF genes. 
ZNF gene clusters are marked by H3K9me3249,250 and this provides a logical explanation for 
HP1 binding at these loci. Knockdown of histone methyltransferases known to deposit 
H3K9me3 at ZNF gene loci, such as SETDB175,251 or Suv39H1248, to reduce H3K9me3 
would be useful in helping to understand how HP1γ binds to these loci. Furthermore, it is well 
documented that HP1 molecules homo- and heterodimerise. To test whether localisation of 
HP1γ depends on HP1β or vice versa, knockdown of either isoform followed by ChIP 
analysis for the other could be performed. Interestingly, the promoter region of ZNF genes 
seems to be depleted of H3K9me3, whereas 3’-exons are highly enriched241, suggesting that 
recruitment of HP1 paralogues to ZNF gene promoters is independent of their chromodomain. 
6.5.4.2. KAP1 binding at ZNF genes   
It is likely that HP1γ is part of large protein complexes regulating gene expression. KAP1 is a 
large scaffold protein known to form large repressor complexes with histone 
methyltransferase SETDB1 or components of nucleosome remodeling and histone 
deacetylation (NuRD) complexes75,252. As KAP1 itself lacks a DNA binding domain it 
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associates with a variety of transcription factors including a large subset of KRAB ZNF 
proteins. This interaction is mediated through its N-terminal RBCC domain111. The 
predominant role of this repressor complex is the suppression of transposable elements112. 
Also, KAP1 predominantly binds 3’-exons of ZNF genes with additional peaks at the TSS241. 
ChIP experiments by Iyengar et al. demonstrated that KAP1 binding to the 3’-exon of ZNF 
genes depends on its interaction with KRAB ZNF proteins, as mutating the RBCC domain 
completely abolished KAP1’s binding to 3’-exons241. Interestingly, mutating the RBCC 
domain did not affect KAP1’s binding to promoter regions of ZNF genes, indicating a 
different mechanism of recruitment. Furthermore, the authors mutated the PxVxL motif of 
KAP1 to abolish its interaction with HP1 and demonstrated that the protein is still able to 
localise to promoter regions, but less efficiently241. These results suggest that KAP1 
recruitment is largely independent of HP1, but HP1 may affect its retention time.  
Whether binding of HP1γ to ZNF genes is dependent on KAP1 remains unclear. To determine 
how HP1γ is recruited to its ZNF target genes, ChIP experiments using different mutants of 
HP1γ that either abolish binding to H3K9me3 (V32M point mutation in chromodomain), 
abolish the interaction with co-factors (PxVxL mutant I166K in chromo-shadow domain) or 
its interaction with RNA (mutation or deletion of hinge region) will be critical to understand 
which domains of HP1γ are important for targeting it to ZNF gene loci.  
6.5.4.3. Is HP1γ suppressing homologous recombination of ZNF genes? 
Expression of the vast majority of HP1γ bound ZNF genes (83%) remained unaffected by 
HP1γ knockdown. ZNF genes have arisen from genomic duplications, hence they are highly 
homologous253. Their 3′-exons encode tandemly arranged highly repetitive ZNF domains and 
it was proposed that heterochromatinisation of these 3’-exons suppresses recombination-
mediated gene deletions241,248.  Intriguingly, both KAP1 and HP1γ, but not HP1α and β, were 
described to suppress homologous recombination in synthetic reporter assays122,123, 
suggesting both proteins could be involved in suppressing recombination of ZNF gene 3’-
exons.  
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In conclusion, I showed that in MCF7 cells, 14% of genes deregulated upon HP1γ depletion 
are actually bound by HP1γ. HP1γ target genes are both down- and up-regulated indicating 
that HP1γ can act as a transcriptional activator and repressor. Differentially expressed genes 
associated with the phenotype of HP1γ depletion in MCF7 cells were not directly bound by 
HP1γ, indicating their gene expression was affected downstream. Intriguingly, differentially 
expressed genes bound by HP1γ are significantly enriched for ZNF genes. HP1γ binding to 
ZNF genes seems to coincide with binding of HP1β and KAP1. Work by other groups, 
however, shows that loss of neither HP1β nor KAP1 affects expression of ZNF genes. My 
results suggest a novel role for HP1γ in regulating ZNF gene expression. To understand the 
means by which HP1γ is involved regulating these genes, it will be critical to determine how 
HP1γ is recruited to these genomic loci. 
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  Chapter 7
Final conclusions 
 
The three mammalian HP1 proteins: HP1α, HP1β and HP1γ are multifunctional proteins and 
their association with chromatin is involved in a myriad of physiological processes. HP1 
paralogues are ubiquitously expressed and due to their high sequence conservation they 
exhibit functional redundancy. Nevertheless, it has become increasingly evident that each 
HP1 paralogue possesses specific functions with respect to chromatin formation and 
transcriptional regulation, which are likely to be cell type specific.  
My PhD work focused on HP1γ, which in contrast to HP1α and HP1β is predominantly 
associated with euchromatic regions and plays a role in transcriptional elongation. I identified 
novel functions of HP1γ in mESCs and breast cancer cells. I characterised a new post-
translational modification of HP1γ called peptidyl-citrullination using in vitro and in vivo 
assays. This work suggests a function for citrullination of HP1γ in stem cell homeostasis. 
Furthermore, I studied the phenotype of HP1γ depletion in two human breast cancer models 
and found that HP1γ is important for cell viability of cancer, but not of normal epithelial cells. 
Whole transcriptome analysis in breast cancer cells depleted of HP1γ, cross-referenced with 
its genomic localisation, identified HP1γ as a novel regulator of zinc finger (ZNF) genes.  
7.1. A role for HP1γ citrullination in pluripotency 
Citrullination describes the conversion of peptidyl-arginine to peptidyl-citrulline resulting in 
loss of a positive charge. In mammalian nuclei, citrullination is catalysed by PADI1, 2 and 4. 
Mass spectrometry analysis in mESCs identified citrullination of HP1γ in the CD at residues 
R38/9. My PhD work shows that HP1γ is citrullinated by PADI4 in vitro and in vivo at 
residues R38/9. The mutant R38/9A, designed to mimic the loss of charge accompanied with 
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citrullination, affects HP1γ’s binding to H3K9me3 peptides in vitro and reduces the residence 
time of HP1γ molecules on chromatin in living differentiated cells, as determined by SPT. 
Pluripotent mESCs require a distinct nuclear architecture, characterised by epigenetic 
signatures enriched with active chromatin marks and hyperdynamic binding of structural 
chromatin proteins. My data show that in these cells the diffusion and residence times of 
HP1γ WT and R38/9A mutant molecules are highly similar, indicating that the time 
molecules spend ‘ON’ and ‘OFF’ chromatin is similar (Figure 7-1). The process of stem cell 
differentiation is accompanied by major chromatin remodeling, which predominantly requires 
formation of facultative heterochromatin to establish cell type specific gene expression. HP1γ 
and other structural chromatin factors such as histone H1 play important roles in this 
process97,168.  
Upon differentiation the percentage of molecules associated with chromatin increases for both 
HP1γ WT and the R38/9A mutant. However, the time that mutant molecules remain stably 
bound to chromatin (‘ON’) is reduced compared to WT proteins, indicating that mutant 
molecules are spending less time ‘ON’ and more time ‘OFF’ chromatin (Figure 7-1). My 
results would suggest that residues R38 and R39 are not necessary for HP1γ’s recruitment to 
chromatin during differentiation, but influence the stable binding of HP1γ molecules once on 
chromatin.  These data are currently being analysed to determine association rates of single 
molecules in different regions of the nucleus. 
Our laboratory described a role for PADI4 in pluripotency and showed that activity of PADI4 
enzymes in differentiated cells is significantly decreased compared to pluripotent stem 
cells190. A subsequent decrease in HP1γ citrullination would fit a model in which stable 
interaction of HP1γ with chromatin is necessary for heterochromatin formation during stem 
cell differentiation. Conversely in pluripotent cells, where a relatively open chromatin 
conformation must be maintained, the regulation of HP1γ by citrullination may be important 
to prevent stable interaction of the protein with chromatin, either to regulate expression of 
specific genes or to prevent chromatin condensation more globally. In the context of recent 
publications describing a role for HP1γ in regulating cell fate decisions and stem cell 
differentiation170-172, the findings of my PhD are compatible with a novel potential function 
for HP1γ citrullination in the maintenance of stem cell homoeostasis. 
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7.2. HP1γ - a novel regulator of zinc finger genes 
The biggest group of ZNF genes encodes KRAB zinc finger transcription factor proteins, 
which are characterised by an N-terminal KRAB domain and a C-terminal region containing 
tandemly arranged arrays of C2H2 zinc finger modules112. Together with their co-factor 
KAP1 they participate in repression of transposable elements (TEs). About 50% of the whole 
human genome comprises TEs and the biggest group of TEs are retroelements112. Although 
less than 1 out of 10000 human TEs are still capable of transposition254, they can cause 
disruption of genes or affect gene expression, as they contain transcription factor binding sites 
such as promoters, enhancers or insulators. Moreover, TEs consist of highly repetitive 
sequences making them potential hot spots of homologous recombination events that could 
cause various genomic aberrations112. Reactivating TEs or altering their chromatin 
environment can have fatal consequences for a cell. Many genetic disorders and different 
types of cancer are associated with novel TE insertions or other types of TE 
deregulation254,255. The correct regulation of TEs is therefore very important.  
My PhD work identifies a novel function for HP1γ in regulating ZNF genes in MCF7 breast 
cancer cells. HP1γ is highly enriched at ZNF gene clusters. A similar observation was made 
for KAP1 and HP1β241,248. Intriguingly, loss of HP1γ but not HP1β or KAP1, affects 
	
Figure 7-1 Model I: Role for HP1γ residues R38/39 during stem cell differentiation.  
Chromatin of pluripotent stem cells has a open and relaxed conformation. In these cells 
dynamics of HP1γ WT and R38/9A mutant molecules are similar. Differentiation is 
accompanied by increased chromatin condensation mediated by structural proteins such as 
HP1 and H1. Although the overall percentage of HP1γ molecules on chromatin is similar, 
residence time (ON) R38/9A mutants is reduced. PADI4 activity is decreased during 
differentiation, while expression and activity (star) are enhanced during reprogramming170. 
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expression of ZNF target genes, indicating a unique role for HP1γ in regulating ZNF gene 
expression. However, the majority of HP1γ bound ZNF genes does not change expression. 
Furthermore, my analysis identifies another group of ZNF genes that is differentially 
expressed, but not bound by HP1γ (compare Table 6-2). These results suggest that loss of 
HP1γ in MCF7 cells perturbs zinc finger gene expression in various ways. There are several 
possible scenarios of how HP1γ could be involved in regulating ZNF genes (Figure 7-2).  
 
	
Figure 7-2 Model II: HP1γ regulates ZNF genes in MCF7 cells. 
Potential roles for HP1γ in regulating zinc finger (ZNF) genes. Option I: HP1γ suppresses 
homologous recombination (HR) and loss of HP1γ results in aberrant recombination of C2H2 
zinc finger modules within 3’-exons of ZNF genes. Option II: HP1γ acts as a transcriptional 
activator of ZNF genes and HP1γ depletion leads to down-regulation of expression and 
consequent de-repression of transposable elements (TEs). Option III: HP1γ acts as a 
transcriptional repressor of ZNF genes and/or TEs. Loss of HP1γ results in enhanced 
expression of ZNF genes and TEs. Possible feedback loops between ZNF gene and TEs 
expression are indicated by black arrows. Reactivation of TEs could be a trigger for activating 
the INFβ/antiviral response and an increase in apoptosis, observed in HP1γ depleted MCF7 
cells. 
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Upon loss of HP1γ, the majority of HP1γ bound ZNF genes (>80%) are not differentially 
expressed. At those genomic loci, the main function of HP1γ may be to suppress homologous 
recombination (HR) (Option I. Figure 7-2). HP1γ is a potent suppressor of HR, while HP1α 
and HP1β are not122,123. C2H2 zinc finger modules of zinc finger proteins are encoded within 
the 3’-exon of ZNF genes. Since ZNF genes derived from gene duplications, these zinc finger 
modules are highly homologous and therefore hot spots of HR112. Zinc finger modules dictate 
the transcription factor’s DNA binding specificity. In order to prevent de novo targeting of 
potent transcription factors and triggering gene expression changes that could be detrimental 
to the cell, HR at 3’-exons of ZNF genes has to be strictly regulated. In order to test my 
hypothesis, I have cultured HP1γ knockout MCF7 cell clones over a long period of time and I 
will sequence their genomic DNA to study aberrant recombination events within the 3’-exons 
of HP1γ target ZNF genes. 
HP1γ can function as a transcriptional activator143. Upon HP1γ depletion, a subset of ZNF 
genes is down-regulated, which suggests a role for HP1γ in positively regulating expression 
of these genes (Option II. Figure 7-2). The main role for KRAB zinc finger transcription 
factors is to repress TEs as part of the KAP1 co-repressor complex112. Hence, a direct 
consequence of down-regulation of KRAB zinc finger proteins may be de-repression of TEs. 
We are currently analysing the RNA-seq data in MCF7s cells to detect differential expression 
of transcripts originating from TEs. As TEs consist of highly repetitive sequences that are 
distributed throughout the human genome, standard mapping algorithms are not suitable to 
detect differential expression of these transcripts. 
The last hypothesis refers to up-regulated ZNF genes, where HP1γ’s role(s) may be more 
complex (Option III. Figure 7-2). Firstly, HP1γ could function as a repressor of ZNF gene 
expression by directly binding to ZNF gene promoters. Loss of HP1γ consequently results in 
up-regulation of the gene. Besides KRAB zinc finger proteins, HP1s are also essential 
components of the KAP1 co-repressor complex and are directly linked to repression of 
TEs240. Therefore, secondly, loss of HP1γ may directly result in de-repression of TEs. 
Transcripts originating from TEs could in turn trigger up-regulation of certain ZNF genes. In 
order to assure TE repression, one could imagine that mammalian cells have developed such 
‘safe-lock’ feedback mechanisms. In support of this hypothesis is the group of differentially 
expressed ZNF genes in HP1γ depleted MCF7 cells, which is not directly bound by HP1γ.  
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Taken together, HP1γ may perturb the regulation of ZNF genes in several different ways and 
none of the aforementioned options are necessarily mutually exclusive. Given the central role 
of KRAB zinc finger transcription factors in suppressing TEs, deregulation of ZNF genes may 
cause or be an indirect result of deregulation of TEs.  
The main phenotype of HP1γ depletion in MCF7 cells is a reduction of cell viability and 
increased apoptosis. Gene expression analysis upon loss of HP1γ identifies a clear activation 
of INFβ response, which in theory should only be activated in response to acute viral 
infection. Conversely, the majority of genes involved in these pathways are not bound by 
HP1γ, indicating pathway activation occurred further downstream. But what triggers the INFβ 
response in MCF7 cells? 
Increased expression of the IFN response/antiviral defense genes in tumor cells can result 
from enhanced transcription of genomic repeats such as retroelements256-259. This fits a model 
in which loss of HP1γ in MCF7 cells either directly or indirectly (via ZNF genes) results in 
de-repression of TEs, resulting in activation of the INFβ response and activation of apoptosis 
(Figure 7-2). In strong support of this hypothesis is a recent study demonstrating that survival 
of drug-tolerant cancer cells requires increased levels of H3K9me3 over LINE-1 (long 
interspersed nuclear element 1) retroelements258. Loss of regulators of H3K9me3-mediated 
heterochromatin formation, including HP1γ, in drug-tolerant cancer cells results in re-
expression of LINE-1 elements, activation of IFN/antiviral defense mechanisms and increased 
cell death258.  
In summary, my PhD thesis identifies a novel role for HP1γ in regulating ZNF genes, which 
may directly or indirectly influence the expression of TEs. Activation of the INFβ response in 
HP1γ depleted breast cancer cells establishes an exciting link between HP1γ mediated 
regulation of the ZNF - TE axis and the viability of breast cancer cells. Overall, my work 
highlights HP1γ as good candidate target for therapeutic intervention in breast cancer. 
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Appendix I 
RNA-seq in MCF7 cells 
Quality control 
The dispersion plot depicted in Figure 1A shows the relationship between the variance in the 
data and the mean. The mean of the normalised read counts across all samples on the x-axis is 
plotted against the dispersion score on the y-axis. Dispersion scores are a measure of the 
square of the coefficient of biological variation. The higher the dispersion, the more varied the 
data are between replicates. Variance here describes a combination of biological noise and 
technical noise. The fitted line indicates the estimated dispersion value based on modelling 
the values across all genes. The black points are the values estimated from the RNA-seq data. 
The final dispersion scores, accounting for the sample-to-sample variation, are illustrated as 
blue circles. To test the similarity between replicates, hierarchical clustering algorithms were 
applied. Results are visualised as a heatmap (Figure 1B). The tree-building algorithm 
calculates the similarity between each sample and all other samples at every iteration step. 
Samples are then connected to the most similar sample at a height that is proportional to the 
similarity. The heatmap illustrates the Pearson correlation coefficient (R) for each pairwise 
comparison.  
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Figure 1 Quality control of MCF7 RNA-seq data. 
A Dispersion plot: Mean of normalised read counts across samples on the x-axis plotted 
against the dispersion score on y-axis. Red: Fitted line indicating estimated dispersion value; 
Black dots: values estimated from the RNA-seq data; Blue circles: final dispersion scores. 
B Hierarchical clustering of technical replicates of sample groups: shCtrl and shHP1γ_1. 
Heatmap illustrates Pearson correlation scores (R) for pairwise comparisons.    
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Figure 2 NOD like receptor signaling (hsa04621). 
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Figure 3 JAK STAT signaling (hsa04630). 
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Figure 4 Toll like receptor signaling (hsa044620). 
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Figure 5 Cytosolic DNA sensing (hsa04623). 
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Determination of differential exon usage using DEXSeq 
 
 
 
	
Figure 6 DEXSeq result for human CD44 and HISTH14H gene in MCF7 cells depleted 
of HP1γ. For a p-value threshold of 0.01 a total number of 882 genes with at least one 
differentially used exon were identified. Exons on the x-axis are plotted against the exon 
usage on the y-axis. An average over all annotated exon variants (in ensemble) is indicted per 
exon. Values are normalised to total expression level of the gene. Differentially used exons 
highlighted in pink. Adjusted p-values and log2 FC (shCtrl vs. sh HP1γ _1) for each exon are 
summarised in table. 
A Result for human CD44 gene. Constant and variable exons are indicated. 
B Result for human HISTH14H gene. 
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Validation of RNA-seq by siRNA mediated knockdown 
 
 
	
Figure 7 Validation of RNA-seq targets by siRNA knockdown of HP1 γ. 
MCF7 cells were transfected with siRNAs (as indicated) and re-transfected after 48h.  
A Immunoblotting of MCF7 lysates after 4 days of siRNA mediated knockdown using 
antibodies as indicated. Lysates from 40000 cells were loaded per well. 
B mRNA levels of indicated genes were assessed 4 days of siRNA mediated knockdown by 
RT-PCR. Graphs show relative mRNA expression after normalisation to TUBB expression. 
SEM of technical replicates are indicated. 
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Appendix II 
ChIP-seq MCF7 
Quality control 
Shown in are distribution plots of the peak coverage for each sample group (HP1γ, H3K4me3 
and H3K36me3). Peaks for each replicate were plotted as histograms and pairwise correlation 
plots of both replicates are shown. Each point represents a single peak from the joint peak 
calling. 
 
	
Figure 8 Pairwise correlation of ChIP-seq replicates. 
Pairwise correlation of filtered peaks of technical replicates for sample groups HP1γ, 
H3K4me3 and H3K36me3. Distribution of peak coverage plotted as histograms. Pairwise 
correlation plots indicated with fitted line (red) indicating correlation. p-value and Pearson 
correlation coefficients (R) are indicated for each pair.   
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Generation of MCF7 HP1γ CRISPR knockout clones
 
	
Figure 9 Generation of MCF7 HP1γ CRISPR knockout clones.  
CRISPR knockout was achieved using the lentiviral CRISPR_V2 vector system with three 
independent guide RNAs targeting CBX3. MCF7 cells were infected with lentiviral vectors 
containing different sgRNA sequences (#79, #81, #83) (see Table 2-11). After selection with 
puromycin for 5 days HP1γ protein levels of bulk cell populations were assessed by 
immunoblotting using indicated antibodies (A). From each bulk cell population single cell 
clones were generated. Number of cell clones generated and their HP1γ status are summarised 
in (B). HP1γ knockout of single cell clones was confirmed by immunoblotting using indicated 
antibodies (C). Control clone #2 (= WT_1) and  #8 (= WT_2); Knockout clone #79_2 (KO_1) 
and 83_5 (= KO_2) were used for ChIP RT-PCR validation experiments (Section 6.3 and 
Section 6.4). Cell lines and figures were generated by Katharina Lindner. 
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HP1γ bound ZNF genes are actively transcribed 
 
 
 
	
Figure 10 Metagene plots of HP1γ, H3K4me3 and H3K36me3 ChIP-seq data over ZNF 
genes. 
Metagene coverage plots of HP1γ, IgG, H3K4me3 and H3K36me3 reads over all annotated 
ZNF genes (n=937). Individual samples are scaled proportionally to mapped library size. All 
transcripts overlapping a peak are scaled to a uniform size of 5kb (plus 2kb upstream of the 
TSS and downstream of the TES). Colour scheme: ranging from 100% enrichment (red) to 
0% enrichment (blue). Genes were clustered into different groups (1-4). Signals for each 
sample were scaled individually (top panel).  
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